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Incorporation of nanoparticles (NPs) into consumer products is on the 
rise and human exposure to NPs is unavoidable. Currently, there is insufficient 
data to assess the safety of nanoparticles. I conducted a series of five studies 
using  the  zebrafish  model  to  determine  which  NP  components  (i.e.,  core 
material  or  surface  functionalization)  contribute  to  biological  responses  and 
how  ionic  strength  influences  these  results.  The  first  study  employed  a 
systematic, rapid embryonic zebrafish assay to identify specific responses to 
precisely engineered lead sulfide (PbS-NPs) and gold nanoparticles (AuNPs) 
functionalized  with  different  surface  ligands.  Lead  sulfide  nanoparticles 
functionalized  with  either  3-mercaptopropanesulfane  (MT)  or  sodium  2,3-
dimercaptopropanesulfonate  (DT)  ligands  with  nearly  identical  core  sizes 
caused differential responses at the same concentration. I determined that the 
different  responses  were  because  MT-functionalized  NPs  released  more 
soluble lead ions than DT-functionalized NPs due to different decomposition 
and  oxidation  rates.  The  second  study  investigated  the  different  biological 
responses  of  three  NPs  identified  during  toxicity  screening  of  a  gold  
 
nanoparticle library. AuNPs functionalized with 2-mercaptoethanesulfonic acid 
(MES),  N,N,N-trimethylammoniumethanethiol  (TMAT),  or  2-(2-(2-
mercaptoethoxy)ethoxy)ethanol  (MEEE),  induced  differential  biological 
responses  in  embryonic  zebrafish  at  the  same  concentration.  Exposure  to 
MES-AuNPs  induced  sublethal  effects,  while  TMAT-AuNPs  were  embryo-
lethal  and  MEEE-AuNPs  were  benign.  Gold  tissue  concentration  was 
confirmed to be similar in exposed embryos using inductively coupled-mass 
spectrometry.  Microarrays  were  used  to  gain  insight  to  the  causes  of  the 
different  responses.  This  approach  identified  that  MES-  and  TMAT-AuNPs 
perturbed inflammatory and immune responses. These differential biological 
responses  may  be  due  to  misregulated  transport  mechanisms  causing 
numerous  downstream  defects  unique  to  each  surface  functional  group‟s 
property.  In  the  next  study,  I  tested  the  long-term  consequences  of 
developmental exposure to TMAT-, MES, and MEEE-AuNPs, and showed that 
MES- and TMAT-AuNPs affected larval behavior that persisted into adulthood. 
During the course of these investigations, I found that high ion concentration in 
exposure solutions results in NP agglomeration, presenting a problem for NP 
testing in the zebrafish model.  For the fourth study, I focused on solving this 
by determining that zebrafish can be raised in nearly ion-free media without 
adverse consequences. When 3-MPA-AuNPs were dispersed in this new low 
ionic media, I observed adverse responses in the embryonic zebrafish toxicity 
assay, but not when the NPs were suspended in high ionic media. Thus, I 
demonstrated that the media greatly influences both agglomeration rates and  
 
biological responses, but most importantly, that the zebrafish is insensitive to 
external ions. The fifth study focused on the adverse response observed when 
embryonic zebrafish were exposed to 3-MPA-AuNPs. Exposed larvae failed to 
respond  to  a  touch  in  the  caudal  fin  at  120  hours  post  fertilization  (hpf). 
Addition of a neuromuscular stimulus, nicotine, revealed the exposed embryos 
were  not  paralyzed,  but  experienced  a  reduction  in  axonal  projections.  A 
global genomic analysis (RNA-seq) using embryos exposed to 3-MPA-AuNP 
and  MEEE-AuNPs  (non-toxic  control)  from  6  to  120  hpf  suggested  that 
neurophysiological  and  signal  transduction  processes  were  perturbed.  
Functional analysis of the data led to the hypothesis that the most elevated 
gene, early growth response 1 (EGR-1), impacts axonogenesis in the caudal 
fin, interfering with glutaminergic synapses and preventing the connection of 
sensory neurons and touch perception. Although MEEE-AuNPs did not cause 
morphological  defects,  the  RNA-seq  analysis  identified  that  these  NPs 
perturbed  immune  and  inflammatory  system  processes.  Collectively,  these 
results suggest that surface functional groups drive the differential responses 
to nanomaterials.  The five studies summarized here confirm that a systems 
toxicological  approach  using  the  zebrafish  model  enables  the  rapid 
identification of structure-activity relationships, which will facilitate the design 
of safer nano-containing products.     
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CHAPTER 1 - INTRODUCTION    
There  are  tens  of  thousands  of  chemicals  and  nanomaterials  (NMs) 
being  manufactured  but,  outside  of  pharmaceuticals,  the  marketing  and 
widespread  use  of  these  chemicals  requires  minimal  assessments  of  their 
potential  hazard  to  human  health.  People  are  knowingly  and  inadvertently 
exposed to these compounds, and potential hazards are often not known until 
adverse health effects occur. To know the hazards associated with exposure 
to a new chemical or a nanomaterial and to prevent costly mistakes requires 
good toxicological data up front.  This is especially important in the case of 
nanomaterials which often consist of a metal core or other elements of the 
periodic table (e.g. carbon, oxides, silica) that can be surface functionalized 
with a vast array of different chemistries. Nanoparticle dispersal in solution, 
core metal ion release and surface functionalization can individually and in 
concert affect the nanomaterial toxicity (Harper et al. 2011, Truong et al. 2011, 
Truong  et  al.  2011,  Truong  et  al.  2012).  Thus,  the  need  for  systematic 
assessments is compounded with the need to understand the mechanisms 
underlying the biological responses to nanomaterials. Without knowing toxicity 
mechanisms,  it  will  be  difficult  to  proactively  avoid  the  generation  of  toxic 
products. 
To  move  the  field  forward,  a  systematic  approach  using  a  relevant 
model  must  be  used  to  facilitate  direct  translation  of  the  results  to  protect 
human health. In this dissertation, I developed and used a high throughput in 2 
 
vivo  screening  assay  to  identify  biologically  active  nanomaterials  and 
conducted transcriptome analysis to begin to identify the early transcriptional 
responses  that  precede  toxicity  (Waters  et  al.  2009,  Truong,  et  al.  2012). 
Collectively, applying this approach to the field of nanotechnology has helped 
the field of nanotoxicology move closer to identifying structure response (SRs) 
relationships  in  order  to  establish  design  principles  for  safer  nanomaterials 
design. 
Nanotechnology 
  Nanotechnology is the development of structure, devices and systems 
that have novel functional properties with size ranging between 1 and 100 nm 
(Jiang et al. 2008). This field is rapidly growing with a range of applications in 
electronics, healthcare, cosmetics, and technologies (Forrest 2001, Lecoanet 
et al. 2004, Lecoanet and Wiesner 2004, Sun et al. 2005). By manipulating 
matter at the atomic level, nanoparticles can be precisely engineered to exhibit 
desired physicochemical properties (Xu et al. 2005). These unique properties 
can  be  exploited  to  improve  targeted  drug  delivery,  diagnostics  systems, 
therapeutics,  and  biocompatibility  leading  to  advances  in  the  biomedical 
sciences (e.g. prosthetics, regenerative medicine, etc) (Caruthers et al. 2007, 
Gaumet et al. 2008, Gil and Parak 2008, Biazar et al. 2009). Physicochemical 
properties unique to nanoparticles are their small size, chemical composition, 
surface structure, solubility, shape and aggregation (Nel et al. 2006). 3 
 
The  attractiveness  of  nanoparticle  chemistry  as  a  revolutionary 
technology platform for consumer and industrial product development resides 
in  the  ability  to  synthesize  particles  with  a  nearly  infinite  array  of  novel 
physicochemical properties. This characteristic is also reason for concern from 
a toxicological prospective.  A large variety of novel chemistries would suggest 
the potential to affect a large number of biological targets. With essentially no 
existing knowledge on how nanomaterials interact with biological systems, the 
comprehensive toxicology that must, sooner or later, accompany the explosion 
of  nanotechnology  is  still  poignantly  lagging.  Simple  facets  alone  of 
nanomaterials suggest the need for comprehensive toxicology. 
The properties of nanostructured materials that make them unique and 
attractive  may  be  the  cause  of  concern  for  unforeseen  health  and 
environmental  hazards.  The  fear  of  harm  is  currently  slowing  down  the 
development  of  nanotechnology,  which  can  be  addressed  with  sound, 
independent, and authoritative information on what the risks are and how to 
avoid them. Currently, there is not a complete understanding of how the size, 
shape,  composition  and  aggregation  of  nanomaterials  influence 
biocompatibility. Without this knowledge, it is unclear whether the exposure of 
humans, animals, insects and plants to nanomaterials could produce harmful 
biological  responses  (Zhang  et  al.  2011,  Yu  et  al.  2012).  For  risk  to  be 
accurately  assessed,  there  is  a  need  for  basic  toxicological  information, 
including  characterizing  how  specific  properties  of  nanoparticles  govern 4 
 
biological responses. Given the variety of new nanoparticles, this task requires 
systematic,  collaborative  scientific  investigations.  Voluntary  testing  adopted 
while the industry is still young might help to avoid introduction of dangerous 
nanoparticles  into  the  marketplace  and  environment  such  as  occurred  with 
chemicals in previous decades (i.e., chloroflurocarobons, commercial use of 
DDT, asbestos, or lead in gasoline and paint products). 
 
Complexity of nanotoxicology  
Dosimetry and agglomeration 
Nanotoxicology is especially complex, precisely because non-traditional 
physicochemical  parameters  must  be  considered  in  dose  estimation.  In 
general, particles and specifically nanoparticles (1- 100 nm), diffuse, settle and 
agglomerate  in  medium  as  a  function  of  density  of  the  medium,  viscosity, 
particle size, shape, charge and density. The dose is a function of the rate of 
transport.  When  considering  the  dose  of  NPs,  the  traditional  toxicological 
method  of  using  equal  mass  concentration  (µg/mL)  is  not  appropriate 
(Teeguarden et al. 2007) because for dissimilar materials, at the same equal 
mass  concentration,  the  corresponding  particle  number  or  surface  area 
concentration doses may differ by orders of magnitude. In addition to using 
inaccurate dosimetry in the field, particle size and density are often overlooked 
(Chithrani et al. 2006, Moss and Wong 2006). When diffusion and gravitational 
rates are considered, significant differences between the exposure dose and 5 
 
“concentration” doses are evident  (Teeguarden, et al. 2007). Without these 
special  considerations  (dosimetry,  agglomeration,  core  decomposition,  ion 
release,  particle  size  and  surface  area),  the  science  is  vulnerable  to 
misinterpretation  of  responses  and  uptake  data for NPs.  To  address  these 
considerations, it will require material; scientists to use precision engineering, 
and thoroughly characterize the batches over time, and then relay this critical 
information to the toxicologist to ensure the appropriate assays are used and 
the results will advance the field of nanotechnology.   
 
Decomposition and ion release 
Breakdown of the nanomaterials and the release of toxic constituents 
are known to occur (Kittler et al. 2010, Domingos et al. 2011, Truong, et al. 
2011). NMs can contain toxic metals and compounds that are readily ionized 
and  released  when  the  nanomaterial  structurally  decays,  or  from  impure 
nanomaterial preparations.  Differentiating  the  toxicity  of  intact  nanoparticles 
from their separate constituents can be difficult and it is nearly impossible to 
determine  what  state  the  nanoparticle  is  in  once  internalized  in  biological 
systems.  
The  decomposition  of  metal  cores  results  in  ion  release.  For  silver 
nanoparticles (AgNPs), the release of silver ions (Ag+) increases the toxicity 
(Powers et al. 2010, Bilberg et al. 2012). Powers et al demonstrated that the 
AgNP effects are distinct from Ag+ alone, and was dependent on other factors 6 
 
such as size and coatings (Powers, et al. 2010). Truong et al identified that the 
differential toxicity observed between two lead based nanoparticles was due to 
the  insufficient  encapsulation  of  the  metal  core  by  the  surface  ligands, 
resulting  in  release  of  lead  ions  over time  (Truong,  et al.  2011).  Cadmium 
sulfide  quantum  dots  (CdS-QDs)  toxicity  is  influenced  by  their  coating, 
however, when not stable, is caused by released metal ions (King-Heiden et 
al. 2009). The inability to distinctly isolate what is an ion release effect vs. a 
nanoparticle,  adds  to  the  complexity  of  nanotoxicology  and  interpreting  the 
results of the field.  
 
Particle size and surface area 
  For instance, smaller particles results in an increase in particle surface 
area. It allows more chemical molecules to attach to this surface, which would 
enhance its reactivity and result in an increase in its toxic effects (Linkov et al. 
2008, Suh et al. 2009). In addition to crossing cell membranes, they reach the 
blood, and various organs because of their size, nanoparticles have a bigger 
surface to volume ratio than larger particles (Ai et al. 2011). This permits just a 
single particle to display and potentially deliver unseen numbers of potential 
ligands to intended as well as unintended targets. The smaller particles can 
cause more pathological and destructive power on the lungs due to their larger 
surface area, and greater tendency to conjugate (Linkov, et al. 2008, Suh, et 
al.  2009).  The  physicochemical  and  structural  property  differences  of 7 
 
nanomaterials  at  the  low  end  of  the  size  range  may  explain  a  number  of 
observed  toxicological  effects  such  as  cytotoxicity  (Pan  et  al.  2007),  and 
inflammatory responses (Waters, et al. 2009, Park et al. 2010). 
 
Toxic effects of nanomaterials 
  The  toxicity  of  nanomaterials  can  be  divided  into  two  categories: 
biological and environmental. 
 
Biological toxicity  
  A common approach to understand nanotoxicology is to study structure 
response  relationships  of  nanomaterials  by  focusing  on  elucidating  the 
relationships between the physical and chemical properties of nanomaterials 
that cause toxic biological responses. Nanoparticles can target the respiratory 
tract via inhalation, but the gastrointestinal tract and other organs and tissues 
are likely affected and must be considered (Oberdörster 2010). NPs could get 
into the gastrointestinal tract indirectly via mucociliary movement, directly by 
oral intake of water, food, cosmetics, drugs and drug delivery systems at the 
nanoscale (Oberdörster et al. 2005).  
  Nanoparticle  interactions  with  biological  systems  can  give  rise  to 
numerous toxic effects such as allergies, fibrosis, organ deposition and failure, 
inflammation,  cytotoxicity,  reactive  oxygen  species  (ROS)  generation,  and 
DNA damage  (Maynard et al. 2006, Nel, et al. 2006, Waters, et al. 2009). 8 
 
Potential mechanistic explanations  for the  adverse  responses  are  oxidative 
stress caused by redox activity and ROS (Meng et al. 2007), the dissolution or 
shedding of toxic ions (Wong et al. 2010, Bilberg, et al. 2012), fibrosis of the 
lungs (Mangum et al. 2006), inflammasome activation by materials with long-
aspect  ratio  (the  length  longer  than  the  width)    (Meng  et  al.  2011),  and 
photoactivation,  which  influences  the  bioactivity  of  the  NP  (Bar-Ilan  et  al. 
2012).  This  short  list  of  potential  mechanisms  is  based  on  a  very  limited 
toxicological scope to date. Much more comprehensive studies are needed to 
begin  addressing  the  incredible  array  of  physicochemical  properties  of 
nanoparticles and correlating them with whole organism and grounding them 
in genomic responses.  
 
Environmental toxicity 
   As the applications of nanotechnology rapidly increase, we will likely 
begin to detect nanoparticle products in the environment virtually anywhere we 
look. Not only is it critical to understand the properties of the nanoparticles in 
its  initial  state,  but  how  these  properties  will  change  when  exposed  to 
environmental conditions. The type of solution and surface functionalization 
greatly  affects  the  charge,  stability,  and  agglomeration  state,  which  in  turn 
impacts transport in various matrices (Darlington et al. 2009). Particle size also 
well  correlated  with  transportability,  along  with  charge  of  the  NPs  in  solid 9 
 
matrix. The three factors that greatly influence the nanoparticle mobility in soil 
is size, charge and agglomeration rate (Darlington, et al. 2009).  
  A  key  part  of  safely  manufacturing,  using  and  disposing  of 
nanomaterials is conducting ecological hazard assessment to understand their 
environmental  impacts.  It  is  critical  to  understand  the  potential  dangers  of 
releasing  nanomaterials  into  the  environment.  This  can  start  with  simply 
characterizing the solubility and degradability of NPs in soils and water and the 
chemical and microbial processes that control transport and removal of NPs in 
water and wastewater.  
 
Nanomaterial exposure 
  In general, we can categorize nanomaterial exposure to three groups: 
1)  occupational  exposure,  2)  consumer  exposure,  and  3)  environmental 
exposure.  With  many  new  nano-containing  products  commercialized, 
concerns  about  human  and  environmental  exposures  are  rising.  Certain 
workplace  conditions  generate  NPs  that  can  reach  higher  exposure 
concentrations  than  typically  found  at  ambient  levels  (Oberdörster,  et  al. 
2005).  Occupational  exposure  of  those  involved  in  the  manufacture  and 
research and development of nanomaterials is not monitored and adequate 
protection is yet undefined. The first carbon nanotube measurements in the 
workplace found very low concentrations; however, it represented a very high 
particle  number  concentration  (Maynard  et  al.  2004).  Inhalation  maybe  the 10 
 
major route of exposure for NPs, but ingestion and dermal exposure needs 
consideration,  especially  for  manufacture,  use  and  disposal  of  engineered 
nanomaterials.  
  Nanomaterial  based  products  include  personal  care  items  such  as 
cosmetics and sunscreens where performance benefits have been realized. 
However, the incorporation of nanoparticles in commercialized products adds 
an  undefined  exposure  with  undefined  hazard  potential  to  uninformed 
consumers. The norm is still for consumers to assume that items one can buy 
at the supermarket must be inherently safe to use. No requirement exists for 
the reporting of NP in consumer product formulations and thus it is already 
difficult at best to assess the quantities and types of NPs to which consumers 
may be exposed.  Recent studies showed that both zinc and titanium oxides 
(ZnO, and TiO2, respectively) occur in major sunscreen brands (Newman et 
al.  2009).  Some  studies  are  contradictory  regarding  NP  safety.  One  study 
demonstrated that ZnO-NPs, and TiO2-NP formulations used in sunscreens 
were  active  photocatalysts  and  generated  free  radicals  under  illumination 
causing  the  sunscreen  formulation  to  degrade  (Picatonotto  et  al.  2001). 
Another  found  that  the  NP  concentrations  used  in  cosmetic  products  were 
non-toxic and conferred skin protection. The weight of toxicological evidence 
would  suggest  that  not  all  TiO2-  and  ZnO-NPs  are  identical,  but  the  UV 
protection and durability afforded by NP based sunscreens outweighs human 
safety concerns about NP exposure from use of these formulations (Schilling 11 
 
et  al.  2010).  To  understand  the  toxicological  impact  TiO2  and  ZnO-NPs, 
structure response relationships must be identified. But many other NP core 
types  and  sophisticated  surface  chemistries  are  already  in  industrial  and 
consumer  use  and,  for  these,  the  hazard  potential  is  completely  unknown.  
The use of nano-containing products will inevitably create an opportunity for a 
wider exposure of the entire ecosystem to nanomaterials through the water 
and  soil.  The  concentrations  of  these  engineered  substances  in  the 
environment are directly proportional to their use in society as evidenced by 
chemical products. 
 
Screening paradigm and test method requirements 
It is now clear that rapid, relevant, and efficient testing methods must be 
developed to assess emerging nanoparticles. The investigation of nanoparticle 
interactions with biological systems should be conducted at multiple levels of 
biological organization (i.e., molecular, cellular, and organismal levels). There 
are many models that could be used to assess nano-biological interactions, 
but due to the rapidly increasing number of manufactured nanoparticles, the 
ideal model must also offer high throughput capabilities. For example, in vitro 
techniques (cell based systems) are preferred for cost- and time- efficiency, 
direct translation to whole organisms or humans is difficult. But challenges to 
in vitro studies include contradictory effects from nano-biological interactions 
depending on the cell type, organ system, or developmental stage of the cells 12 
 
being used (Nakamura and Isobe 2003, Bosi et al. 2004, Sayes et al. 2005, 
Isakovic et al. 2006, Teodoro et al. 2011). In vivo models (typically rodents) 
are more comprehensive, and perhaps predictive, but the animal and labor 
related cost, and the high-test material demands lend rodent-based studies 
incompatible  for  high  throughput  data  collection.  Rapid,  applicable  toxicity 
screens are necessary to assess the backlog of untested nanoparticles and to 
begin defining the basic NP characteristics that drive biological responses.   
 
Application of embryonic zebrafish 
  As  a  widely  accepted  model  for  mechanistic-based  toxicological 
studies, the embryonic zebrafish offers a rapid, high throughput platform to 
assess  the  nanomaterial  and  biological  system  interactions  (Furgeson  and 
Fako 2009, George et al. 2011). The zebrafish and human genomes are highly 
homologous.    Furthermore,  zebrafish  share  many  cellular,  anatomical,  and 
physiological characteristics with all vertebrates, including humans (Barbazuk 
et al. 2000). The embryos are small, develop externally, and are optically clear 
which  allows  for  non-invasive  evaluations.  Additionally,  a  single  female 
zebrafish can produce hundreds of eggs in one spawn (Lessman 2011), which 
allows for statistical power, and rapid assessments. The small nanomaterial 
quantities needed to fully evaluate the toxicity of engineered nanomaterials is 
also a major advantage for high throughput assessments. For example, less 
than one mg is required to fully evaluate the toxicity of a novel nanomaterial, 13 
 
and this includes assessments across a wide range of concentrations in many 
replicate animals. Finally, early developmental life stages are inherently more 
susceptible to stressors as this is the most dynamic period in an organism's 
lifespan.  The  full  repertoire  of  gene  products  is  expressed  during 
embryogenesis  because  these  products  are  required  to  successfully 
accomplish cellular and organ system development  (Richardson and Keuck 
2002). Thus, if there is a unique biological target for a given nanomaterial that 
must be “hit” to produce a toxicological response, the probability of identifying 
this interaction is enhanced during the early developmental stage because all 
targets are expressed. 
  To fully exploit the embryonic zebrafish model for nanoparticle testing, I 
developed a tiered in vivo approach to define structural properties that lead to 
adverse  biological  consequences.  Tier  1:  Rapid  96-well  plate  screening 
experiments  are  conducted  to  assess  the  toxicity  of  a  wide  range  of 
structurally  well-characterized  nanomaterials.  Nanomaterials  found  to  elicit 
significant adverse effects proceed to Tier 2 testing. Tier 2: Potential cellular 
targets and modes of action are defined in vivo using a suite of transgenic 
fluorescent reporter zebrafish lines and indicators of cellular oxidative state. 
Nanomaterials are then grouped according to structural indices and effects. 
Representative nanomaterials from each group are selected for Tier 3 testing. 
Tier  3:  Global  gene  expression  profiles  are  used  to  define  the  genomic 14 
 
responses  to  nanomaterials.  Data  from  these  studies  are  used  to  define 
structure response relationships. 
A key component necessary for defining a structure response relationship is to 
begin  with  well  characterized  nanoparticles.  There  are  currently  many 
methods  to  create  nanoparticles  (Moody  et  al.  2008,  Harper,  et  al.  2011, 
Klemm  et  al.  2011),  but  there  exists  no  standard  guiding  the  collection  or 
characterization data (i.e., purity, concentration, ligand size, core size, particle 
size, etc). Without knowing the basic structural and purity information, it is not 
possible to define the  structure  variable. Therefore,  insufficiently  purified  or 
characterized materials are of no value for structure relationship studies. 
 
Going forward - leveraging good data to design “safer” 
nanoparticles 
Addressing potential risks of nanoparticles should be a priority concern 
not only for regulatory agencies, but also for the researchers and companies 
producing  the  particles.  Collaborations  between  scientific  investigators  and 
manufacturers will preemptively minimize negative consequences and allow 
for  development  of  the  most  environmentally  benign  nanochemistries  and 
manufacturing methods. Greener nanotechnology is a practice pioneered at 
the  University  of  Oregon  to  include  replacing  or  minimizing  usage  of 
hazardous chemicals (Harper et al. 2008). Greener nanoscience also seeks to 
alter  nanoparticles  to  render  them  nontoxic  (e.g.,  via  new  reaction 15 
 
mechanisms,  controlling  physical  properties,  or  surface  functionalization) 
(Harper, et al. 2008).  
The embryonic zebrafish is the ideal vertebrate model for testing the 
exponentially increasing number of nanoparticles in development and already 
in the marketplace. However, the data obtained in this model, or any model 
will be of little value unless a widely available and easily searchable repository 
of experimental data and conclusions is available. Data obtained from other in 
vitro or in vivo models is encouraged as a greater wealth of structure response 
studies,  characterized  in  a  diversity  of  models,  will  only  facilitate  better 
nanoparticle  chemistry.  A  database  of  SRs  that  is  readily  available  to 
manufacturers  would  be  an  invaluable  resource  where  R&D  budget 
constraints may not allow for extensive in-house safety testing of promising 
nanochemistries.  A  comprehensive  knowledge  database  of  SRs  in  high 
throughput models,  including  the  embryonic  zebrafish,  will enable  tuning  of 
nanoparticles  to  maximize  performance  and  safety  before  they  reach 
commercial production. 
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Abstract 
As  the  number  of  nanoparticle-based  products  increase  in  the 
marketplace, there will be increased potential for human exposures to these 
engineered  materials  throughout  the  product  life  cycle.  We  currently  lack 
sufficient  data  to  understand  or  predict  the  inherent  nanomaterial 
characteristics that drive nanomaterial-biological interactions and responses. 
In  this  study,  we  utilized  the  embryonic  zebrafish  (Danio  rerio)  model  to 
investigate  the  importance of  nanoparticle  (NP) surface functionalization,  in 
particular  as  it  pertains  to  nanoparticle  stability,  on  in  vivo  biological 
responses. This is a comparative study where two lead sulfide nanoparticles 
(PbS-NPs)  with  nearly  identical  core  sizes,  but  functionalized  with  either 
sodium  3-mercaptopropanesulfonate  (MT),  or  sodium  2,3-
dimercaptopropanesulfonate  (DT)  ligand  were  used.  Developmental 
exposures  and  assessments  revealed  differential  biological  responses  to 
these  engineered  nanoparticles.  Exposures  beginning  at  6  hours  post 
fertilization  (hpf)  to  MT-functionalized  nanoparticles  (PbS-MT)  led  to  100% 
mortality by 120 hpf while exposure to DT-functionalized nanoparticles (PbS-
DT) produced less than a 5% incident in mortality at the same concentration. 
Exposure  to  the  MT  and  DT  ligands  themselves  did  not  produce  adverse 
developmental effects when not coupled to the NP core. Following exposure, 
we confirmed that the embryos took up both PbS-MT and PbS-DT material 
using  Inductively  Coupled  Plasma  –  Mass  Spectrometry  (ICP-MS).  The 
stability of the nanoparticles in the aqueous solution was also characterized. 23 
 
The nanoparticles decompose and precipitate upon exposure to air. Soluble 
lead  ions  were  observed  following  nanoparticle  precipitation  and  in  greater 
concentration for the PbS-MT sample compared to the PbS-DT sample. These 
studies  demonstrate  that  in  vivo  assessments  can  be  effectively  used  to 
characterize  the  role of  NP  surface functionalization  in  predicting  biological 
responses. 
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Introduction 
Nanoparticles (NPs) are becoming ubiquitous as they are incorporated 
into  an  increasing  number  of  commercial  products.  Exploiting  their  unique 
material  properties,  nanoparticle-based  applications  will  undoubtedly 
revolutionize many features of our lives. Nanotechnology is used in a broad 
spectrum  of  applications,  encompassing  cosmetics,  biomedical  supplies, 
fluorescent bioimaging, and electronics (Minchin and Martin 2010; Usenko et 
al. 2007; Bharali et al. 2009; Newman et al. 2009). 
Despite the rapid growth of the nanotechnology industry, research into 
interactions of nanoparticles with environmental and biological systems has 
not  kept  pace  with  material  development.  Currently,  the  interplay  between 
nanoscale materials and biological systems is poorly understood, and hazards 
have  not  been  fully  evaluated.  Without  toxicological  data  regarding  the 
biocompatibility of nanoparticles, it is impossible to identify risk associated with 
nanoparticle exposure. An efficient testing method, if proven predictive, would 
help fill these critical data gaps. 
Various  biological  models  have  been  proposed  for  toxicological 
assessments including in vitro and in vivo methodologies. In vitro studies, such 
as cell culture, are rapid, efficient, and low-cost. However, results from these 
studies are often difficult to translate to the whole organism. Utilizing in vivo 
models  may  offer  a  more  immediately  relevant  platform  for  translational 
studies (Teraoka et al. 2003; den Hertog 2005; Hall et al. 2007). The widely 25 
 
accepted rodent model is both cost and labor intensive; it requires extensive 
animal care facilities and significant quantities of test materials for the toxicity 
assessments.  A  powerful  alternative  is  the  zebrafish  model  (Parng  2005), 
which  is  now  widely  accepted  for  mechanistic-based  toxicological  studies 
(Haendel et al. 2004; Hill et al. 2005; Ton et al. 2006; Usenko et al. 2007; 
Furgeson et al. 2009).  
Zebrafish have a high degree of homology to the human genome and 
share many cellular, anatomical, and physiological characteristics with other 
vertebrates (Barbazuk et al. 2000). Their small size, rapid development, and 
short  life  cycle  make  zebrafish  an  ideal  rapid  assessment  model,  which  is 
needed  to  provide  solid  and  crucial  toxicological  data  (Dodd  et  al.  2000; 
Rubinstein  2003;  and  Yang  et  al.  2003).  Female  zebrafish  are  capable  of 
producing hundreds of embryos a day, thereby providing statistical power to 
the analysis. Embryos develop externally and are transparent for the first few 
days of their development, allowing for non-invasive assessments (Kimmel et 
al. 1995). The small quantity needed to fully evaluate biological responses to a 
novel  engineered  nanoparticle  (typically,  less  than  1  mg)  is  also  a  major 
advantage  for  “green  by  design”  synthesis  strategies.  With  other  models, 
material requirements are orders of magnitude greater. This combination of 
rapid assessments, unlimited embryos, and minimal material needs, makes 
the  zebrafish  model  ideal  for  investigation  of  nanomaterial-biological 
interactions. 26 
 
Lead  sulfide  nanoparticles  (PbS-NPs)  have  been  increasingly 
developed and studied due to their unique electrical and optical properties. 
Like  other  semiconductor  nanoparticles,  they  exhibit  quantum  confinement 
below  a  certain  size  threshold  –  the  so-called,  quantum  size  effect  –  that 
allows their optical and electrical properties to be precisely tuned with size. 
Lead sulfide, in particular, has shown promise as a material that is optically 
active  in  the  near  infrared  (NIR)  region  of  the  electromagnetic  spectrum. 
Sensitivity  to  this  spectral  window  is  critical  for  a  variety  of  photonic 
applications, including single- and multi-junction solar cells (Koleilat et al. 2008 
and  McDonald  et  al.  2005),  NIR  photodetectors  for  telecommunications 
(Konstantatos et al. 2006), and NIR light-emitting diodes (LEDs) (Konstantatos 
et  al.  2005).  Additionally,  solubilized  PbS-NPs  have  been  studied  as 
fluorescent  biomarkers  that  can  take  advantage  of  the  transparent  tissue 
window at 700-1000nm for in vivo cellular imaging (Hyun et al. 2007, Hinds et 
al. 2007, and Lim et al. 2003). 
Despite increased interest in PbS-NPs as industrial materials, very little 
is  known  about  their  biological  or  environmental  interactions.  Compounds 
containing lead can induce a wide variety of adverse human effects (ATSDR 
2007), such as genotoxicity (Zelikoff 1988), oxidative stress (Sharma 2010), 
and neurological effects (De Gennardo 1978). It is known that lead can affect 
multiple  systems  in  the  body,  most  notably  the  nervous  system. 
Cardiovascular, immune, and reproductive systems as well as bones, teeth, 27 
 
and kidneys are also sensitive targets (White et al 2007). Lead sulfide (PbS) – 
galena – is an extensively mined ore, which is negligibly soluble in aqueous 
systems,  making  bioavailability  in  solutions  limited.  PbS  can  undergo 
decomposition  processes,  and  reduced  particle  size  is  known  to  increase 
decomposition rates (Liu et al. 2009), which influences the amount of ionic 
lead  available.  To  complicate  the  understanding  of  nanoparticle-biological 
interaction, nearly all colloidal nanoparticle preparation has organic stabilizing 
molecules,  ligands,  that  bind  to  the  surface  of  the  core,  passivate  surface 
states, retard particle growth and agglomeration, and imbue the nanoparticles 
with solubility. 
Toxicological studies on other nanoparticle systems have identified key 
structural  features  important  to  understanding  nanomaterial-biological 
interactions  (Kirchner  et  al.  2005;  Kotov  et  al.  2009).  One  such  feature, 
chemical composition of the nanoparticle core, has been identified as a good 
predictor  of  toxicity.  Nanoparticles  composed  of  known  toxic  metals  for 
example cadmium (Samia et al. 2003; Kirchner et al. 2005) and silver (Wise et 
al. 2009)) – are generally more toxic than those composed of inert materials 
such as gold (Furgeson et al. 2009). Core size is also an important feature, 
with  smaller particles  of  the  same  core material,  generally  more  toxic than 
larger ones (Meng et al. 2007; Guo et al. 2008). Smaller particles are thought 
to  interact  more  strongly  with  biological  systems,  either  through  enhanced 
cellular uptake, or through faster decomposition due to greater surface area-28 
 
to-volume ratios compared to larger particles. In addition to the composition of 
the nanoparticle core, ligand shells can affect nanoparticle toxicity (Hoshino et 
al. 2004).  
This wide array of variables can make correlation of structure-activity 
relationships  difficult.  The  aim  of  this  study  was  to  isolate  one  of  these 
variables – ligand head group as a key factor in nanoparticle stability, while 
keeping  all  other  factors  (core  material,  core  size,  and  ligand  tail  group) 
constant.  At  the  same  time,  we  hoped  to  open  investigation  into  the  little 
understood  toxicity  of  the  technologically-relevant  nanomaterial  –  PbS. 
Specifically, in this study, two types of water soluble PbS-NPs were tested in 
the embryonic zebrafish system. Both PbS-NP had similar core size (~3nm), 
and  were  functionalized  with  either  a  sodium  3-mercaptopropanesulfonate 
(MT)  ligand,  or  its  bidentate  analogue  –  sodium  2,3-
dimercaptopropanesulfonate  (DT).  These  two  ligands  are  structurally 
analogous; both ligands have the same carbon backbone and sulfonate tail 
group, and differ only in the head group – mono- vs. di- thiol, respectively. 
Prior  studies  on  these  nanoparticles  revealed  that  the  two  ligands  offered 
differential protection against oxidative decomposition, with MT-functionalized 
particles being less stable to precipitation (Moody et al. 2008). This feature 
made MT- and DT-capped nanoparticles a compelling set in which to study the 
effects  of  particle  stability  on  nanoparticle  toxicity,  while  keeping  other 
structural  features  unchanged.  Utilizing  the  zebrafish  model  to  screen  for 29 
 
developmental toxicity revealed that the different surface functionalizations of 
the nanoparticles produced different biological responses. 
 
Materials and Methods 
 
Nanoparticles 
Materials: Lead (II) oxide (PbO); oleic acid (OLA, 90% technical grade); 1-
octadecene  (ODE,  90%  technical  grade);  bis-(trimethylsilyl)sulfide;  3-
mercaptopropanesulfonic  acid,  sodium  salt  (MT,  90%);  and,  2,3-
dimercaptopropanesulfonic acid, sodium salt, monohydrate (DT, 95%) were all 
purchased  from  Aldrich.  Deuterium  oxide  was  obtained  from  Cambridge 
Isotope Laboratories, Inc. Acetonitrile and toluene were distilled under nitrogen 
from P2O5 and Na/benzophenone, respectively, before use. Nanopure water 
and  other  solvents  were  deoxygenated  either  by  sparging  with  nitrogen  or 
freeze-pump-thaw degassing.  
 
Synthesis of Lead Sulfide Nanoparticles (PbS-NPs): Moody et al (2008) 
have previously reported this procedure. Briefly, PbO was dissolved in OLA 
and heated under vacuum to remove water and form lead oleate. To form 
PbS-NPs, a solution of bis-(trimethylsilyl) sulfide in ODE was quickly injected 
into the stirring mixture of lead oleate at 130ºC under nitrogen. After cooling, 
the  crude  nanoparticle  solution  was  purified  by  a  series  of  precipitation-
centrifugation-resuspension steps, using distilled toluene and methanol as the 30 
 
solvent and non-solvent, respectively. Oleic-acid capped PbS-NPs were then 
exchanged with either MT or DT ligands in a biphasic solution of toluene and 
water.  Biphasic  mixtures  were  manually  shaken  for  one  hour  and  then 
centrifuged. The organic layer, along with any remaining organic-soluble NPs, 
were removed from the aqueous layer and discarded. Thiol-functionalized NPs 
in the aqueous layer were washed with toluene to remove any remaining free 
OLA. To purify the nanoparticles, another series of precipitation-centrifugation-
resuspension steps was performed using nanopure water and acetonitrile, as 
the solvent and non-solvent, respectively. A typical exchange procedure used 
equal volumes of a 25 mg/mL solution of PbS-OLA in toluene and either a 180 
mM solution of MT or 78 mM solution of DT in water. 
At all steps in the synthesis and exchange, standard air-free techniques 
were employed. Samples and reagents were stored under nitrogen in Schlenk 
flasks  or  centrifuge  tubes  with  septa  caps,  and  transferred  via  gas-tight 
syringes.  
 
Physical Characterization of Nanoparticles: 
 Near-Infrared  (NIR)  Absorption  Spectroscopy-  Absorption 
spectra were measured on a Perkin-Elmer Lambda 19 UV/VIS/NIR 
Spectrophotometer.  To  reduce  solvent  absorption  in  the  spectral 
window of interest, deuterium oxide was used in place of water for 
this  measurement.  Nanoparticle  solutions  were  diluted  to  a 31 
 
concentration  regime  (~1  mg/mL)  where  a  linear  dependence  of 
absorbance on concentration was observed.  
 Transmission Electron Microscopy (TEM) – Samples of PbS-MT 
and  PbS-DT  were  prepared  using  amine-functionalized  “Smart 
Grids”  obtained  from  Dune  Sciences,  Inc.  To  prepare,  a  "Smart-
Grid" was floated atop a drop of dilute nanoparticle solution. After 10 
seconds, the grid was dipped in deionized water to remove excess 
sample, then blotted dry from beneath with a Kimwipe. Images were 
taken  using  an  FEI Titan 80-300  S/TEM microscope operating  at 
300  keV  at  56k  magnification  and  a  pixel  resolution  of  2.58 
pixels/nm. 
Size analysis was performed using ImageJ software. Image contrast 
was  enhanced  to  the  minimum  level  necessary  for  automated 
particle  counting,  and  all  images  were  processed  identically.  To 
improve contrast, a Gaussian blur function and bandpass filter were 
applied.  Segmenting  was  achieved  using  the  “MultiThresholder” 
plug-in,  utilizing  the  “Intermodes”  method.  Prior  to  automated 
counting, size and circularity constraints were used to remove large 
agglomerates from the count. The results of the automated particle 
analysis were checked against the original image. Particle diameter 
was taken to be the average of the major and minor axes of the 
ellipse fit. 32 
 
  Lead  Analysis  by  Inductively  Coupled  Plasma  –  Optical 
Emission Spectrometry (ICP-OES) –Three aliquots (50 µL each) 
for  both  fresh  PbS-MT  and  PbS-DT  (nominally,  3  mg/mL)  were 
analyzed. Aliquots were digested with 196 µL of ultra pure nitric acid 
(HNO3)  (VWR:  87003-226)  for  12  hours  prior  to  analysis.  The 
remaining nanoparticle solutions were then left to precipitate (age) 
under  ambient  conditions  for  five  days.  When  precipitated,  the 
nanoparticles  from  both  solutions  collected  as  insoluble 
agglomerates,  leaving  fractions  of  solubilized  lead  in  the  clear 
supernatant. For each aged sample, the supernatant was drawn off 
and  centrifuged  at  13,000  rpm  for  10  minutes  to  remove  any 
remaining nanoparticles. The centrifuged supernatant (50 µL) was 
then  digested  in  the  same  manner  as  for  the  fresh  nanoparticle 
solution aliquots (three replicates). Prior to sampling, each sample 
was diluted to 10 mL with Milli-Q water. Samples were vortexed and 
placed  into  autosampler  racks  prior  to  being  analyzed.  The  ICP-
OES was calibrated using a lead standard in 0.5% HNO3 at seven 
concentrations (0.25, 0.5, 5, 10, 20, 35 and 50 ppm). The calibration 
curve created by the standard solutions had an R
2 value of 0.996. 
Measured  concentrations  of  lead  in  the  undiluted  nanoparticle 
solutions were back-calculated from the lead content determined by 
ICP-OES in the aliquots, and the dilution factor. The percentage of 33 
 
recovered  lead  was  calculated  from  the  ratio  of  the  measured 
concentration  to  the  theoretical  concentration.  The  theoretical 
concentration is based on several assumptions: the nanoparticles 
are spherical, the Pb to S ratio in the core is 1:1, and the surface Pb 
atom to ligand ratio is 1:1. Given these assumptions, the calculated 
theoretical concentrations of lead in the fresh solutions were 2189 
ppm for PbS-MT and 2129  ppm for PbS-DT. 
  Dynamic Light Scattering (DLS) – Equal concentrations (40 ppm) 
of  PbS-MT  and  PbS-DT  were  prepared  by  diluting  aqueous 
nanoparticle stock solutions (20 mg/mL in deionized water) with fish 
water (FW). Immediately after dilution, solutions underwent a single 
pass through a 0.2µm filter to remove dust that could influence the 
scattering  experiments.  Hydrodynamic  radii  were  taken  as  the 
average of three samples, and measured using a Brookhaven 90 
Plus Particle Size Analyzer. 
Zebrafish 
Exposure Protocol: Embryonic zebrafish were obtained from a Tropical 5D 
strain  of  zebrafish  (Danio  rerio)  reared  in  the  Sinnhuber  Aquatic  Research 
Laboratory (SARL) at Oregon State University. Adults were kept at standard 
laboratory conditions of 28°C on a 14h light/10h dark photoperiod in fish water 
(FW) consisting of reverse osmosis water supplemented with a commercially 
available salt (Instant Ocean®) to create a salinity of 600 microsiemen and 34 
 
sodium bicarbonate was added as needed to adjust the pH to 7.4. Zebrafish 
were group spawned and embryos were collected and staged as described by 
Kimmel  et  al  (1995).  To  increase  bioavailability,  the  chorion,  an  acellular 
envelope surrounding the embryo, was removed enzymatically with pronase at 
4 hours post fertilization (hpf). Briefly, embryos were placed in 25 mL of FW 
with 50 μL of 50 mg/mL pronase (Fluka #81748) for 4-5 minutes; the water 
was  decanted  and  replenished  with  fresh  FW  for  a  total  of  10  minutes. 
Embryos were allowed to rest for at least 30 minutes prior to the initiation of 
nanoparticle  exposure.  After  the  rest  period,  dechorionated  embryos  were 
transferred  to  individual  wells  of  a  96-well  plate  with  100  μL  of  prepared 
nanoparticle solution. Control animals were exposed to FW only. Non-exposed 
animals (embryos raised in FW with the chorion intact) were also retained to 
monitor inherent embryo quality. Embryos were exposed to a FW control and 
six concentrations of nanoparticles (n=24, three replicates), with the highest 
concentration being 320 µg/mL (ppm) and the remainder from sequential two-
fold  dilutions  down  to  10  ppm.  The  static  nanoparticle  exposure  continued 
under  standard  laboratory  conditions  in  sealed  plates  until  120  hours  post 
fertilization  (hpf).  Each  individual  embryo  was  scored  for  mortality  and 
morphological  malformations  at  120  hpf.  Only  surviving  embryos  were 
accounted  for  when  assessing  for  malformation.  Fifteen  morphological 
malformations were evaluated: yolk sac edema, bent body axis, eye, snout, 
jaw,  otolith  pericardial  edema,  brain,  somite,  caudal  fin,  pectoral  fin, 35 
 
circulation,  pigmentation,  trunk  length,  and  swim  bladder.  Representative 
images were captured of malformed embryos using an Infinity 3 CCD camera. 
The percent mortality and total malformations were calculated and graphed as 
a mean of three replicates with standard error bars. 
 
Determination of Nanoparticle Uptake by ICP-MS: Embryos were exposed 
beginning at six hpf to PbS nanoparticle solutions of 10, 20, 40, 80, 160, and 
320 µg/mL, and the embryos were sampled at 12 hpf to quantify their overall 
lead  tissue  concentrations.  For  each  exposure  group,  three  embryos  were 
removed with plastic pipette tips and washed with 40 µL of Milli-Q water three 
times  in  a  35mm  plastic  petri  dish.  The  pooled  embryos  were  placed  into 
individual 14mL round bottom plastic tubes and stored at -20ºC until time to 
sample. Twelve hours prior to sampling, the embryos were digested using 98 
µL nitric acid; 1 ppb of internal standard (Indium, Rhenium and Bismuth) was 
added; and, the samples were brought to a total volume of 5mL with Milli-Q 
water. Samples were vortexed for 10 seconds prior to being placed into the 
autosampler racks. The ICP-MS was calibrated using a lead standard in 0.5% 
HNO3  at  five  concentrations  (0.01,  0.1,  1,  5,  10  ppb)  with  1  ppb  internal 
standards. The calibration curve created by the standard solutions had an R
2 
value of 0.992. The mass of lead contained in each embryo was calculated 
from the measured lead concentration of the aliquots and the dilution factor. 
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Statistics: All analyses were compiled using SigmaStat/Plot 11 (SPSS Inc, 
Chicago, IL). Dose response significance was determined using one-way 
ANOVA (p<0.05) and Dunnetts post hoc tests. All exposure groups consisted 
of 24 individually exposed embryos (N=24), three replicates unless otherwise 
noted with 80% confidence of significant difference.  
 
Results 
 
PbS  Nanoparticles  Synthesized  through  Ligand  Exchange  from  a 
Common Core 
Sodium  3-mercaptopropanesulfonate  (MT),  or  sodium  2,3-
dimercaptopropanesulfonate  (DT)  capped  lead  sulfide  nanoparticles  were 
synthesized (Figure 1a) and purified in an identical manner, using a biphasic 
exchange from oleic acid-capped lead sulfide nanoparticles (see Materials and 
Methods). Furthermore, each toxicological trial was performed using PbS-MT 
and PbS-DT nanoparticles prepared from the same parent batch of oleic-acid-
capped  nanoparticles.  This  was  done  to  minimize  the  possibility  that 
differences in biological response arose from different synthesis preparations. 
In addition, post-synthesis characterization of the nanoparticle cores was also 
conducted. Transmission electron microscopy (TEM) was used to image and 
calculate  average  nanoparticle  sizes.  Size  analysis  performed  on  TEM 
micrographs of representative samples of PbS-MT (Figures 1c) and PbS-DT 
(Figure  1d)  revealed  similar  average  particle  diameters  (3.0  and  3.5  nm, 37 
 
respectively).  Corresponding  near-infrared  (NIR)  absorption  spectroscopy 
experiments  (Figure  1b)  showed  close  spectral  overlap  between  the  two 
materials, with exciton peaks observed at 1188 (PbS-MT) and 1202 nm (PbS-
DT).  Both  TEM  and  NIR  absorption  measurements  were  done  on  freshly-
made particles and indicate initial properties. Precipitation of the nanoparticles 
over  the  course  of  the  zebrafish  exposures  made  post-exposure 
characterization infeasible. 
 
PbS-MT,  PbS-DT  and  Lead  Nitrate  Elicit  Differential  Biological 
Responses 
Embryos  were  exposed  to  suspensions  of  lead  sulfide  nanoparticles 
capped with either the monothiol sodium 3-mercaptopropanesulfonate (PbS-
MT) or the dithiol sodium 2,3- dimercaptopropanesulfonate (PbS-DT) over a 
two-fold  concentration  (10  -  320  µg/mL)  range  to  determine  if  the 
nanoparticles  elicited  embryo  mortality  or  induced  developmental 
malformations. Exposure to PbS-MT induced mortality in 100% of the animals 
at 160 µg/mL (Figure 2a). At concentrations as low as 20 µg/mL, PbS-MT 
induced 20% mortality in the embryos, the remaining 80% survivors had an 
average  of  five  malformations  (Figure  2b).  The  multiple  malformations 
observed upon PbS-MT exposure are visually represented in Figure 3b and 
include  bent  body  axis,  jaw,  brain,  and  snout.  At  40  and  80  µg/mL,  the 
incidence of mortality was statistically significant (p<0.001) and increased to 
75%  and  92%,  respectively.  All  surviving  embryos  exposed  to  PbS-MT 38 
 
displayed multiple malformations, with an average of 4.5 at 40 µg/mL (Figure 
2b, 3b). Embryos exposed to PbS-DT nanoparticles, however, did not display 
statistically significant mortality at the same concentrations tested for PbS-MT 
(Figure  2a,b;  3c).  PbS-DT  exposed  embryos  had  a  consistent  number  of 
malformations  (between  1.5  -  2.3)  at  concentrations  between  10  and  320 
µg/mL, which is similar to that observed at higher concentrations (>80 µg/mL) 
for  the  ionic  lead  control  sample,  lead  nitrate  (Pb(NO3)2).  The  lead  nitrate 
control was intended to model the extreme situation where the NPs entirely 
decomposed into water soluble lead salts, which is admittedly unlikely given 
the insolubility of PbS (Ksp of 2.5 x 10
-27). Lead nitrate is soluble in pure water, 
but  the  presence  of  carbonate  and  other  anions  in  the  FW  used  for  the 
experiments leads to some precipitation. Further, the addition of Pb(NO3)2 also 
results in acidification of the FW to as low as 5.2 at the highest concentrations. 
It is noted that PbS-MT and Pb-DT are soluble in FW at the concentrations 
used  in  this  study,  and  their  addition  does  not  affect  the  pH.  The  various 
equilibria  involving  lead  ion  in  FW means  that  the  listed  concentrations for 
Pb(NO3)2 do not necessarily represent the concentration of freely soluble lead. 
Nevertheless, Pb(NO3)2 remains a good control because the same equilibria 
affecting  its  bioavailability  also  operate on  any  ionic lead  leached from  the 
nanoparticles.  The  onset  of  mortality  in  Pb(NO3)2  exposures  occurred  at  a 
greater  concentration  than  that  observed  for  PbS-MT  exposures.  Embryos 
exposed to 10 – 40 µg/mL of lead nitrate had 0.25 or fewer malformations, but 39 
 
the average number of malformations rose to 2.3 at 160 µg/mL. Lead nitrate 
induced  a  statistically  significant  increase  in  bent  body  axis  in  the  embryo 
(Figure 3d) at 160 µg/mL. Near 320 µg/mL, 100% mortality was observed for 
both Pb(NO3)2 and PbS-MT. At this concentration, no significant mortality was 
observed for PbS-DT exposures.  
 
Monothiol and Dithiol Ligands Did Not Induce Biological Responses 
To  determine  if  the  ligands  themselves  were  responsible  for  the 
adverse biological response, embryonic zebrafish were exposed to MT and DT 
ligands  independent  of  the  nanoparticles.  Both  ligands  were  tested  at  the 
same  concentrations  used  for  the  nanoparticle  exposures.  These 
concentrations  were  greater  than  the  ligand  concentrations  in  the 
corresponding  nanoparticle  solutions,  since  the  ligands  make  up  only  a 
fraction of the nanoparticle-ligand complex. As seen in Figures 2c, and d, 
there  was  no  statistically  significant  increase  in  malformation  or  mortality 
observed in embryos exposed to the ligands. 
  
PbS-MT Nanoparticles Decomposed More Readily Than PbS-DT 
PbS-MT  and  PbS-DT  nanoparticles  are  known  to  precipitate  from 
aqueous solution upon exposure to air, however, the effects of salinity from 
exposure  to  FW  were  hitherto unexplored. To  test  the  relative  stabilities of 
PbS-MT  and  PbS-DT  nanoparticles  in  FW,  dynamic  light  scattering  (DLS) 40 
 
measurements  were  performed.  Although  zebrafish  exposures  were  made 
using  unfiltered  nanoparticle  solutions,  DLS  measurements  required  pre-
filtering  to  remove  dust  that  could  affect  the  scattering  experiments. 
Hydrodynamic  radii  were  measured  at  times  0,  24,  48,  and  120hr.  Both 
samples showed evidence of agglomeration with hydrodynamic radii greater 
than the average nanoparticle diameter. However, PbS-MT exhibited greater 
particle size and destabilized more quickly than the PbS-DT samples. PbS-DT 
samples maintained a consistent particle size of ~80 nm at 0, 24, and 48hr, 
but had completely precipitated by 120hr. Conversely, PbS-MT samples had 
average hydrodynamic radii of 140 nm at 0 hr and 340 nm at 24hr, and had 
completely precipitated by 48hr. 
It was hypothesized that degradation of the nanoparticle cores could 
follow  precipitation  and  give  rise  to  ionic  lead  decomposition  products.  To 
quantify the concentration of ionic lead after five-day exposure to air (aged), 
nanoparticle solutions were monitored using an Inductively Coupled Plasma – 
Optical  Emission  Spectrometer  (ICP-OES).  Aged  solutions  were  first 
centrifuged to remove insoluble species (i.e. precipitated nanoparticles), and 
the  resulting  supernatant  digested  with  nitric  acid.  The  lead  content  in  the 
supernatants  of  the  aged  nanoparticle  solutions  was  87  +/-  0.4  ppm  (4% 
recovery rate) for PbS-MT, and 1.075 +/- 0.002 ppm (0.02% recovery rate) for 
PbS-DT, a statistically significant difference. It is important to note that the 87 
ppm lead content measured for the aged PbS-MT sample is not due to the 41 
 
original  nanoparticles;  fresh  solutions  of  PbS-MT  nanoparticles  at  this 
concentration are clearly colored due to absorption from the nanoparticle core, 
whereas the supernatant was colorless. Precaution was taken to ensure that 
differences  in  lead  concentration  seen  in  the  supernatants  of  the  aged 
solutions  was  not  simply  due  to  different  starting  concentrations  of 
nanoparticles  in  the  fresh  solutions.  As  a  control,  aliquots  of  the  fresh 
nanoparticle solutions were digested with nitric acid, and the total lead content 
measured  in  an  analogous  manner  using  ICP-OES.  Analysis  of  the  fresh 
nanoparticle solutions revealed a  similar amount of lead present for the two 
materials (Figure 4). PbS-MT had 1927 +/- 7 ppm of lead while PbS-DT had 
2270 +/- 10 ppm (Figure 4a), corresponding to approximately 90% and 110% 
recovered lead for PbS-MT and PbS-DT, respectively (Figure 4b).  This study 
demonstrates that the nanoparticles were decomposing over time, releasing 
ionic lead into solution. 
 
Lead Quantified in PbS-MT, PbS-DT and Lead Nitrate Exposed Embryos 
Inductively Coupled Plasmas – Mass Spectrometry (ICP-MS) was used 
to quantify the amount of lead in or tightly associated to the embryo. These 
measurements were done to determine if the differential biological response to 
the PbS could be explained by differences in particle uptake. Embryos were 
exposed  to  concentrations  (0  -  320  µg/mL)  of  either  PbS-MT,  PbS-DT,  or 
Pb(NO3)2 and samples were collected at 12 hpf. At this developmental time 42 
 
point,  there  was  no  strict  dose-dependent  increase  in  lead  uptake  at  low 
concentration; however, there was a significant increase in lead concentration 
following 160 µg/mL lead exposure for PbS-MT. A dose-dependent increase in 
the tissue concentration of lead was observed in the PbS-DT and Pb(NO3)2 
exposed embryos (Figure 5). PbS-DT exposed embryos had the highest lead 
level for all concentrations up until 160 µg/mL, where PbS-MT embryos had 
significantly more lead tissue burden.  
 
Discussion 
In  this  in  vivo  study,  we  find  that  the  biological  response  following 
exposure  to  lead  sulfide  nanoparticles  (PbS-NPs)  is  influenced  greatly  by 
surface functionalization. Two major effects can be gleaned from the exposure 
trials.  First,  DT-functionalized  PbS  nanoparticles  (PbS-DT)  elicit  fewer 
responses than MT-functionalized PbS nanoparticles (PbS-MT). Exposure to 
PbS-MT induces 100% mortality at 160 µg/mL in zebrafish embryos at 120 hpf 
and also a variety of sublethal malformations. Conversely, embryos exposed 
to PbS-DT elicit little to no mortality and fewer sublethal adverse responses. 
Second,  PbS-MT  exposure  causes  significantly  more,  and  PbS-DT 
significantly less, mortality than the ionic lead source, lead nitrate (Pb(NO3)2). 
PbS-MT  and  Pb(NO3)2  exposed  embryos  were  morphologically  similar  at 
concentrations near the onset of mortality. The simplest explanation for these 
results  is  a  correlation  between  toxicity  and  nanoparticle  stability. 43 
 
Destabilization of the nanoparticles occurs over the course of the exposure. 
The two ligands offer differential resistance to this destabilization, leading to 
differential biological responses in the embryos. 
Nanoparticle  stability  can  greatly  influence  exposure  of  the  core 
surface.  Thiolate  ligands  at  the  metal  chalcogenide  nanoparticle-ligand 
interface  are  susceptible  to  oxidative  decomposition  (Aldana  et  al.  2001, 
Moody et al. 2008). This instability can lead to ligand desorption, resulting in 
particle  agglomeration,  greater  exposure  of  the  nanoparticle  core,  and 
decomposition of the core with the possible generation of soluble ionic lead 
species. 
To our knowledge, no prior toxicity studies have been conducted on 
PbS-NPs;  however,  lessons  can  be  learned  from  studies  on other material 
sets.  In  general,  nanoparticles  have  been  observed  to  cause  cytotoxicity 
(Lewinski  et  al.  2008),  oxidative  stress  (Long  et  al.  2006),  and  immune 
responses  (Dobrovolskaia  and  McNeil  2007),  either  through  biochemical 
interactions  with  the  nanoparticles  themselves  or  from  their  toxic 
decomposition  products. The  ligand  shell  can  influence  toxicity  by  affecting 
nanoparticle  uptake  and  distribution  in  biological  systems  (Goldsmith  and 
Leary 2009) or as an integral part of the entire nanoparticle-ligand assembly. 
The  accessibility  of  the  nanoparticle  core  has  also  been  implicated  as  a 
potentially  important  factor.  Nanoparticles  that  have  a  denser  coverage  of 
surface ligands, or are encapsulated by an inert material (Zhang et al. 2006), 44 
 
are generally less toxic than those particles that offer greater access to the 
core.   
  Prior comparisons between PbS-MT and PbS-DT nanoparticles have 
shown  that  both  materials  are  susceptible  to  oxidative  decomposition  in 
aqueous solution (Moody et al. 2008). Specifically, the thiol head groups of 
both MT and DT ligands oxidize to form disulfides, which bind poorly to the 
nanoparticle  surface.  The  MT  ligands  oxidize  relatively  quickly,  resulting  in 
rapid  ligand  desorption  and  nanoparticle  precipitation.  Oxidation  of  the  DT 
ligands  proceeds  more  slowly,  and  in  a  manner,  which  leaves  the  ligands 
partially attached to the nanoparticle surface. Although these studies were not 
conducted in fish water, they suggest that differential decomposition could play 
a role in the observed biological effects. 
  In  this  study,  differential  stability  resulting  from  different  surface 
functionalization  is  implicated  as  the  major  contributor  to  the  differential 
biological  response  to  the  nanoparticles.  DLS  measurements performed on 
nanoparticles  in  fish  water  showed  that  although  solution  salinity  affects 
agglomeration,  PbS-DT  nanoparticles  are  more  stable  than  PbS-MT 
nanoparticles, just as in prior studies using nanoparticle solutions in deionized 
water.  Core  size  was  not  a  significant  variable  in  the  differential  response. 
Direct  comparisons  of  PbS-MT  and  PbS-DT  nanoparticles  were  conducted 
using  nanoparticles  prepared  from  the  same  OLA-capped  precursor,  and 
exhibited similar core-related properties. Effects from the ligands themselves 45 
 
were also ruled out as significant factors, as they induce no to low incidence of 
mortality and morbidity. It is certainly possible that the differential response of 
the  nanoparticles  is  due  to  differences  in  the  biological  interactions  of  the 
entire intact nanoparticle structure. We look to oxidative stability as the likely 
differentiator,  however,  because  it  is  the  most  notable  difference  in  the 
physicochemical  properties  of  the  nanoparticles.  The  differential  oxidative 
stability is due to the ligand head group (monothiol vs. dithiol).   
  The mechanism for how the different decomposition rates of PbS-MT 
and PbS-DT result in differential nanoparticle-biological interactions remains 
unclear.  Two  likely  causes  for  the  toxicity  are  interactions  with  either  1) 
presumably ionic lead decomposition products or 2) the exposed nanoparticle 
cores.  The  primary  reason  the  interaction  cannot  be  distinguished  is  the 
challenge of quantifying dose. Two studies shed light on the dose of either 
nanoparticles or its decomposition products received by the embryos. The first 
is  the  ICP-OES  measurements  performed  on  aged  nanoparticle  solutions. 
Soluble lead products are observed during the oxidative decomposition and 
precipitation of the nanoparticles, with a much greater concentration of ionic 
lead observed for PbS-MT relative to PbS-DT. Analysis of the fresh PbS-MT 
and  PbS-DT  solutions  began  with  similar  concentrations  of  nanoparticles. 
However, analysis of the aged solutions show that the  two ligands are not 
equal in their protection of the nanoparticle surface; as they decompose and 
precipitate, MT-capped nanoparticles leach ~ 80 times more ionic lead into 46 
 
solution than DT-capped nanoparticles. As the PbS-NP solutions age, ligands 
are  oxidized  and  desorb  from  the  nanoparticle  surface,  resulting  in 
nanoparticle precipitation. During this process, lead can leach from exposed 
sites  on  the  nanoparticle  cores.  The  concentration  of  soluble  lead 
decomposition products observed in the aging studies was below the onset of 
toxicity at 160g/mL for Pb(NO3)2, even given the much higher concentration 
(3000  g/mL)  of  nanoparticles  used  for  the  ICP-OES  studies  than  for  the 
toxicity studies. What is important, however, is not simply the concentration of 
soluble lead in the fish water but the actual dose received by the embryos. 
This dose is dependent on the distribution of nanoparticles, which suggests 
that the PbS-NPs are associating with the embryos in the exposure media and 
resulting in localized soluble lead decomposition products. 
  Tissue uptake studies were performed in an attempt to better define the 
dose. In these studies, exposed embryos were washed and then analyzed for 
lead  content  using  ICP-MS.  One  limitation  of  this  technique  is  that  no 
distinction can be made between lead tightly bound to, or within the embryo. 
Visual inspections of the embryos after exposure revealed signs of adsorbed 
nanoparticles.  It  is  hypothesized  that  at  higher  concentrations,  nanoparticle 
solutions are more susceptible to agglomeration, and that these agglomerates 
may  adhere  preferentially  to  the  embryos.  This  effect  would  substantially 
increase  the  local  concentration  of  lead  around  the  embryos,  leading  to 
increased  uptake  relative  to  a  uniform  solution  distribution.  Note  that  the 47 
 
uptake studies were performed at early exposure times. At these early times, 
only the PbS-MT induced substantial mortality at 320 g/mL. Near the onset of 
this  mortality  (160  g/mL),  the  PbS-MT  nanoparticles  exhibited  a  sharp 
increase in uptake to levels higher than those observed for either the PbS-DT 
or Pb(NO3)2 exposures.  
The  uptake  and  decomposition  studies  do  not  definitively  distinguish 
between direct nanoparticle toxicity and nanoparticle decomposition product 
toxicity. The differential toxicity of the PbS-MT vs. PbS-DT nanoparticles can 
be explained by greater exposure of the nanoparticle core in the former during 
decomposition. This mechanism  also  provides  a  simple  explanation for the 
greater toxicity of the PbS-MT nanoparticles relative to Pb(NO3)2. Alternatively, 
nanoparticle decomposition products could be responsible for the increased 
toxicity of PbS-MT relative to PbS-DT consistent with the greater amount of 
lead observed to leach from aged solutions of the PbS-MT. The enhanced 
toxicity of PbS-MT relative to Pb(NO3)2 is explained by the agglomeration of 
nanoparticles  on  or  in  the  embryos,  which  acts  to  increase  the  local  lead 
concentration.  Such a  local increase  is consistent  with  the  substantial lead 
uptake observed near the onset of toxicity (160 g/mL) in the 12 hpf uptake 
studies. 
  Further studies will be needed to differentiate between the biological 
interactions with either the nanoparticle cores and/or soluble decomposition 
products.  Regardless,  these  studies  illustrate  the  substantial  changes  in 48 
 
nanoparticle toxicity that can be induced by a relative minor change in ligand 
composition.  With  the  knowledge  that  manipulating  physicochemical 
properties  of  nanoparticles  results  in  differential  biological  responses,  a 
systematic  methodical  use  of  the  rapidly  developing  embryonic  zebrafish 
model will aid in elucidating the key design principles to develop minimal to 
non-toxic nanoparticles.  
Additionally, these studies using the PbS-NPs highlight the important 
role nanoparticle decomposition plays in toxicity. The possibility of ionic lead 
leaching from the nanoparticles also suggests that more studies should be 
conducted  to  understand  the  poorly-known  mechanisms  of  lead  toxicity. 
Physicochemical characterization of NPs in their synthesis media is important, 
but as demonstrated in these studies, it is critical to conduct characterization 
of the NPs in exposure media in parallel to toxicity assessments to gain a 
better  understanding  of  aggregation  state  and  other  physicochemical 
properties.  As  the  field  of  nanotechnology  expands  and  matures,  greater 
understanding of the nanomaterial-biological interface will be imperative. 
 
Conclusions 
The  data  presented  demonstrates  the  usefulness  of  the  embryonic 
zebrafish model as a platform to rapidly assess the nanomaterial-biological 
interaction of nanoparticles. With this set of nanoparticles, different biological 
responses  between  PbS-MT  and  PbS-DT  nanoparticles  was  attributed  to 49 
 
differences  in  their  rates  of  decomposition.  This  study  illustrates  the 
importance of using well-characterized nanoparticles both from the start, as 
well  as  over  time.  It  also  opens  discussion  on  the  hitherto  unexplored 
biological  interactions  of  lead  sulfide  nanoparticles.  Use  of  the  embryonic 
zebrafish  to  conduct  nanomaterial-biological  interaction  assessments  will 
increase the speed at which key physicochemical properties will be identified 
and used to implement a design rule to produce safer nanomaterials. 
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Figure 2- 1. Physical properties of PbS-MT and PbS-DT nanoparticles. 
(a) Schematic of two ligands used in the study – sodium 3-mercaptopropane 
sulfonate (MT) and sodium 2,3-dimercaptopropane sulfonate (DT). (b) Near-
infrared  absorption  spectra  of  solutions  of  PbS-MT(solid)  and  PbS-DT 
(dashed) nanoparticles.  Peak  position  is indicative  of average  particle  size. 
Plots were scaled to better illustrate spectral overlap. (c and d) TEM images of 
PbS-MT  and  PbS-DT,  respectively,  with  corresponding  particle  size 
histograms. Scale bars represent 50 nm. Values in histograms show average 
nanoparticle diameter, with standard deviation in parentheses. 
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Figure 2- 2. Mortality and malformation curves for embryos exposed to 
PbS-MT, PbS-DT, Pb(NO3)2, and MT and DT ligands. 
Embryos were exposed to PbS-MT, PbS-DT or Pb(NO3)2 at 6 hpf and were 
evaluated  for  malformations  and  mortality  at  120  hpf.  Mortality  (a)  was 
statistically significant for PbS-MT (40 - 320 μg/mL) and Pb(NO3)2 (only at 320 
μg/mL).  All  surviving  embryos  exposed  to  PbS-MT  had  malformations 
(average of 5 at 20 μg/mL) (b). Pb(NO3)2 exposed embryos had little to no 
malformations  (<0.25)  up  until  40  μg/mL,  where  a  steady  increase  of 
malformations was observed at 80 and 160 μg/mL. PbS-DT exposed embryos 
caused  a  consistent  number  of  malformations  (~2)  at  all  concentrations.  A 
summary  of  the  statistically  significant  malformations  observed  in  PbS-MT, 
PbS-DT and Pb(NO3)2 exposed embryos is visualized in a table (e), where 
shaded boxes indicate statistical significance (Fishers Exact, p<0.05). MT and 
DT  ligands  did  not  induce  mortality  (c)  or  malformations  (d)  in  exposed 
embryos.  Data  presented  with  **  designate  statistically  significant  values 
(Fishers Exact, **p<0.001). Three replicates, n=24. 56 
 
 
Figure 2- 3. Representative images of exposed zebrafish embryos.  
Embryonic zebrafish exposed to PbS-MT nanoparticles (b) and Pb(NO3)2 (d) 
induced a statistically significant increase in bent body axis (1), jaw (2) and 
snout  (3)  malformation  compared  to  control  (a).  PbS-DT  (c)  elicited  a 
statistically significant increase in bent body axis, and jaw malformation, but 
not snout abnormalities. All images were taken at 120 hpf, and except for the 
control embryo, represent exposures at a concentration of 40 µg/mL.   57 
 
 
 
Figure 2- 4. Concentration of lead (Pb) in fresh and aged PbS-MT and 
PbS-DT solutions. 
Nanoparticle solutions that were initially opened (fresh) and left to oxidize for 5 
days  (aged)  were  digested  with  nitric  acid,  and  Pb  concentration  was 
measured 18 hours later (a) with ICP - Optical Emission Spectrometer (OES). 
Expected  Pb  percent  recovery  concentrations  were  calculated  for  both 
nanoparticles  for  fresh  and  aged  solutions  (b).  Data  presented  with  ** 
designate statistically significant values (Student t-Test, **p<0.001). 
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Figure 2- 5. Tissue concentration of lead in embryos exposed to PbS-MT, 
PbS-DT and Pb(NO3)2.  
Embryos  were  exposed  to  10  -  320  μg/mL  solutions  of  PbS-MT,  DT,  and 
Pb(NO3)2 at 6 hpf and sampled at 12 hpf. Embryos exposed to PbS-MT at 320 
μg/mL did not survive to the time of sampling. Both Pb(NO3)2 and PbS-DT 
tissue concentration followed a dose dependent manner, except PbS-DT only 
followed this trend until 80 μg/mL. Data presented with * designate statistically 
significant values (Kruskal-Wallis ANOVA - Tukey Test, p<0.05). 
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Abstract 
Incorporation of gold nanoparticles (AuNPs) into consumer products is 
increasing; however, there is a gap in available toxicological data to determine 
the  safety  of  AuNPs.  In  this  study,  we  utilized  the  embryonic  zebrafish  to 
investigate  how  surface  functionalization  and  charge  influences  molecular 
responses. Precisely engineered gold nanoparticles with 1.5 nm cores were 
synthesized and functionalized with three ligands: 2-mercaptoethanesulfonic 
acid  (MES),  N,N,N-trimethylammoniumethanethiol  (TMAT),  or    2-(2-(2-
mercaptoethoxy)ethoxy)ethanol  (MEEE).  Developmental  assessments 
revealed differential biological responses when embryos were exposed to the 
functionalized AuNPs, at the same concentration. Using Inductively Coupled 
Plasma  –  Mass  Spectrometry  (ICP-MS),  AuNP  uptake  was  confirmed  in 
exposed embryos. Following exposure to MES- and TMAT- AuNPs from 6-24 
or 6-48 hours post fertilization, pathways involved in inflammation and immune 
response  were  perturbed.  Additionally,  transport  mechanisms  were 
misregulated after exposure to TMAT and MES-AuNPs, demonstrating surface 
functionalization influences many molecular pathways.   61 
 
Introduction 
Despite  the  rapid  growth  of  the  nanotechnology  industry,  research 
assessing the interaction of nanoparticles and biological systems has not kept 
pace.  At  present,  the  mechanisms  of  how  nanoparticles  induce  biological 
responses  are  poorly  understood.  It  will  be  impossible  to  identify  risk 
associated  with  nanoparticle  exposure  without  evaluating  nanoparticle 
interaction  with  biological  systems.  The  use  of  an  efficient  and  relevant 
toxicological model with a systematic approach to assess the nanoparticles 
can help fill these knowledge gaps.  
Gold  nanoparticles  (AuNPs)  have  shown  great  potential  to 
revolutionalize therapeutics as delivery  vectors (Kim et al. 2009, Kim et al. 
2009) and as ultra sensitive probes for detecting proteins (Nam et al. 2003). A 
suite of gold nanoparticles (AuNPs) that are well-characterized and precisely 
engineered  is  ideal  to  systematically  isolate  the  effects  of  individual 
physicochemical  features,  or  a  combination  of  multiple  properties,  on 
biological  responses.  AuNPs  can  be  synthesized  with  precise  control  over 
size,  shape,  purity,  surface  charge  and  functionalization,  enabling  the 
independent evaluation of each aspect (Shipway et al. 2000, Kim et al. 2005, 
Dahl  et  al.  2007).  They  are  characterized  using  transmission  electron 
microscopy (TEM) to determine shape and size; ultraviolet-visible absorption 
spectroscopy  (UV-Vis)  to  assess  core  size  and  agglomeration  state  and 
nuclear  magnetic  resonance  (1H  NMR)  to  confirm  that  the  ligands  are 
attached  to  the  gold  core  and  the  samples  are  free  of  or  other  molecular 62 
 
impurities. In addition, AuNPs dose can be quantified within complex biological 
systems by using either Instrumental Neutron Activation Analysis (INAA) or 
Inductively Coupled Plasma – Mass Spectrometry (ICP-MS). It is, therefore, 
critical  to  understand  all  aspects  of  how  AuNPs  interact  with  biological 
systems.  
There  have  been  many  proposed  biological  models  to  screen  for 
nanomaterial bioactivity, such as cell culture and rodent models. Cell culture-
based approaches are rapid, cost effective, and amendable to high-throughput 
analysis, but lack the complexity of whole animal systems, making it difficult to 
extrapolate to human safety (Teraoka et al. 2003, den Hertog 2005). Rodent 
models are the gold standard for safety prediction (Paigen 2003), but are labor 
and cost intensive, and require hundreds of milligrams or larger quantities of 
test material, which is impractical for evaluating numerous types of precisely 
engineered  nanoparticles.  A  useful  toxicological  model  must  enable  rapid 
assessment of the backlog of untested nanoparticles and facilitate definition of 
the basic nanoparticle characteristics that drive the biological response. 
An  emerging  model  to  investigate  how  nanoparticle  physicochemical 
properties influence biological responses is the embryonic zebrafish (Usenko 
et al. 2007, Truong et al. 2010, Harper et al. 2011, Truong et al. 2011, Truong 
et  al.  In  Press).  Zebrafish  have  a  high  degree  of  homology  to  the  human 
genome (~80%) (Barbazuk et al. 2000) and share many cellular, anatomical 
and  physiological  characteristics  with  other  vertebrates.  The  embryos  are 63 
 
optically clear, small in size, and have a short life cycle (Dodd et al. 2000, 
Rubinstein 2003, Yang et al. 2009). Embryos develop externally (Kimmel et al. 
1995),  thereby  allowing  for  non-invasive  assessments  of  the  embryo  over 
time. One of the clear advantages of using the embryonic zebrafish to assess 
nanomaterial-biological  interactions  is  that  much  less  material  is  required 
compared to rodent-based studies. 
The  aim  of  this  study  was  to  isolate  one  feature  –  surface 
functionalization - while keeping all the other factors (core size, composition, 
and shape) constant. We hoped to gain insight into understanding the toxicity 
of these medically relevant nanoparticles. In a previous study, three types of 
water soluble AuNPs were evaluated in the embryonic zebrafish (Harper, et al. 
2011). The AuNPs had similar core size (~1.5 nm) and were functionalized 
with different ligands either N,N,N-trimethylammoniumethanethiol (TMAT), 2-
mercaptoethanesulfonic acid (MES) or 2-(2-(2-mercaptoethoxy)ethoxy)ethanol 
(MEEE). Differential biological responses were observed for each nanoparticle 
type.  TMAT-AuNPs  were  lethal to  embryos,  MES-AuNPs  induced  sublethal 
malformations,  and  MEEE-AuNPs  did  not  induce  any  in  vivo  biological 
response.  The  focus  of  this  study  was  to  evaluate  how  these  nanoparticle 
physicochemical  properties  induce  differential  biological  response  at  a 
molecular  level  by  evaluating  tissue  concentration  and  gene  expression 
profiling. 64 
 
Materials and Methods 
 
Materials: Hydrogen tetrachloroaurate (HAuCl4• H2O) was purchased from 
Strem (Newburyport, MA) and was used as received. Dichloromethane was 
distilled  over  phosphorous  pentoxide  prior  to  use.  Chloroform  was  filtered 
through a plug of basic alumina prior to use to remove acid impurities. 2-[2-(2-
mercaptoethoxy)ethoxy]ethanol (Woehrle et al. 2004) and thiocholine (N,N,N-
trimethylaminoethanethiol  iodide)  (Warner  and  Hutchison  2003)  were 
synthesized  according  to  known  procedures.  All  other  compounds  were 
purchased  from  Sigma-Aldrich  Chemical  Co.  (St.  Louis,  MO)  and  used  as 
received. 
 
Procedure  for  preparation  of  MES-,  TMAT-  and  MEEE-AuNPs:  Water 
soluble 1.5 nm particles were synthesized using known procedures (Woehrle 
et al. 2005).  
 
Physicochemical  characterization  of  nanoparticles:  Proton  Nuclear 
Magnetic Resonance (NMR) spectra were collected at 25°C on a Varian Unity 
Inova  300  MHz  spectrometer  in  D2O.  UV-visible  (UV-Vis)  spectra  were 
obtained on a Hewlett-Packard 8453 diode array instrument with using 1-cm 
quartz  cuvettes.  Transmission  electron  microscopy  (TEM)  images  were 
collected  at  300kV  with  an  FEI  Titan  using  a  Cs  aberration  corrector. 
Nanoparticle samples were prepared on amine functionalized SMART grids by 65 
 
soaking  each  in  a  dilute  nanoparticle  solution  (0.2  mg/mL)  and  then  in 
nanopure water for 2 minutes each. The grid was air dried. Zeta potentials 
were measured on samples diluted in reverse osmosis (RO) water (~ 2.5 – 9 
ppm)  using  the  ZetaPALs  system  (Brookhaven  Instruments,  Redditch, 
Worcestershire,  UK).  Each  sample  was  diluted,  vortexed  and  read  on  the 
machine within 5 minutes. The zeta potential for 1.5 nm MES-, TMAT- and 
MEEE-AuNPs in fish water were -13.3, 8.71, 2.91, respectively.  
 
Zebrafish  maintenance  and  exposure  protocols:  Tropical  5D  zebrafish 
(Danio  rerio)  were  reared  in  the  Sinnhuber  Aquatic  Research  Laboratory 
(SARL)  at  Oregon  State  University  (OSU).  Adults  were  kept  at  standard 
laboratory conditions of 28°C on  a 14 h light/10 h dark photoperiod in fish 
water  (FW)  consisting  of  reverse  osmosis  water  supplemented  with  a 
commercially  available  salt  solution  (0.6%  Instant  Ocean®).  Embryos  were 
collected and staged (Kimmel, et al. 1995) from group-spawned zebrafish. The 
chorion was enzymatically removed with pronase to increase bioavailability at 
4 hours post fertilization (hpf) using protocols previously published (Truong, et 
al. 2011). Dechorionated embryos were left to rest for at least 30 minutes prior 
to  the  initiation  of  nanoparticle  exposure.  Embryos  were  transferred  to 
individual wells of a 96-well plate with 100 μl of prepared nanoparticle solution. 
A subset of embryos with intact chorions was kept to monitor inherent clutch 66 
 
quality. Exposure plates were sealed to prevent evaporation and wrapped with 
aluminum foil to guard against potential photo-oxidation of the nanoparticles. 
 
Nanoparticle Exposure: Embryos were exposed to seven concentrations and 
an  embryo  media  (EM)  control  (n=12,  three  replicates)  with  the  highest 
concentration at 250 µg/mL (ppm), and five-fold dilutions down to 0.016 ppm. 
The  static  nanoparticle  exposure  continued  under  standard  laboratory 
conditions  in  covered,  sealed  plates  until  120  hpf.  At  120  hpf,  individual 
embryos  were  scored  for  mortality,  then  euthanized  prior  to  evaluation  of 
morphological malformations. For malformation statistics, only embryos that 
survived  were  considered.  Fifteen  morphological  malformations  were 
evaluated. The percent mortality and total malformations were calculated and 
graphed as a mean of three replicates. Embryo media consisted of 15 mM 
NaCl, 0.5 mM KCl, 1 mM MgSO4, 0.15 mM KH2PO4, 0.05 mM Na2HPO4, 
and 0.7 mM NaHCO3 (Westerfield 2000). 
 
Nanoparticle Uptake by ICP-MS: Six hpf embryos were statically exposed to 
embryo media, 2, 10, 50, 250 ppm of each AuNP solution and sampled at 24 
and  48  hpf  to  quantify  overall  gold  tissue  concentration.  Briefly,  for  each 
exposure  group,  three  embryos  were  washed  thoroughly  with  milli-Q  water 
and then placed individually into 14 mL round bottom plastic tubes and stored 
at -20ºC until time to sample. Twelve hours prior to sampling, the embryos 67 
 
were  digested  using  nitric  acid,  a  final  concentration  of  1  ppb  of  internal 
standards (Indium, Rhenium and Bismuth) were added, and the samples were 
brought to a total volume of 5 mL with milli-Q water. Samples were vortexed, 
then placed into the autosampler racks. A five-point calibration curve (0.01, 
0.1, 1, 5, 10 ppb) was created using a purchased gold standard and had a R2 
value of 0.996. The number of gold particles per embryo was back-calculated 
using the assumption that a 1.5 nm AuNP core consists of 101 gold atoms. 
 
NimbleGen Zebrafish Expression Array: Zebrafish expression arrays were 
printed by  Roche  NimbleGen  (Madison, WI),  based  on  Ensembl Zv7  build. 
MES- and TMAT-AuNPs gene expression was completed on the 385K format 
that had 37,157 genes, with 12 probes per target (60mer). 
 
Gene  Expression  Exposure  and  RNA  Collection:  Six  hpf  dechorinated 
embryos were exposed to 1.5 nm MES- and TMAT-AuNPs at 50 and 10 ppm, 
respectively,  and  to  vehicle  control  (fish  water)  as  described  in  the  above 
exposure  protocol.  Embryos  were  pooled  into  three  replicates  of  forty 
embryos,  euthanized  using  MS-222,  and  washed  with  milli-Q  water.  Once 
thoroughly  washed,  embryos  were  transferred  to  sterile  1.7  mL 
microcentrifuge tubes where excess water was removed from samples and 
400  µL  of TriReagent  (Sigma  Aldrich  St.  Louis,  MO)  was  added  to  extract 
RNA. Samples were homogenized using a plastic pestle and battery operated 68 
 
mortar.  After  homogenization,  600  µL  of  TriReagent  was  added  and  the 
samples  were  stored  at  -80ºC  until  processing.  Twenty  four  and  48  hpf 
samples were collected for 1.5 nm MES- and TMAT-AuNPs. Once all samples 
were collected, homogenates were thawed on ice and centrifuged at 12,000 g 
at  4ºC.  The  supernatant  was  removed  and  transferred  to  a  new 
microcentrifuge tube, where 200 µL of chloroform was added. The samples 
were centrifuged and the clear aqueous layer was extracted and transferred to 
a  new  microcentrifuge  tube.  Five  hundred µL  of  isopropanol was  added  to 
each microcentrifuge tube. The samples were once again centrifuged, then all 
liquid was removed, and the RNA pellet was washed several times with 75% 
ethanol:  RNase  Free  H2O.  The  RNA  pellets  were  air  dried  and  then 
resuspended  in  12  µL  with  RNase  Free  water.  A  small  aliquot  (1  µL) was 
removed and diluted in 3 µL of RNase Free water. The remaining RNA was 
stored at -80 ºC. The aliquot was used to verify quality and quantity using a 
NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE) and 
an  Agilent  BioAnalyzer  2100  (Palo  Alto,  CA)  at  the  Center  for  Genome 
Research and Biocomputing (CGRB) at OSU.  
 
Nimblegen  Microarray  Processing:  Ten  µg  of  total  RNA  was  reverse 
transcribed using SuperScript III and oligo (dT) primer (Invitrogen, Carlsbad, 
CA), and double stranded cDNA was synthesized and purified using Qiagen 
Minelute PCR Purification spin column. Double strand cDNA were labeled with 69 
 
Cy5  dNTP,  and  then the  samples  were  hybridized  to  385K  zebrafish  gene 
expression arrays (Roche Nimblegen, Madison, WI) and scanned using the 
Axon GenePix 4200A Pro  scanner (Molecular Devices, Sunnyvale, CA) with a 
green laser (532nm) and a hardware setting of 450 pmt, laser power of 100, 
and a pixel size of 5. Histogram analysis was performed to assure that the 
normalized  counts  lie  between  1e-4  and  1e-5  at  the  signal  intensity  of 
saturation (65,000).    
 
Data  and  Pathway  Analysis:  Raw  data  were  extracted,  background 
subtracted and quantile normalized (Bolstad et al. 2003) using NimbleScan 
v2.5 software. Gene calls were generated using the Robust Multichip Average 
(RMA) algorithm (Irizarry et al. 2003, Irizarry et al. 2003). Statistical analysis 
was performed by one-way ANOVA for unequal variance or by unpaired t-test 
with  Tukey‟s  posthoc  test  (p<0.05)  and  5%  FDR  in  GeneSpring  GX. 
Unsupervised hierarchical clustering was performed using Euclidean distance 
metric and centroid linkage clustering to group gene expression patterns by 
similarity.  The  clustering  algorithms,  heat  map  visualizations  and  centroid 
calculations were performed in Multi-Experiment Viewer, MEV, (Saeed et al. 
2003) software.  Functional enrichment  statistics  and  network analysis  were 
determined using DAVID (http://david.abcc.ncifcrf.gov/home.jsp) (Dennis et al. 
2003, Lempicki et al. 2007) and Metacore (GeneGo, St. Joseph, MI) to identify 
the most significant biological processes affected by nanoparticle treatment. 70 
 
The DAVID functional annotation tool utilizes the Fisher Exact test to measure 
gene enrichment in biological process. Gene Ontology (GO) category terms 
for significant genes were compared to a background list, which included all 
genes on the zebrafish Nimblegen platform. Functional annotation clustering 
with high stringency was used to group similar annotations together into non-
redundant  functional  groups.  The  statistical  scores  in  MetaCore  were 
calculated using a hypergeometric distribution, where the p value represents 
the probability of a particular mapping arising by chance for experimental data 
compared  to  the  background.  Networks  were  built  in  MetaCore  for 
experimental data utilizing the direct interactions algorithm.  
 
Gene  Validation:  RNA  was  isolated  from  embryos  exposed  to  50  µg/mL 
MES-AuNPs and 10 µg/mL TMAT- AuNPs, as described above. cDNA was 
synthesized from 1 µg of RNA in a 20 µL reaction following the SuperScript III 
First Strand Synthesis Kit Protocol (Invitrogen, Carlsbad, CA). After cDNA was 
synthesized, samples were diluted to 1:10 prior to storage. Six genes (PTRH1, 
HOXC9A, BTR29, PDE11A, KIF4A, and RPH3AL) were selected to represent 
both elevated and repressed transcripts from the microarray. Quantitative real 
time –PCR (qRT-PCR) was used to validate these genes. Briefly, a melt curve 
was generated for each primer set (Supplemental Table 1) at six temperatures 
(55, 57, 58, 59, 60, and 61) to find an optimal temperature that worked for 
most primers. Using the Lonza (Basel, Switzerland) Flashgel system, the PCR 71 
 
products were assessed to ensure the product was the expected size. Each 
sample included three biological replicates for both the control and treated, 
along with a no template control (no cDNA) and adult zebrafish cDNA. For 
each sample, a reference gene was used (beta actin) for normalization. CT 
mean values were used and normalized to beta actin, and then corresponding 
biological replicates were averaged. The average value of treated and controls 
were transformed to a ratio to determine the fold change magnitude of the 
treated sample compared to the control.  
 
Statistics: All analyses were compiled using SigmaStat/Plot 11 (SPSS Inc, 
Chicago,  IL).  Dose  response  significance  was  determined  using  one-way 
ANOVA (p<0.05) and Dunnetts post hoc test. A two-way ANOVA (p<0.05) and 
Dunnetts post hoc test with time and concentration as factors was used to 
determine  tissue  concentration  significance.  Statistically  significant  genes 
supporting microarray data was determined using a Student t-Test. 
 
Results 
 
Characterization of functionalized 1.5 nm gold nanoparticles  
Previously,  we  developed  a  precisely  engineered  gold  nanoparticle 
(AuNPs)  library  to  determine  how  the  individual  effects  of  core  size,  and 
surface functionalization impacts biological responses (Harper, et al. 2011). 
These  AuNPs  are  rigorously  purified  by  diafiltration  and  are  thoroughly 72 
 
characterized  using  TEM,  1H-NMR  and  UV-Vis  spectral  analysis. 
Transmission electron microscopy (TEM) was used to determine nanoparticle 
size and distribution for each formulation. As illustrated in Supplemental Figure 
1a,  d,  g,  the  functionalized  AuNPs  were  monodispersed  and  did  not 
agglomerate. Size analysis of the TEM micrographs of MES- (Supplemental 
Figure 1a), TMAT- (Supplemental Figure 1d), and MEEE- (Supplemental 
Figure 1g) AuNPs revealed an average size of 1.6 ± 0.5 nm (N=250), D=1.6 ± 
0.5  nm  (N=199),  D=1.3  ±  0.5  nm  (N=657),  respectively.  Further 
characterization using  nuclear magnetic  resonance  (1H  NMR)  spectrometry 
(Supplemental Figure 1b, e, h) showed peaks at approximately 4.3 – 4.5, 
which illustrate the residual proton from the solvent used for NMR, while the 
other peak around 3.5 corresponds to the protons of the ligand shell. This 
confirms  that  the  free  ligand  and  other  small  molecular  impurities  were 
successfully removed. 
 
Stability of 1.5 nm AuNPs in test media (embryo media) 
The characterization of these AuNPs in nanopure water illustrated that 
they are highly dispersed and were not agglomerated in solution. However, the 
embryo media (EM) used for these toxicological studies consisted of ions that 
buffer the pH. Those ions may cause the nanoparticles to agglomerate and 
precipitate. Thus, prior to conducting toxicity studies, AuNPs were dispersed in 
embryo media and monitored with UV-Vis spectroscopy at least through the 73 
 
experimental  duration  (0  –  120  hpf)  to  determine  whether  the  particles 
remained in solution. As Supplemental Figure 1c, f, and i illustrate, when 
MES-, TMAT- and MEEE- AuNPs were suspended in embryo media at 250 
µg/mL, the absorbance patterns at 24 hpf, 120 hpf, 14 days, and one month, 
were similar to when the first measurements were taken (t=0). The surface 
functionalized  1.5  nm  AuNPs  were  stable  in  the  test  media,  and  any 
responses observed in the assay would not be attributed to agglomeration. 
 
Functionalized  gold  nanoparticles  induce  differential  biological 
responses 
In a previous study conducted by our lab, MES-, TMAT- and MEEE- 
AuNPs were assessed for developmental toxicity in the embryonic zebrafish 
model (Harper, et al. 2011), but without controlling for factors that influence NP 
stability. Here, we have conducted all experiments with EM, a defined matrix 
with a known pH (7.4) buffering capacity for at least seven days. MES-, TMAT- 
or MEEE-AuNPs were dispersed in EM, and embryos were statically exposed 
to seven concentrations (0 – 250 µg/mL) from 6 - 120 hpf. As illustrated in 
Figure  1a,  at  120  hpf,  TMAT-AuNPs  induced  100%  morphological 
malformations  at  10  µg/mL,  while  MES-AuNPs  induced  40%  and  MEEE-
AuNPs  did  not.  At  50  µg/mL,  TMAT-AuNPs  induced  80%  mortality,  while 
MES- and MEEE-AuNPs did not. MES-AuNPs induced statistically significant 
higher  incidence  of  malformations  compared  to  MEEE-AuNPs  at  2  µg/mL. 74 
 
These  results  are  comparable  to  our  previous  study  using  fish  water, 
confirming that the observed toxicological responses were influenced by NP 
surface functionalization and not the pH or media composition.  
 
AuNPs are bioavailable to embryonic zebrafish 
The  differential  toxicity  of  the  three  AuNPs  led  us  to  ask  whether 
responses were associated with differential bioavailability. Inductively Coupled 
Plasma – Mass Spectrometry (ICP-MS) was used to quantify the amount of 
gold tightly associated with the embryos after exposure (followed by careful 
washing to remove free particles and digestion in nitric acid) to 2 – 250 µg/mL 
of either MES-, TMAT- or MEEE- AuNPs. As illustrated in Figure 1b, at both 
24 and 48 hpf, and at the same concentration, the numbers of gold particles 
per embryo were similar for all three nanoparticles. The one exception was at 
250 µg/mL, exposure to TMAT-AuNPs resulted in no embryos surviving to the 
sample  time  point.  The  number  of  particles  associated  with  an  embryo 
increased  with  NP  concentration  in  the  water.  The  quantity  of  AuNPs 
associated with an embryo did not significantly change from 24 to 48 hpf for 
any exposure concentration or type of AuNP. We observed that the control 
embryos had detectable gold, which can be explained by our use of nitric acid, 
with  its  low  level  (ppb)  of  elemental  gold.  The  use  of  nitric  acid  was 
unavoidable  since  it  is  the  preferred  acid  for  the  ICP-MS.  This  finding 
suggested that (1) the surface functionalizations studied did not differentially 75 
 
influence uptake into the embryo, (2) the uptake was rapid, and (3) none of the 
AuNP types accumulated over time. 
 
Gene expression changes elicited by MES and TMAT at 24 and 48 hpf 
To explore the mechanism of how surface functionalized AuNPs are 
inducing differential biological responses over time, we conducted global gene 
expression studies using embryos exposed to 50 µg/mL of 1.5 nm MES- and 
10 µg/mL of TMAT-AuNPs from 6 to 24 and 6 to 48 hpf. Due to the lack of 
biological response in other assays by MEEE-AuNPs, this nanoparticle was 
not included in these experiments. At 24 hpf, exposure to MES-AuNPs led to 
the  misexpression  of  more  transcripts,  than  TMAT-AuNPs  (24  and  18, 
respectively).  Fourteen  misexpressedd  transcripts  were  common  between 
both AuNPs (Figure 2a). By 48 hpf, the number of transcripts misexpressed 
by  MES-  and  TMAT-AuNPs  increased  to  316  and  58,  respectively.  The 
number of transcripts common to both were 184 (Figure 2b). The statistically 
significant  genes  for  all  samples  (606)  were  grouped  using  bi-hierarchical 
clustering by Multi-Experiment Viewer (MeV) to produce a heat map (Figure 
2c). The heatmap had a gene expression pattern that was consistent over 
time. By taking the generally elevated- or repressed transcripts by AuNPs from 
the heat map, significant biological process networks were identified (Figure 
2d). As Figure 2d illustrates, the most significant biological process networks 
relating to the elevated transcripts were inflammation – complement system, 76 
 
cell  adhesion-leucocyte  interactions,  immune  response  -  phagocytosis  and 
signal transduction- nitric oxide signaling. While the significant pathways for 
repressed transcripts were signal transduction – WNT and NOTCH signaling, 
inflammation  –  IL-12,  15,  18  signaling,  cell  cycle  –  G1-S  growth  factor 
regulation,  muscle  contraction,  reproduction-gonadotropin  regulation, 
inflammation – histamine signaling, and immune response  – IL-5 signaling. 
There were more elevated transcripts than repressed, however, there were 
fewer    statistically  significant  biological  process  networks  (only  4).  These 
networks  were  involved  in  inflammation  and  immune  response.  Biological 
processes such as immune and inflammatory responses are elevated by both 
surface functional groups.  
From this heat map, we used qRT-PCR to confirm that the changes in 
gene expression were similar to gain confidence that the networks identified 
were,  in  fact,  a  result  of  exposure  to  1.5  nm  MES-  or TMAT-  AuNPs. We 
validated  6  misregulated  transcripts  that  were  elevated  or  repressed.  As 
illustrated  in  Table  1,  the  direction  and  magnitude  of  the  gene  expression 
changes  observed  by  qRT-PCR  corresponded  to  those  of  the  microarray, 
thereby confirming the changes caused by MES- and TMAT-AuNPs at 24 or 
48 hpf.  
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Pathway analysis comparison of MES- and TMAT- AuNPs  
Due  to  the  differential  biological  responses  caused  by  exposure  to 
MES- and TMAT-AuNPs, we specifically analyzed the gene expression data to 
identify  genes  that  are  differentially  expressed  between  MES-  and  TMAT-
AuNPs. When the surface functional groups on the nanoparticles, TMAT and 
MES,  were  directly  compared  to  one  another,  512  and  1,737  statistically 
significant differentially expressed transcripts were identified at 24 and 48 hpf, 
respectively.  To  accomplish  this  analysis,  each  surface  functionality  was 
normalized  to  their  time  matched  control,  and  then  a  Student  T-test  was 
performed. As Figures 3a and 3b illustrate, there is a difference in response 
for each nanoparticle. However, the magnitude of response varied among one 
another.  Figure  3c  demonstrates  that  when  comparing  the  gene  lists 
generated for each time point, at 24 hpf there were 486 unique genes, while at 
48 hpf there were 1,711. There were 26 common genes between the two time 
points.  This  direct  comparison  of  the  TMAT-  and  MES-  response  provided 
evidence that as early as 24 hpf, the surface functional groups were already 
perturbing  the  embryo  in  different  ways,  and  these  events  led  to  more 
molecular  disruption  at  48  hpf.  Additionally,  the  surface  functionalities  are 
driving  the  gene  expression  changes  and  are  undergoing  differential 
mechanisms to induce these differential biological responses. 
The  significantly  enriched  biological  processes  at  24  hpf  were 
associated  with  immune  system,  inflammation,  protein  folding,  proliferation 78 
 
and  G-protein  coupled  receptor  protein  signaling  (Table  2a).  Immune 
response  and  inflammatory  related  biological  processes  were  the  most 
prevalent processes, which included three genes (ELF4, RUNX3, and c-Fos) 
that  were  elevated  by  TMAT  compared  to  MES,  and  eight  genes  (STAT4, 
PAK2, PP2A cat [alpha], PP2A catalytic, p70 S6 kinases1, Ubiquitin, NF-AT1 
and ATF-2) that were repressed by TMAT vs. MES. The G-protein coupled 
receptor  signaling  pathway  was  also  elevated  by  TMAT-AuNPs,  meaning 
TMAT-AuNPs causes an increase in cellular responses.  
At 48 hpf, the significantly enriched biological pathways identified by 
Metacore were mainly related to G-protein coupled receptor protein signaling 
pathways,  transport,  proliferation  and  responses  to  protein  stimulus  (Table 
2b). The proliferation pathway was one of the largest biological pathways and 
include  a  large  number  transcripts  that  were  repressed  by  TMAT  vs.  MES 
(PKR, NDPK A, NF2, GRB2, KLF4, and PAX6) compared to those that were 
elevated (VEGF, CDK2m TGFB-1, and TGFB-3).   
 
Discussion 
In  this  in  vivo  study,  we  report  that  exposure  to  1.5  nm  gold 
nanoparticles functionalized with TMAT, MES, and MEEE induced differential 
biological  responses  in  dechorionated  embryonic  zebrafish.  TMAT 
functionalized  AuNPs  induced  embryo  lethality,  while  mortality  was  not 
observed after exposure to MES- and MEEE-AuNPs. MES functional group 79 
 
caused sublethal malformations to the embryos. No adverse responses were 
observed after exposure to MEEE-AuNPs. The differential biological response 
was not due to a difference in the ability of the embryos to uptake certain 
AuNPs. Here, we report that the different adverse responses observed can be 
attributed to the surface functional groups. We found that surface functionality 
influenced the gene expression profile when the two surface groups (MES and 
TMAT) was directly compared to one another.  
  In  a  previous  study  (Harper,  et  al.  2011),  we  used  these  same 
functionalized gold nanoparticles dissolved in fish water, which is made up of 
reverse osmosis water and Instant Ocean and found that each AuNP induced 
differential  biological  response  in  the  zebrafish.  However,  since  the  media 
used  for  the  toxicological  study  consist  of  Instant  Ocean,  which  has  a 
proprietary recipe, it makes it near impossible to control or predict how the 
nanoparticles will behave in repeated studies. Characterization of AuNPs in 
ion-rich vs. low ion media often yields different agglomeration and precipitation 
properties. Ions in media are known to cause nanoparticles to agglomerate 
and  to  display  unpredictable  surface  area,  charge  and  size  characteristics 
compared to the original synthesized particles (Saleh et al. 2008, Liu et al. 
2009).  These  changes  in  parameters  influence  the  toxicological  outcome 
(Truong,  et  al.  In  Press).  Although  agglomeration  did  not  occur  for  MES-, 
TMAT- and MEEE-AuNPs in ion-rich media, it is critical to evaluate the stability 80 
 
of the NPs over time to ensure that the biological responses observed are 
ascribed to a known NP formulation.  
There is great interest in efficiently assessing toxic potential of NPs and 
in understanding the physicochemical properties that elicit the toxic response. 
The  effects  of  core  material  size  and  surface  functionalization  have  been 
assessed for gold, silver, and titanium NPs (Euliss 2005, Sayes et al. 2006, 
Pan et al. 2007, Furgeson et al. 2009, Li et al. 2010, Park et al. 2010). Under 
some circumstances, gold nanoparticles cause cytotoxicity (Pan, et al. 2007), 
cell death (Homberger and Simon 2010) and immune-responses (Karthikeyan 
et al. 2010). While NP size is an important determinant of biological response 
(Pan,  et  al. 2007,  Liu  et  al. 2010),  so are the  NP  surface functionalization 
(Toru  et  al.  2004).  In  other  studies,  cationic  AuNPs  exposed  to  Japanese 
medaka fish resulted in mortality in less than 24 hours (Zhu et al. 2010), which 
is similar to what we observed in our cationic AuNPs (TMAT-AuNPs) (Harper, 
et  al.  2011).  Our  studies  indicate  that  alteration  of  a  NP  physical  property 
changes the biological response.  
Understanding  the  differential  toxicities  is  a  challenge.  Differential 
uptake  was  hypothesized,  but  this  study  suggests  it  is  not  a  factor.  We 
demonstrated that the uptake is not predictive of toxicity, which is consistent 
with other studies. In a study using Daphnia magna, exposure to 13-17 nm 
AuNPs  did  not  cause  toxicity  at  low  concentrations,  even  though  the 
nanoparticles accumulated over time in the gut (Lovern et al. 2008). The D. 81 
 
magna observation supports our finding that a lack of biological response to 
AuNPs cannot be attributed to low or no uptake. From this study alone, we 
conclude that at 24 and 48 hpf, regardless of surface functionalization on the 
AuNPs, gold was detected in exposed embryos and that the uptake level is not 
directly correlated to any specific physical parameter.  
Our  gene  expression  profiling  is  not  the  first  study  to  identify 
misregulation in pathways related to inflammation and immune responses. A 
study using gold nanoparticles found that when macrophages were exposed 
to  35nm  AuNPs  in  vitro,  some  toxicity  was  observed  (Shukla  et  al.  2005). 
Silica  particles  stimulated  inflammatory  protein  and  induced  macrophage 
cytotoxicity (Waters et al. 2009). These studies used nanoparticles that varied 
in size, core material, and surface functionalization to ours, but illustrate that a 
general immune response can be initiated by varying NP structural attributes.  
NP effects on cell cycle control and proliferation are not without precedent. 
AuNPs  with  a  diameter  of  300  nm  inhibited  VEGF  and  induced  cell 
proliferation and migration (Karthikeyan, et al. 2010). It is likely that when such 
pathways  are  impacted  during  development  there  will  be  deleterious 
consequences.  Transport  mechanisms  were  more  elevated  by  TMAT  than 
MES,  including  metal  ion  transport.  The  ion  transport  process  was  also 
repressed by TMAT. In general, transport channels are always open, but they 
are highly selective and will only allow specific molecules through (Zilman et 
al.  2010).  Zilman  et  al  (2010)  demonstrated  that  certain  particles  can  be 82 
 
strongly trapped and have an enhanced presence for transport regardless of 
the  presence  of  other  particles.  However,  there  is  a  certain  range  of 
intermediate trapping strength for the ion transporters that allows the particles 
to penetrate the channel to a certain degree, and mostly accumulate near the 
entrance  (Zilman,  et  al.  2010).  This  clogging  causes  a  change  of  particle 
density inside the channel. It could be that TMAT-AuNPs have a high trapping 
strength for metal ion transporter and are able to get into the cell readily at 24 
hpf, resulting in the perturbation of the G-coupled protein receptor signaling 
pathway,  and  in  the  end,  various  transport  mechanisms  within  the  cell.  In 
comparison,  it  is  possible  that  MES-AuNPs  have  an  intermediate  trapping 
strength, which causes a blockage of the channel, resulting in a disruption of 
the metabolic processes at 24 and 48 hpf, due to the imbalance of ions inside 
and outside the cell. This identification of affected pathway candidates has 
provided  a  first  pass  at  understanding  the  molecular  mechanism  by  which 
MES- and TMAT-AuNPs induce differential biological responses at both the 
molecular and phenotypical level. 
  In summary, surface functionalization of gold nanoparticles influences 
the biological response at  the phenotypical and molecular levels. From this 
study,  we  have  identified  that  inflammation  and  immune  response  is  a 
relatively  general  response  to  NPs  exposure.  Additionally,  transport 
mechanisms were misregulated after exposure to different surface functional 
group AuNPs. Further studies using different surface functional groups can 83 
 
help identify pathways that are driving these adverse responses at the mRNA 
level. Collectively, these results suggest that surface functionalization plays 
the largest role in producing differential responses. We believe that this and 
other recent NP toxicity studies demonstrate efficacy of systematic toxicology 
studies  to  establish  structure-activity  relationships  between  size,  surface 
functionalization and charge, and the biological response.    84 
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Figure 3- 1. Differential biological responses induced by AuNPs. 
 (a) Embryos were dechorionated and exposed from 6 to 120 hpf . 1.5 nm 
TMAT-AuNPs  was  embryo  lethal,  causing  mortality  in  100%  of  exposed 
embryo  at  250  µg/mL,  while  MES-AuNPs  induced  little  mortality,  but  did 
induce malformations at concentrations of 2 µg/mL and above. MEEE-AuNPs 
did not induce any differential biological response. (b) Tissue concentration of 
embryos exposed to 2-250 µg/mL of MES-, TMAT- and MEEE-AuNP from 6 to 
24  and  6  to  48  hpf.  Error  bars  are  standard  error.  Data  with  *  denotes 
statistical significance (p<0.05).  
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Figure 3- 2. Venn diagram of misregulated transcripts after exposure to 
MES- and TMAT-AuNPs at (a) 24 hpf and (b) 48 hpf (c) hierarchical 
clustering and (d) functional enrichment of statistically significant genes 
(p<0.05) elevalted or repressed by MES- and TMAT-AuNPs. 
Orange  bars  represent  significant  Biological  Process  networks  (MetaCore, 
GeneGo) for elevated transcripts and blue bars for the repressed transcripts 
compared to the control. 
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Figure 3- 3. Direct comparison of genes differentially expressed by 
TMAT- v. MES- AuNPs. 
Heat map of significantly different genes(p<0.05) at 24 hpf (a, 512 genes) and 
48 hpf (b, 1737 genes). A venn diagram comparing the gene lists for each 
time point at 24 and 48 hpf (c). 
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Table 3- 1. Validation of statistically significant genes identified by the 
microarray using qRT-PCR 
Genes were selected from the statistically significant gene lists generated from 
the heatmap to determine if the misregulation identified by the microarray was 
valid. These transcripts were selected to represent both elevated and 
repressed transcripts. qRT-PCR was used to confirm  that the direction of the 
misregulation is consistent; but not necessarily that the magnitude of the 
change is not identical. * denotes a gene identified using Ensembl database, 
and 
± from TIGR.  
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Table 3- 2. Functional enrichment of biological processes at (a) 24 and 
(b) 48 hpf. 
Significantly  (p<0.05)  enriched  biological  network  processes  (Metacore, 
GeneGo) and biological process GO terms for genes differentially expressed 
at (a) 24 and (b) 48 hpf. 
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Figure 3S- 1. Characterization data on MES-, TMAT – and MEEE-AuNPs. 
TEM,  NMR  and  UV-VIS  characterization  of  MES-  (a-c),  TMAT-(d-f),  and 
MEEE-  AuNP  (g-i).  Scale  bars for  the  TEM  images  are  20,  10  and  50nm 
(respectively). UV-VIS spectra show the stability of the nanoparticles in the 
exposure media: MES-AuNPs remain stable in solution through at least 14 
days (yellow); TMAT-AuNPs remain stable in solution up to 114 hours (green); 
and  MEEE-AuNP  remain  stable  in  solution  up  to  one  month  (black).    The 
proton NMR spectra show broadened signals for bound ligand between 3-4 
ppm.  The lack of intense, narrow signals in this region suggests that there is 
no free ligand.  The peaks at greater than 4.5 ppm are due to residual protons 
in the deuterated NMR solvent. 
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Table 3S- 1. qRT-PCR Primer Sequences. 
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Abstract 
As the number of products containing nanomaterials increase, human 
exposure to nanoparticles (NPs) is unavoidable. Presently, few studies focus 
on the potential long-term consequences of developmental NP exposure. In 
this study, zebrafish embryos were acutely exposed to three gold NPs that 
possess  functional  groups  with  differing  surface  charge.  Embryos  were 
exposed  to  50  µg/mL  of  1.5  nm  gold  nanoparticles  (AuNPs)  possessing 
negatively charged 2-mercaptoethanesulfonic acid (MES) or neutral 2-(2-(2-
mercaptoethoxy)ethoxy)ethanol (MEEE) ligands  or 10 µg/mL of the AuNPs 
possessing  positively  charged  trimethylammoniumethanethiol  (TMAT).  Both 
MES- and TMAT-AuNP exposed embryos exhibited hypo-locomotor activity, 
while those exposed to MEEE-AuNPs did not. A subset of embryos that were 
exposed to 1.5 nm MES- and TMAT-AuNPs during development from 6-120 
hours post fertilization were raised to adulthood. Behavioral abnormalities and 
the  number  of  survivors  into  adulthood  were  evaluated  at  122  days  post 
fertilization. We found that both treatments induced abnormal startle behavior 
following  a  tap  stimulus.  However,  the  MES-AuNPs  exposed  group  also 
exhibited abnormal adult behavior in the light and had a lower survivorship into 
adulthood. This study demonstrates that acute, developmental exposure to 1.5 
nm MES- and TMAT- AuNPs, two NPs differing only in the functional group, 
affects larval behavior, with behavioral effects persisting into adulthood. 
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Introduction 
With  the  number  of  nanotechnology-enabled  products  entering  the 
consumer  world  increasing  steadily  (Scholars  et  al.  2011)  exposure  to 
nanoparticles (NPs) is inevitable. At present, there are many unknowns about 
how NPs affect human and environment health. Most studies have focused on 
understanding  how  acute  nanoparticle  exposure  affects  organ  system 
development  or  causes  mortality  using  both  in  vitro  and  in  vivo  models 
(Powers et al. 2010; Zhu et al. 2010; Gao et al. 2011). While these studies are 
critical and provide informative data, there are other areas of potential concern 
regarding nanoparticles that have yet to be explored, including potential long-
term effects following short-term developmental exposure. Because many NPs 
are designed with metal cores, some of which are known neurotoxicants (e.g., 
lead), there is particular interest in the long-term effects of NP exposure on the 
nervous system. While some groups are beginning to address this data gap by 
either investigating the effects of NPs on brain development following in utero 
exposure (Gao et al. 2011) or behavior following long-term exposure as adults 
(Oszlanczi et al. 2011) few groups have coupled these endpoints and tested 
the  behavior  of  adults  following  developmental  exposure.  Additionally, 
because metal cores are often the focus of toxicity studies, few groups have 
considered  the  potential  effects  of  surface  functional  groups  on  nervous 
system development and function, even when the metal NP core is apparently 
benign (e.g., gold). The paucity of research in these two areas leaves a data 
gap regarding potential long-term effects of NP exposure on the developing 99 
 
nervous  system.  The  first  objective  of  this  research  was  to  investigate  the 
short- and long-term behavioral effects of developmental NP exposure. The 
second  objective  was  to  investigate  whether  surface  functional  groups 
surrounding  a  benign  metal  core  (i.e.,  gold)  affect  nervous  system 
development and long-term behavior. 
We conducted this study using the zebrafish model. The zebrafish is the most 
appropriate model for this type of study because embryos develop externally, 
all of their organs have formed within 5 days (Amacher 2001), and the fish 
mature to adulthood in just 3 months (Brand et al. 2002). Due to their small 
size and external development, an entire cohort of embryos can be exposed 
using just ~1 mg of nanoparticles, while the traditional rodent model would 
require  gram  quantities.  Furthermore,  due  to  their  predictable  swimming 
habits,  both  larval  and  adult  behavior  tests  using  locomotor  activity  as  the 
endpoint can be quickly and efficiently conducted.  
  Based on a previous study (Truong et al. Submitted), we elected to use 
three  types  of  gold  nanoparticles  with  a  core  diameter  of  1.5  nm  and 
functionalized  with  either  2-mercaptoethanesulfonic  acid  (MES), 
trimethylammoniumethanethiol  (TMAT)  or  2-(2-(2-
mercaptoethoxy)ethoxy)ethanol  (MEEE).  The  primary  difference  between 
these three NPs is the charge of their surface functional groups. MES has a 
negative  charge,  TMAT  has  a  positive  charge,  and  MEEE  has  a  neutral 
charge.  These  different  surface  charges  greatly  influence  biological 100 
 
responses. Previously, we found that the positively charge surface functional 
group (TMAT) induced embryo lethality, the negatively charge (MES) induced 
sublethal toxic effects,  while  the  neutral  group  (MEEE) caused  no  adverse 
biological  response  (Harper  et  al.  2011).  Our  goal  was  to  identify  whether 
acute exposure to MES- and TMAT-AuNPs during development would lead to 
deleterious  effects  that  persist  into  adulthood.  Specifically,  we  wanted  to 
detect  whether  the  charged  surface  functional  groups  on  these  gold 
nanoparticles  would  impact  development  of  the  central  nervous  system 
leading to abnormal behavior or survivorship in adulthood. 
 
Materials and Methods 
Preparation of TMAT-, MES- and MEEE-AuNPs: 1.5 nm gold particles were 
synthesized using published procedures (Woehrle et al. 2005). All reagents 
were purchased from Sigma (St. Louis, MO) or Strem (Newburyport, MA) and 
used as received. Dichloromethane was distilled over phosphorous pentoxide, 
and chloroform was filtered through a plug of basic alumnia prior to use. 2-[2-
(2-mercaptoethoxy)ethoxy]ethanol  (Woehrle  et  al.  2004)  and  thiocholine 
(N,N,N-trimethylaminoethanethiol  iodide)  (Warner  et  al.  2003)  were 
synthesized according to known procedures. 
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Nanoparticle Characterization and Analytical Procedures:  
Proton NMR spectra, UV-visible spectra and transmission electron microscopy 
(TEM)  images  were  collected  for  each  nanoparticle  to  confirm  the  size, 
composition and purity of the samples. Varian Unity Inova 300 MHz was used 
to collect proton NMR spectra in D2O. A Hewlett-Packard 8453 diode array 
instrument was used to obtain UV-visible spectra in a 1-cm quartz cuvette. 
TEM images were obtained on an FEI Titan at 300kV using a Cs aberration 
corrector. Amine functionalized SMART grids (Dune Sciences, Inc) were used 
for TEM imaging. SMART grids were soaked in the nanoparticle solution and 
then in nanopure water for 2 minutes each to produce samples for TEM with 
an even distribution of particles across the grid. Characterization data for the 
batch of MES-, TMAT- and MEEE-AuNPs used in this study can be found in a 
study conducted in parallel (Harper et al. 2011). 
 
Zebrafish: Adult Tropical 5D strain of zebrafish (Danio rerio) were reared at 
Oregon  State  University  -  Sinnhuber  Aquatic  Research  Laboratory  (SARL). 
Fish were kept at standard laboratory conditions of 28°C on a 14h light/10h 
dark  photoperiod  in  fish  water  (FW)  consisting  of  reverse  osmosis  water 
supplemented with a commercially available salt (Instant Ocean®). 
 
Exposure Protocol:  Adult zebrafish were group spawned, and their embryos 
were collected and staged according to Kimmel et al. (Kimmel et al. 1995). At 102 
 
4  hours  post  fertilization  (hpf),  the  embryonic  chorion  was  enzymatically 
removed  with  pronase  to  increase  bioavailability  using  protocols  previously 
published (Truong et al. 2011). Dechorionated embryos were  rested for 30 
minutes  prior  to  nanoparticle  exposure.  For  both  the  larval  behavior 
assessment and the adult studies, embryos were exposed from 6 to 120 hpf in 
the  individual  wells  of  a  96-well  plate  with  100  μl  of  either  embryo  media 
(Kimmel et al. 1995), 10 µg/mL of TMAT-AuNPs, 50 µg/mL of MES-AuNPs, or  
50 µg/mL of MEEE-AuNPs. The NP exposure concentrations were selected as 
the most appropriate for behavior testing based on a previous study showing 
that  developmental  exposure  to  these  concentrations  does  not  lead  to 
significant  morphological  defects  (e.g.,  yolk  sac  edema)  which  could  affect 
swimming behavior and confound the results of the behavior tests (Truong et 
al. Submitted). Additionally, TMAT-AuNPs induced 100% embryo lethality at 
50 µg/mL, therefore a lower concentration was selected that did not induce 
mortality or sublethal effects. For the larval behavior assessment, 24 embryos 
were  exposed  per  treatment  (3  replicates);  for  the  adult  assessments,  96 
embryos were exposed per treatment, but only 50 were selected to be raised 
into adulthood. Note that embryo media was used as the control for the adult 
study  based  on  the  results  of  the  larval  behavior  tests,  which  showed  no 
statistical  behavioral  difference  between  embryos  exposed  to  MEEE  or 
embryo media (see Figure 1b). Embryos for the adult study were thoroughly 
washed at 120hpf then raised under standard conditions until adulthood. A 103 
 
subset of embryos with intact chorions was kept to monitor inherent clutch 
quality. Exposure plates were sealed to prevent evaporation and wrapped with 
aluminum  foil  to  eliminate  potential  light  degradation  of  the  NPs  during 
exposure. 
 
Larval  Behavior  Assay:  At  120  hpf,  exposed  embryos  were  tested  in  the 
original 96-well exposure plate by placing the plate in a Viewpoint ZebraBox 
(software version 3.0, Viewpoint Life Sciences, Lyon, France) and measuring 
locomotor activity using the tracking setting during alternating periods of light 
and dark. This test is a modification of that described by MacPhail et al. 
13. 
Larvae subjected to this test typically move less during the light periods and 
more  during  dark  periods  (Figure  1a)  and  behavioral  differences  following 
developmental exposures can be determined by comparing distances moved 
during  the  light  or  dark  periods.  Briefly,  the  test  consisted  of  acclimating 
embryos in the light for 20 minutes, after which a cycle of 10 minutes in the 
light, then 10 minutes in the dark, was repeated three times over a course of 
one hour. Raw data files were processed using a custom perl script to average 
total distance traveled for each of the three dark periods. Twenty-four embryos 
were used for each replicate, with a total of three replicates for each of the 
three AuNPs or embryo media controls. A two way ANOVA-Dunnetts Post Hoc 
Test using conditions of cycle and treatment was used to compare whether 
larval locomotor activity differed across each of the three dark cycles. 
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Survivorship Measurements: Ninety-six embryos were exposed from 6 - 120 
hpf  to  embryo  media  control,  TMAT-  and  MES-AuNPs.  At  120  hpf,  50 
phenotypically normal larvae were selected from each treatment and washed 
with fish water prior to being raised to adulthood on a recirculating FW system. 
The larvae were initially reared at a density of 50 per tank. At 22 days post 
fertilization (dpf), larvae were split to a density of 25 per tank. On 44 dpf, each 
treatment  group  was  evenly  distributed  between  two  tanks  to  control  for 
possible density effects. The number of surviving larvae was recorded at 22, 
44 and 122 dpf. These evaluation dates correspond to when juvenile zebrafish 
transition to different sized food (based on the mouth size).  A Fisher Exact 
Test  (p<0.05)  was  applied  to  the  raw  data  (the  number  of  survivors  into 
adulthood). For ease of visualization, percent survivors was graphed rather 
than number of individuals.   
 
Adult  Behavior  Assay:  One  day  prior  to  behavioral  assessment,  five  fish 
(n=5)  were  randomly  selected  from  each  treatment  group  and  placed  into 
individual 2 liter tanks in the behavior testing room. The behavior room was 
temperature controlled on a 14 h light/10h dark cycle and had a custom built 
shelf that held 15 tanks at a time, and at each location, had a solenoid that 
was manually triggered from a remote location to create a brief tap on the 
outside  of the tank.  A  custom  light  setup  with  a  sheet diffuser was  placed 
behind the shelf system and controlled remotely using a light switch placed in 105 
 
a different part of the room. A Sony High Definition camcorder (HDR-SR11) 
was set up on a tripod 15 feet away from the tank arrays to capture movement 
of the fish. After capturing the videos, Noldus Ethovision XT version 7 software 
(Leesburg, VA) was used to quantify total distance moved and velocity. All 
data  obtained  were  normalized  by  averaging  the  total  velocity  or  distance 
travelled  among  the  five  fish  per  treatment  and  dividing  this  value  by  the 
average length for the same five fish for each treatment (see section 2.8). A 
one  way  ANOVA  and  Dunnett‟s  post  hoc  test  was  used  to  assess  total 
distance travelled after a light and startle stimulus and the velocity after the 
light  stimulus  for  each  nanoparticle-treated  group  for  the  adult  behavior 
assessments.  An  ANOVA  on  ranks  with  Dunn  post  hoc  test  was  used  to 
assess  average  velocity  after  startle  assay  for  control  compared  to  each 
treatment. 
Light Stimulus: After moving fish to the behavior testing room, they 
were left in the dark for 20 minutes to acclimate to their new 
environment; afterwards, the light stimulus was produced by turning on 
the lights. The camcorder was used to record the movement of the fish 
for 10 minutes following the light stimulus, after which the fish were 
allowed to settle down in the dark. 
Startle Stimulus: Approximately 60 minutes after the light stimulus test 
was conducted, the same fish underwent a startle stimulus assay. The 106 
 
test began when the tap trigger was manually initiated and lasted 10 
minutes during which the fish movements were recorded.  
 
Adult Weight and Length Measurement: On 117 days post exposure, and 
after  behavioral  analysis  was  complete,  all  adult  zebrafish  were  humanely 
euthanized  using  MS-222.  Body  mass  was  measured  using  a  digital  scale 
length was measured from the snout to the end of the caudal fin using digital 
calipers.  Condition  factor  (K)  indices  was  calculated  for  each  treatment  to 
quantify  the  condition  of  the  fish  [K=weight  (g)x  100/  length
3  (mm)]
14.  An 
ANOVA on ranks with Dunn post hoc test was used to assess average weight, 
and condition factor indice for control compared to each treatment. A one way 
ANOVA and Dunnett‟s post hoc test was used to average length for control 
compared to each treatment. 
 
Results 
 
Surface functionalization of 1.5nm AuNPs impacts larval behavior 
After exposure to the three types of gold nanoparticles, we conducted a 
1-hour larval behavior test consisting of recording distance moved during three 
cycles of alternating 10-minute light and dark periods. After determining that 
there was no statistical difference between the distances moved during each 
of the three dark periods (data not shown), total distance traveled in the three 
dark  periods  was  averaged  and  distance  moved  was  compared  across 107 
 
treatments (Figure 1b). Embryos exposed to MES- and TMAT- AuNPs swam 
50% and 33% less distance in the dark compared to the control, respectively, 
while  those  exposed  to  MEEE-AuNPs  showed  no  difference  in  distance 
traveled compared to the control. This data suggests that the MES- and TMAT 
surface  functionalizations  (i.e.,  charge)  impacted  development  leading  to 
altered  locomotor  behavior.  Note  that  since  the  larval  test  showed  no 
difference in behavior between MEEE-exposed embryos and those raised in 
embryo media, the embryo media exposed were used as the control for the 
adult tests rather than adding an additional NP control (MEEE). As a control, 
embryo media exposed embryos was used rather than fish water because the 
embryo media composition is known, while fish water chemistry is unknown 
due to the use of a commercial product with proprietary ingredients.  
 
Acute exposure to AuNPs impacts survivorship into adulthood 
Embryos that were exposed to TMAT-AuNPs at 10 µg/mL, MES-AuNPs 
at 50 µg/mL or an embryo media control from 0 to 5 dpf were raised in fresh 
water until 122 dpf. By 117 days post exposure (dpe) to the nanoparticles or 
the control, there was a statistically significant decrease in the percentage of 
MES-AuNP-exposed  survivors,  while  survivorship  of  fish  that  had  been 
exposed  to  TMAT-AuNPs  was  not  statistically  different  from  the  control 
survival rate . At 117 dpe, both the control and TMAT-AuNPs exposed groups 
had 80% survivors, while MES-AuNPs had only 50%. Figure 2 illustrates that 108 
 
both  control  and  TMAT-AuNP-exposed  fish  had  similar  rates  of  mortality 
throughout the experiment, while the majority of the death to the MES-AuNP-
exposed fish occurred between 17 to 39 dpe. The MES-AuNP treated group‟s 
survivorship dropped from 90% at 17 dpe to 60%, 22 days later. Overall, this 
data shows that acute exposure to 1.5nm MES-AuNPs decreases the number 
of survivors into adulthood.  
 
Surviving adults exhibit higher condition factor indices 
To  determine  if  acute  exposure  to  MES-  and  TMAT-AuNPs  affects 
zebrafish development, we measured the length and weight of all survivors for 
each of the three groups. The surviving fish in both MES- and TMAT-AuNPs 
treatment groups were statistically longer than the control (34 ± 0.22 mm) with 
an average length of 38 ± 0.32 and 36 ± 0.31 mm, respectively. MES-AuNP 
treated fish weighed more than the control (0.53 +/- 0.03 g vs 0.42 +/- 0.02 g). 
To account for the different number of survivors per treatment, we calculated a 
condition  factor  index  (K)  to  evaluate  the  quality  of  the  fish.  The  condition 
factor index (K= weight x 100 / length
3) for the control group was  0.97 +/- 
0.049, while both the MES- and TMAT-AuNPs fish had an average K of 1.12 
(Table  1).  These  results  demonstrate  the  importance  of  taking  into 
consideration  the  different  number  of  survivors  per  treatment  and  that 
exposure to either positively or negatively charged AuNPs during development 
leads to an increase in both weight and length of adult zebrafish. 109 
 
Behavioral abnormality detected in acutely exposed zebrafish 
Zebrafish  exposed  during  development  to  MES-  and  TMAT-AuNPs 
exhibited behavioral abnormalities at 5 dpf. We wanted to evaluate whether 
these behavioral abnormalities persistent into adulthood. To assess this, we 
performed two adult assays of locomotor activity. Since the NP-exposed adults 
were bigger than the controls, and bigger fish may be expected to travel larger 
distances than smaller fish, all locomotor data was normalized to the average 
body length. The first assay was to measure the total distance travelled and 
the average velocity for 10 minutes following a tap on the tank. As Figure 3a 
illustrates, after the startle stimulus, the control fish moved a total distance of 
207 cm, while both MES and TMAT-AuNP treated fish travelled a statically 
significant shorter distance, 35 and 69 cm, respectively. The velocity for the 
control and TMAT-AuNPs exposed fish were 0.60 and 0.27 cm/s, respectively, 
while the velocity of MES-AuNP exposed fish was lower than the control (0.22 
cm/s). The second assay consisted of measuring the total distance travelled 
and  the  average  velocity  during  10  minutes  in  the  light  following  a  light 
stimulus (Figure 3b). For this assay, the control fish travelled a total distance 
of 197 cm, while TMAT-AuNP-exposed fish travelled 421 cm). MES-AuNPs 
exposed fish travelled a statistically significant greater distance (527 cm than 
the control. The velocity of the fish followed the same trend, where MES-AuNP 
exposed fish had an average velocity that was greater than the control (1,04 
vs 0.65 cm/s, respectively), while both the control and TMAT-AuNP-exposed 110 
 
fish  had  an  average  velocity  of  0.79  cm/s.  These  results  demonstrate  that 
acute  exposure  to  both  MES-  and  TMAT-AuNPs  cause  behavioral 
abnormalities that persists into adulthood.  However, the negatively charged 
MES-AuNPs have a more severe impact on both larval and adult behavior 
compared to the effects of the positively charged TMAT-AuNPs.  
 
Discussion 
In this study, we report for the first time that acute exposure to 1.5 nm 
MES-  and  TMAT-  AuNPs  during  embryonic  development  results  in  larval 
behavioral  abnormalities  that  persist  into  adulthood.  Additionally, 
developmental exposure to both NPs resulted in larger adults, and exposure to 
1.5  nm  MES-AuNPs  at  50  µg/mL  resulted  in  reduced  adult  survivorship. 
Although there is a lack of significant differences in condition factor index (K), 
the data suggests that the fish are compositionally similar when adjusted for 
length and weight. Historically, the condition factor index is considered a good 
indicator of health in fish; however, it has only been applied to one zebrafish 
study where the average K was 1, which is similar to our finding in this study 
(Siccardi  et  al.  2009).  Applying  a  condition  factor  index  to  adult  zebrafish 
studies  is  appropriate  as  it  illustrates  the  health  of  the  fish  and  allows 
comparison to other studies.  
  Ours  is  the  first  study  where  embryonic  zebrafish  were  exposed  to 
nanoparticles only during development, then raised in freshwater to adulthood. 111 
 
Previous studies have tested chemicals using this same method and model 
(Görge  et  al.  1990;  Gerlai  et  al.  2006).  What  we  are  learning  from  these 
studies is that even brief exposure during development can result in potentially 
maladaptive  effects  later  in  life.  As  others  have  suggested,  embryonic 
development is the most critical and sensitive life stage (Aparicio et al. 2002; 
Rubinstein  2003)  and  if  any  molecular  pathways  are  perturbed  during  this 
period,  permanent  derailment  of  development  may  occur.  Effects  on 
development can be minute or cause a cascade of effects that result in either 
mortality or inhibition of growth and possibly central nervous system damage. 
While behavior tests are a comprehensive assessment of potential impacts on 
nervous system development, follow-up studies are required to determine the 
“window of exposure” and the mode of action underlying the observed effects. 
  While altered locomotor activity suggests an impact on nervous system 
development, it does not exclude the possibility that the NP is impacting other 
target organs such as the eye (i.e., ability to detect light) or neuromuscular 
system (i.e., ability to swim). By utilizing both a light and tap stimulus tests, we 
tested the effects of the NPs on both vision and sensory perception. The ability 
to sense a tap is achieved through the hair cells on the lateral line of teleosts 
(Crispino 1983). Our results suggest that while MES may impact both vision 
and sensory perception, TMAT is unlikely to have an impact on vision. The 
next step in determining whether these NPs impact nervous system, vision, 
sensory-motor perception, or all three target organ systems, is to begin to look 112 
 
at  the molecular  events  underlying  the  observed  changes  in behavior.  The 
zebrafish  is  an  excellent  model for  investigating  mode  of  action  underlying 
observed phenotypes mainly due to being genetically tractable. The shared 
genomic  homology  between  humans  and  zebrafish  (Barbazuk  et  al.  2000) 
makes studies using developing zebrafish highly relevant to human health. We 
can use this model to investigate gene expression changes underlying a given 
phenotype, and begin to identify which genes or pathways in any organ of 
interest  (e.g.,  brain,  eye,  or  somites)  are  being  misexpressed  following 
developmental NP exposure.  
In  a  previous  study,  global  gene  expression  data  were  collected  on 
embryos exposed to 1.5 nm TMAT- and MES-AuNPs from 6 - 24 and 6 - 48 
hpf (Truong et al. Submitted). Analysis of this data using Ingenuity Pathway 
Analysis  software  (Ingenuity®  Systems,  www.ingenuity.com),  found  that  for 
both exposure time points, nervous system development and function was one 
of  the  biological  processes  most  perturbed.  Although  the  gene  expression 
profiling  was  conducted  using  samples  collected  during  the  most  rapid 
development  of  the  zebrafish  central  nervous  system  (suggesting  that  our 
results could be merely reflective of normal developmental patterns), pathways 
related  to  cellular  function  and  maintenance,  and  nervous  system 
development and function were significantly impacted compared to their time-
matched control. The gene expression data corroborates our hypothesis that 
exposure  to  TMAT-  and  MES-AuNPs  during  development  perturbs 113 
 
neurophysiological processes by 5 dpf leading to permanent damage to the 
central nervous system that persists into adulthood. Further analyses will be 
required to determine the extent to which the central nervous system or other 
target organs contribute to the observed behavioral phenotypes.  
An additional clue to the molecular impact of the tested NPs comes 
from  the  NPs,  themselves.  Our  study  demonstrates  that  exposure  to  gold 
nanoparticles  functionalized  with  MES  or  TMAT,  induces  unexpected 
behavioral  effects  that  are  driven  by  the  surface  functionalities..  The 
behavioral  abnormalities  detected  cannot  be  generalized  to  every  gold 
nanoparticle. For example, MEEE-AuNP exposed embryos did not exhibit any 
behavior defects, but MES- and TMAT-AuNP exposed embryos did. These 
results suggest that surface coatings, and in this case the charge specifically, 
either positive or negative, has a significant impact on development. Further 
studies are currently being conducted by our group to begin to determine how 
NP surface charge impacts development. 
 
Conclusion 
In  summary,  evaluation  of  adult  zebrafish  after  acute  exposure  to 
nanoparticles during embryonic development provides critical information for 
predicting potential long-term effects of specific NPs. From this study, we have 
learned that exposure to NPs during development can have lasting impacts on 
the  central  nervous  system.  More  follow-up  studies  using  different 114 
 
nanoparticles  must  be  conducted  to  determine  what  physicochemical 
properties are driving these responses. Collectively, all data point to surface 
functionalization of a nanoparticle being a critical driver to adverse response 
since  the  effects  observed  are  isolated  to  only  certain  functional  groups. 
Utilizing  the  zebrafish  model  for  acute  NP  exposure  and  long-term 
development studies provides insight into potential human health implications 
and  allows  for follow-up  investigation  at  the molecular level to address  the 
mode of action underlying these undesired effects. Studies using this model 
will  help  regulatory  agencies  establish  safety  precautions  to  minimize 
detrimental  effects  from  nanoparticles  and  provide  data  that  will  aid  NP 
manufacturers in developing safer NPs that are both effective and nontoxic. 
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Figure 4- 1. Transient AuNP exposure results in abnormal behavior at 
120 hpf. 
(a) Distance moved for embryos exposed to 50 µg/mL of MES- and MEEE- 
AuNP or 10 µg/mL TMAT-AuNPs. (b) Analysis of the total distance traveled 
during the dark cycle for the sum of three consecutive  cycles. Data with * 
denotes  statistical  significance  determined  by  one-way  ANOVA,  Dunnet‟s 
post-test. *p<0.05, **p<0.01. Error bars represent standard error. 
   119 
 
 
 
Figure 4- 2. AuNPs effect on development into adulthood. 
Percent of adult survivorship of embryos exposed to 1.5 nm MES- or TMAT- 
AuNPs, or embryo media control from 0 to 5 days post fertilization (dpf), and 
were  rinsed  prior  to  being  raised  in  fresh  water  until  122  dpf.  Statistical 
significance was determined using a Fisher Exact Test. *p<0.05.  
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Figure 4- 3. Total distanced traveled and velocity following a stimulus. 
Immediately after a tap on the tank (a) or a light stimulus (b), total distance 
travelled and velocity was recorded for 10 minutes for 5 fish (n=5). To account 
for  size  difference  in  the  treated  versus  control  fish,  movement  data  were 
normalized to fish size using the average morphometric index determined for 
each treatment group. Statistical significance (p<0.05) relative to control was 
determined using One way ANOVA with a Dunnett‟s Post Hoc Test. Error bars 
represent standard error. 
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Table 4- 1. Mean growth, survival and condition factor indices (± SEM) of 
adult zebrafish exposed to embryo media, MES- or TMAT- AuNP. 
Means  with  different  superscript  letter  designations  within  columns  are 
statistically significantly different from the embryo media control (p<0.05). 
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Abstract 
Embryonic zebrafish were  used  to assess the  impact  of  solution  ion 
concentrations on agglomeration and resulting in vivo biological responses of 
gold  nanoparticles  (AuNPs).  The  minimum  ion  concentration  necessary  to 
support  embryonic  development  was  determined.  Surprisingly,  zebrafish 
exhibit no adverse outcomes when raised in nearly ion free media. During a 
rapid throughput screening of gold nanoparticles, 1.2 nm 3-mercaptopropionic 
acid-functionalized  gold  nanoparticles  (1.2  nm  3-MPA-AuNPs)  rapidly 
agglomerate in exposure solutions. When embryos were exposed to 1.2 nm 3-
MPA AuNPs dispersed in low ionic media, both morbidity and mortality were 
induced,  but  when  suspended  in  high  ionic  media,  there  was  little  to  no 
biological response. We demonstrated that the media ionic strength greatly 
affects agglomeration  rates  and  biological  responses.  Most  importantly,  the 
insensitivity  of  the  zebrafish  embryo  to  external  ions  indicates  that  it  is 
possible, and necessary, to adjust the exposure media conditions to optimize 
NP dispersion prior to assessment. 
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Introduction 
The  use  and  incorporation  of  nanoparticles  (NPs)  into  industrial and 
consumer  products  is  increasing.  At  the  present,  their  impact  on  the 
environment  and  human  health  remains  largely  unknown.  Although  many 
studies  have  investigated  NP  effects,  the  materials  used,  the  experimental 
assays, the model and platform (in vivo or in vitro) are highly diverse. These 
non-systematic  approaches  make  it  difficult  to  interpret  the  results  and 
understand potential health and environmental implications of NPs. Without 
toxicological  data  collected  systematically  (with  similar  materials,  relevant 
platforms  and  assays),  it  will  be  challenging  to  identify  potential  risks 
associated  with  NP  exposure.  Efficient,  relevant,  and  reliable  toxicological 
models will help acquire this data. 
One means of bridging this knowledge gap is by assessing nanoparticle 
toxicity in complex biological systems. Toxicological assessments can utilize 
both in vitro and in vivo methodologies. While cell culture-based approaches 
are rapid, cost effective and amendable to high throughput analysis, the utility 
and predictivity of in vitro data is limited as individual cells in artificial culture 
environments lack the complexity of whole animal systems. Commonly used in 
vivo  systems,  such  as  laboratory  rodents  (Paigen  2003),  are  likely  more 
relevant and are extensively used for hazard identification as part of a risk 
assessment process. However, for the evaluation of numerous nanoparticles, 
the animal and labor related cost, and the high-test material demands lend 
rodent-based studies incompatible for high throughput data collection. Rapid, 125 
 
applicable toxicity screens are necessary to assess the backlog of untested 
nanoparticles  and  to  begin  defining  the  basic  NP  characteristics  that  drive 
biological responses.  
An alternative model to help understand the influence of nanoparticle 
stability  on  biological  responses  is  the  embryonic  zebrafish  model  (Parng 
2005, Bowman and Zon 2010). As a widely accepted model for mechanistic-
based  toxicological  studies,  the  embryonic  zebrafish  offers  a  rapid,  high 
throughput  platform  to  assess  chemical  and  biological  system  interactions 
(Rubinstein  2003,  Furgeson  and  Fako  2009,  Yang  et  al.  2009).  Female 
zebrafish produce a few hundred embryos each spawn, which allows for large 
sample  sizes  and  rapid  assessments.  Embryos  develop  externally  and  are 
optically clear, allowing for non-invasive evaluations. While other researchers 
have used zebrafish to assess NPs toxicity (Lee et al. 2007, Bar-Ilan et al. 
2009), our group has developed rapid methods using this model to quickly 
evaluate NP responses in a multi-well plate format in a systematic manner 
(Usenko et al. 2007, Harper et al. 2008, Truong et al. In Press). Using this in 
vivo platform, the impact of NP exposure on mortality, morbidity, and complex 
central nervous system function can be rapidly assessed. These assessments 
are  simultaneous  and  allow  for  evaluations  using  a  minimal  amount  of 
nanomaterials, which further favors rapid throughput data collection. 
Most in vivo and in vitro screening approaches utilize media that are 
rich  in  ionic  species.  These  ions  are  often  critical  for  viability  and  cellular 126 
 
function.  It  is  well  established  that  suspension  of  nanoparticles  in  ion-rich 
aqueous solution often agglomerate resulting in a loss of NPs monodispersion 
(Murdock et al. 2008). This issue of nanoparticle agglomeration in aqueous 
conditions extends to effect assessment of NPs in other systems such as cell 
culture  (Jin  et  al.  2010)  and  in  vivo  models  such  as  embryonic  zebrafish. 
Agglomeration  of  nanoparticles  is  problematical  since  the  resulting  surface 
area, charge, and sizes are drastically different compared to the synthesized 
particle. Clearly, these parameters influence resulting toxicological outcome. 
At  present,  most  researchers  assess  nanoparticle  stability  following 
synthesis in  deionized  or reverse  osmosis (RO)  water (Sayes  and Warheit 
2009),  while  toxicological  studies  are  often  evaluated  in  ion-rich  assay 
systems. Many groups have tackled the dispersion challenge by coating NPs 
with  various  moieties.  These  include  surfactants  and  compounds  such  as 
sodium dodecyl sulfate (SDS), sodium citrate, gum arabic, polyvinylpyrrolidone 
(PVP), or ligands and polymers (Olenin et al. 2008, Tolaymat et al. 2008). 
Although these agents are effective in favoring dispersion, they dramatically 
alter NP surface properties. Coating types on quantum dots are the primary 
determinant  of  cytotoxicity  and  immunotoxicity  in  HEK  cell  lines  (Ryman-
Rasmussen  et  al.  2007).  Alteration  to  the  surface  coatings  results  in 
significantly varied cytotoxic response to iron oxide nanoparticles (Ying and 
Hwang 2010). When natural organic matter is added, the surface properties 
and  size  characteristics  are  dramatically  altered.  For  example,  Suwannee 127 
 
River humic acid and fulvic acid, when added to C60 fullerenes, agglomerate 
size, and morphology significantly changed (Xie et al. 2008). The widespread 
use of coatings is a major concern as they are used to modify the surface 
properties of the suspended test material. Since NP surface properties are 
major  drivers  of  the  nanoparticle-biological  interface,  NP  coating  for 
experimental  convenience  may  complicate  data  interpretation.  We  propose 
that  the  zebrafish  offers  an  alternative  method  to  assessing  NP  toxicity  by 
overcome  some  of  these  limitations.  Zebrafish  are  brackish  fish  that  can 
tolerate  a  wide  range  of  ion  concentrations  (Lawrence  2007,  Uliano  et  al. 
2010), but the tolerable range is not well-defined for embryonic development. 
Embryos can tolerate increased salinity level of 0.196 parts per thousand [ppt] 
up to 2 ppt (Sawant et al. 2001). 
With this information, we instead focused on defining the minimum ion 
concentration necessary to support normal embryonic zebrafish development. 
We  reasoned  that  if  zebrafish  could  develop  normally  in  low  ionic 
concentration media, more classes of NPs could be assessed because NP 
agglomeration  could  be  minimized  during  the  exposure  period.  In  previous 
studies, we assessed nanoparticle-biological interactions from a library of gold 
nanoparticles. During that screening, 1.2 nm gold nanoparticles functionalized 
with 3-mercaptopropionic acid (1.2 nm 3-MPA-AuNPs) rapidly agglomerated 
and fell out of solution. The goal of the current proof of concept study was to 
determine  the  influence  of  ionic  strength  on  agglomeration  and  resulting 128 
 
biological responses. We determined that zebrafish can develop normally up 
to 120 hours post fertilization (hpf) in the absence of externally added ions and 
that the ionic concentration of the media greatly influenced the agglomeration 
rate  and  biological  responses  of  1.2  nm  3-MPA-AuNPs.  The  tolerance  of 
zebrafish  embryos  to  various  ionic  strength  media  will  have  the  practical 
advantage in extending the range of materials that can be more accurately 
assessed in this powerful in vivo model. 
 
Materials and Methods 
Nanoparticles 
Materials: Hydrogen tetrachloroaurate (HAuCl4• H2O) was purchased from 
Strem.  Dichloromethane  and  tetrahydrofuran  (THF)  were  purchased  from 
Mallinckrodt  Chemicals.  All  other  compounds  were  purchased  from  Sigma-
Aldrich Chemical Co. All chemicals were used as received. Nanopure water 
(18.2 MΩ•cm resistivity) was prepared with a Barnstead Nanopure filtration 
system  and  used  for  all  aqueous  samples.  Polyethersulfone  diafiltration 
membranes Omega TI10K were obtained from Pall Life Sciences. The amine 
functionalized  SMART  Grids  for  TEM  imaging  were  purchased  from  Dune 
Sciences. 
 
Procedure for preparation of 3-mercaptopropionic (MPA) protected gold 
nanoparticle:  Water  soluble,  3-mercaptopropionic  stabilized  nanoparticles 129 
 
were prepared through interfacial ligand exchange reaction between 1.5 nm 
phosphine-stabilized  nanoparticles  (Au101(PPh)21Cl5)    dissolved  in 
dichloromethane/THF  mixture  with  3-mercaptopropionic  acid  in  water  using 
the literature procedure (Woehrle et al. 2005). Briefly, a solution of 45 mg of 
1.5 nm Au101(PPh)21Cl5  in 20 mL of dichloromethane/THF (1:1 mixture) was 
added  to  a  solution  of  23  mg  of  3-mercaptopropionic  acid  in  30  mL  of 
phosphate  KH2PO4/K2HPO4  buffer    (10mM,  pH=8).  The  biphasic  reaction 
mixture was stirred rapidly at room temperature for 4 hours. The reaction was 
completed  when dark  colored  nanoparticles  transferred from  the organic to 
aqueous  phase.  The  layers  were  separated,  and  organic  impurities  were 
removed by washing the aqueous layer with dichloromethane. Solvents were 
removed under reduced pressure at room temperature and crude material was 
purified from excess ligand by diafiltration using 10 kDa membrane with 50 
volumes of nanopure water. After lyophilization, the powdered material was 
obtained and characterized. 
 
Analytical  procedures:  Proton  NMR  spectra  were  collected  at  25°C  on  a 
(ppm) with residual  -
visible  (UV-Vis)  spectra    were  obtained  on  a  Hewlett-Packard  8453  diode 
array instrument with a fixed slit width of 1 nm using 1-cm quartz cuvettes. 
Transmission electron microscopy (TEM) images were collected at 300kV with 130 
 
an  FEI  Titan  using  a  Cs  aberration  corrector.  Nanoparticle  samples  were 
prepared on amine functionalized SMART grids by soaking the grid in a dilute 
nanoparticle solution (0.2 mg/mL) and then in nanopure water for 2 minutes 
each. The grid was then dried in the air.  
 
Zebrafish 
Exposure protocol: Adult Tropical 5D strain of zebrafish (Danio rerio) 
were kept at standard laboratory conditions of 28°C on a 14h light/10h dark 
photoperiod in fish water (FW) consisting of RO water supplemented with a 
commercially available salt solution (0.6% Instant Ocean®). Zebrafish were 
housed  and  reared  at  Sinnhuber  Aquatic  Research  Laboratory  (SARL)  at 
Oregon State University. Adult zebrafish were group spawned and embryos 
were collected and staged (Kimmel et al. 1995). To increase bioavailability, at 
four  hours  post  fertilization  (hpf),  the  chorion,  an  acellular  envelope 
surrounding  the  embryo  was  removed  by  pronase.  Briefly,  embryos  were 
placed in 25mL of FW with 50 μL of 41 mg/mL pronase (Sigma Aldrich) and 
gently agitated for 6.5 minutes; the water was decanted and replenished with 
fresh  FW  for  10  minutes.  Embryos  were  rested  for  30  minutes  prior  to 
transferring into exposure solution. After resting, dechorionated embryos were 
transferred  to  individual  wells  of  a  96-well  plate  with  100  µL  of  exposure 
solution (n=16, three replicates). Exposures were static and continued under 
standard laboratory conditions in sealed plates and kept in the dark until 120 131 
 
hpf.  At  24  hpf,  each  individual  embryo  was  scored  for  mortality  and 
developmental  progression.  By  120  hpf,  each  embryo  was  assessed  for 
mortality,  and  fifteen  morphological  malformations(Truong  et  al.  2010).  The 
percent of mortality and total morbidity were calculated and graphed as mean 
of three replicates with standard error bars.  
 
Exposure  solutions:  1.2  nm  3-MPA-AuNPs  was  suspended  with  varying 
ionic  concentrations  of  embryo  media  (EM),  these  solutions  were  used  to 
create working solutions with a concentration of 50 µg/mL. A Calipher Zephyr 
Liquid Handler was used to create five-fold serial dilutions (0 – 50 µg/mL, five 
concentrations)  for  each  ionic  strength  medium  in  96-  well  plates.  Embryo 
medium  consisted  of  15  mM  NaCl,  0.5  mM  KCl,  1  mM  MgSO4,  0.15  mM 
KH2PO4, 0.05 mM Na2HPO4, and 0.7 mM NaHCO3 (Westerfield 2000). Six 
ionic  strength  media  were  made  by  diluting  100%  EM  with  RO  water  [0% 
(11µS, 0.007 ppt), 0.16% (14µS, 0.01 ppt), 0.8% (34 µS, 0.024 ppt), 4% (113 
µS, 0.08 ppt), 20% (480 µS, 0.34 ppt), and 100% (2420 µS, 1.7 ppt) EM]. 
Since the buffering capacity of the solution would be reduced at the lower ionic 
strength solutions, the pH of 1.2 nm 3-MPA-AuNPs suspended in the various 
ionic concentrations was measured and did not vary more than 0.5 units from 
an average pH of 6.5.  
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Behavior  assay:  Using  Viewpoint  LifeScience  Zebrabox  Quantization 
System, behavioral responses were evaluated in exposed embryos prior to the 
toxicity assessment. Prior to evaluation, embryos were acclimated to the light 
for  20  minutes,  after  which  the  lights  were  turned  off  (dark  period)  for  10 
minutes, and then on for five minutes (light period). The output data files were 
processed  using  a  custom  perl  script  to  average  total  movement  (pixel 
changes  per  second)  for  the  dark  period.  Sixteen  embryos  were  used  per 
concentration and three replicates were completed. 
 
Statistics:  All  analyses  were  compiled  using  SigmaPlot  11  (SPSS  Inc, 
Chicago,  IL).  One-way  ANOVA  (p<0.05)  and  Dunnetts  post  hoc  test  were 
used to assess mortality, morbidity and behavioral changes. Each exposure 
group  for  each  concentration  consisted  of  16  individual  exposed  embryos 
(n=16) and three replicates 
 
Results 
Characterization of 1.2 nm 3-MPA-AuNPs  
Each toxicological assessment was performed using the same parent 
batch  of  1.2  nm  3-MPA-AuNPs.  After  synthesis,  characterization  was 
completed to define the core size and surface functionalization. TEM was used 
to calculate the average size of the nanoparticles. Size analysis (Figure 1a) 133 
 
revealed  the  average  particle  diameter  was  1.2  ±  0.3  nm  (N=399).  Proton 
NMR showed broad peak at 2.4–4.2 ppm (Figure 1c) confirming the 3-MPA 
ligand  (Figure  1b)  was  attached  to  the  gold  core  and  no  impurities  (which 
would appear as sharp signals) were detected. Additionally, ultraviolet-visible 
absorption  spectroscopy  (UV-Vis)  was  used  to  confirm  the  core  size  and 
degree of agglomeration of 1.2 nm 3-MPA-AuNPs in nanopure water (Figure 
1d).  These  methods  demonstrate  that  these  AuNPs  are  free  of  molecular 
impurities and are precisely engineered 1.2 nm gold particles functionalized 
with 3-mercaptopropionic acid ligands. 
 
Embryo medium causes precipitation of 1.2 nm 3-MPA-AuNPs  
Embryos were exposed to 1.2 nm 3-MPA-AuNPs suspended in 100% 
embryo  medium  over  a  five-fold  concentration  range  (0.08  -  50  µg/mL)  to 
determine  if  the  nanoparticles  elicited  mortality  or  if  they  induced 
developmental malformations. Upon suspension of the dried 1.2 nm 3-MPA-
AuNPs, no precipitation was immediately visible. However, when the embryos 
were  assessed  at  24  hpf,  nanoparticle  precipitants  were  detected  on  the 
bottom  of  the  wells  and  surrounding  the  animal.  This  exposure  scenario 
continued until 120 hpf, when the zebrafish were evaluated. We tracked the 
agglomeration state of 1.2 nm 3-MPA-AuNPs using UV-VIS and we found that 
after 18  hours, most of  the  AuNPs  were  no  longer in  solution  (Figure  2a). 
Under these conditions, exposure to 1.2 nm 3-MPA-AuNPs did not increase 134 
 
mortality  or  malformations.  However,  at  50  µg/mL,  100%  of  the  exposed 
embryos  lacked  a  touch  response  (data  not  shown).  Although  the 
nanoparticles had agglomerated, they still induced a subtle adverse biological 
response. 
We took the approach to identify a dilution of embryo medium (EM) with 
a level of ions that could support a stable NP dispersion which should favor an 
increase  in  nanoparticle  bioavailability  throughout  an  extended  exposure 
period.  We  evaluated  nanoparticle  agglomeration  at  the  two  highest 
concentrations (10 and 50 µg/mL) over six percentages of EM (0  - 100%). 
Absorbance was measured at 18 and 114 hours, which corresponded to the 
time points the when exposed zebrafish would be evaluated for toxicological 
responses. As illustrated in Figure 2b, in 0% EM, the 1.2nm 3-MPA-AuNPs did 
not  agglomerate.  On  the  other  hand,  when  1.2  nm  3-MPA-AuNPs  were 
suspended  in  100%  EM,  only  3  and  0.1%  of  the  particles  remained  in 
suspension at 114 hours, at 10 and 50 µg/mL, respectively (Figure 2c). At 
concentrations  between  4  and  100%  EM,  there  was  a  low  percentage  of 
dispersed 1.2 nm 3-MPA-AuNPs. With the decreased ionic concentration, the 
amount of suspended AuNPs increased. At concentrations between 0 - 0.8% 
EM,  the  amount  of  dispersed  AuNPs  was  typically  greater  than  90%.  This 
demonstrates that the concentration of ions in the test media indeed plays a 
major role in the degree of 1.2 nm 3-MPA-AuNPs agglomeration. 
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Dechorionated zebrafish embryos can tolerate low ion concentrations 
Although embryonic zebrafish are sensitive to toxicants and well suited 
for  mechanistic-based  toxicological  studies,  the  importance  of  media  ionic 
strength for embryonic development in the absence of the chorion is unknown. 
To  reveal  the  minimum  ionic  strength  required  to  support  embryonic 
development, embryos were dechorionated and exposed to six different ion 
concentration media (five-fold serial dilution: 0, 0.16, 0.8, 4, 20, 100% EM in 
RO water) at six hpf. The initial assessments at 24 hpf revealed no differences 
between the groups when scoring for mortality or changes in developmental 
progression. At 120 hpf, exposed embryos were evaluated for mortality and a 
full suite of complex morphological endpoints. As Figure 3a illustrates, even at 
the  lower  concentrations  of  EM  (0  –  0.8%),  the  incidence  of  mortality  and 
malformation at 120 hpf were not statistically different. To determine if varying 
ion concentration affected central nervous system function, exposed embryos 
were  assessed  for  motor  activity  in  the  dark  using  ViewPoint  LifeScience 
Zebralab. Larvae in 100% EM had a movement level of five pixels per second 
in the dark (Figure 3b). At the lower concentrations (0 and 0.16% EM) there 
was  only  a  modest  and  not  statistically  significant  decrease  in  pixels  per 
second  (~4).  Visually,  the  embryos  exposed  to  0%  and  100%  EM  were 
morphologically  indistinguishable  (Figure  3c).  These  studies  indicate  that 
dechorionated embryos can tolerate low ionic strength solutions and develop 
normally to at least 120 hpf. 136 
 
1.2 nm 3-MPA-AuNPs developmental toxicity 
To investigate whether the agglomeration of 1.2 nm 3-MPA-AuNPs was 
masking toxic potential, the AuNPs were prepared at five concentrations (0 – 
50  µg/mL)  in  various  ionic  strength  media.  These  solutions  were  then 
continuously and statically exposed to six hpf dechorionated embryos until 120 
hpf. As Figure 4a illustrates, at the higher ionic concentrations (20  - 100% 
EM), there was little mortality and malformation above background (less than 
13%). This correlates well with the stability data showing that less than 20% of 
the AuNPs was in solution by 120 hpf. For the other ion concentrations (0 - 4% 
EM),  the  percent  of  mortality  and  malformations  increased  as  the  ion 
concentration  decreased.  For  each  ionic  concentration,  a  dose  dependent 
increase  in mortality  and malformation  was  observed.  At  120  hpf,  exposed 
embryos  were  assessed  for  behavioral  abnormalities.  Data  generated  from 
dead or malformed embryos was removed prior to processing. At the higher 
ion  concentrations  (4  -  100%  EM)  there  were  no  statistically  significant 
differences  in  the  motor  activity  level  between  the  groups,  while  the  lower 
concentrations  (0  –  0.8%  EM)  motor  deficits  were  significant  at  the  higher 
nanoparticle  concentrations  (Figure  4b).  Collectively,  as  the  ionic 
concentration  decreased,  more  1.2  nm  3-MPA-AuNPs  remained  in  solution 
and  there  was  a  corresponding  increase  in  the  percent  of  mortality, 
malformation, and behavioral deficits in the exposed embryos. 
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Discussion 
In this in vivo study, we report that dechorionated zebrafish embryos 
develop normally up to 120 hpf in low ionic strength medium. Furthermore, we 
report  that  the  response  to  1.2  nm  3-MPA-AuNPs  exposure  is  highly 
dependent on the medial constituents. When suspended in high ionic strength 
medium, agglomeration occurs within 18 hours and the AuNPs precipitate and 
elicit  little  to  no  adverse  biological  responses.  On  the  other  hand,  when 
suspended in low ionic strength, the AuNPs remain dispersed in solution and 
induce significant morbidity and mortality. 
One potential explanation for the increased sensitivity to 1.2 nm 3-MPA-
AuNPs in low ionic strength solutions is that the low salt conditions lead to a 
general increase in embryonic stress, and the changes in agglomeration state 
plays  little  or  no  role  in  the  differential  toxicological  response.  To  directly 
address this possibility, we exposed embryonic zebrafish to gold nanoparticles 
with  a  1.5  nm  core  and  functionalized  either  with  MES  (2-
mercaptoethanesulfonic  acid)  or  TMAT  (2-mercapto-N,  N,  N  – 
trimethylethanaminium).  Previous  studies  have  demonstrated  that  these 
materials induce differential biological responses in zebrafish, but they do not 
agglomerate over time in standard high ionic strength medium (Harper et al. In 
press,  Truong  et  al.  Submitted).  When  these  particular  nanoparticles  were 
suspended  in  RO  water,  the  biological  responses  for  1.5nm  TMAT-AuNPs 
(unpublished  data)  and  MES-AuNPs  (Supplemental  Figure  1)  were 138 
 
indistinguishable  from  the  responses  observed  when  the  particles  were 
suspended in high ionic strength medium. This strongly suggests that altering 
the medium‟s ionic strength does not lead to a general stress response, and 
the increase in 1.2 nm 3-MPA-AuNPs toxicity is attributed to changes in the 
particle properties themselves. The embryo medium used for most embryonic 
zebrafish  toxicity  studies  typically  contains  high  concentrations  of  divalent 
ions, and these ions are known to lead to nanoparticles agglomeration and 
produce complex particle behaviors (Saleh et al. 2008, Liu et al. 2009). By 
diluting the EM with RO water, we found that ion concentration of medium 
influenced agglomeration rate, which is consistent with what was found for cell 
culture (Jin, et al. 2010) and other mediums (Elimelech and Omelia 1990). 
When NPs agglomerate, their dissolution is impacted. Agglomeration of silver 
nanoparticle  causes  dissolution  rate  to  be  reduced,  but  this  is  highly 
dependent on the electrolytes and its concentration in the medium (Li et al. 
2010). The number of available particles is drastically different when solutions 
are  monodispersed  versus  clustering  together.  When  nanoparticles 
agglomerate, this effectively changes the surface area to volume ratio. Particle 
surface area is a major player in nanoparticle-induced toxicity. For example, 
particle  surface  area  was  the  principle  driver  in  producing  differential  gene 
expression  changes  than  was  particle  mass  or  number  in  alveolar 
macrophages (Waters et al. 2009). Cytotoxicity is also induced by iron oxide in 
a  surface  area  dependent  manner  (Ying  and  Hwang  2010).  When  NPs 139 
 
agglomerate,  there  is  a  wide  distribution  of  sizes  produced.  It  is  currently 
impossible to understand what fractional agglomerate size is responsible for 
producing  a  biological  response.  In  a  recent  study,  cytotoxicity  was  size-
dependent when exposed to 0.8 to 15 nm gold nanoparticles (Pan et al. 2007) 
and 5, 20 and 50 nm silver nanoparticles (Liu et al. 2010) where the smaller 
nanoparticles were more toxic than their larger counterpart. Gold and silver 
nanoparticles regulate membrane receptor internalization in a size-dependent 
manner (Jiang et al. 2008). These studies suggest that particle size influences 
the biological response. So effectively, agglomeration of nanoparticle causes a 
change  in  concentration,  dissolution,  surface  area,  and  particle  size,  which 
ultimately results in complex differential responses. 
We  found,  for  the  first  time,  that  dechorionated  embryos  develop 
morphologically normal and display normal CNS function up to at least 120 hpf 
when raised in reverse osmosis (RO) water. These finding will provide new 
opportunities to exploit embryonic zebrafish to identify the physico-chemical 
NP properties that are important to produce specific biological responses. With 
this flexibility, we can now adapt the testing model to conditions ideal for the 
NPs rather than the other way around. For example, researchers are routinely 
adding agents to the NP solutions that favor dispersion, but after addition of 
these  agents,  the  NP  surface  properties  are  drastically  changed.  Although 
these coating agents help to disperse NPs in aqueous medias, the addition of 140 
 
capping agents at the very least, complicates the interpretation of toxicological 
response data with the added variability. 
In  summary,  since  embryonic  and  larval  zebrafish  can  tolerate  wide 
ranges  of  ionic  strength,  we  recommend  an  approach  where  initial  NP 
agglomeration studies are performed under multiple ionic strengths covering 
the  exposure  duration.  Adjusting  the  assay  to  match  optimal  dispersion 
conditions  will  enhance  bioavailability  and  thus  increase  assay  sensitivity. 
Controlling agglomeration without the addition of arbitrary capping agents will 
allow assessment of a more broad range of nanoparticles and move us one-
step closer to identifying the key physico-chemical NP properties that drive 
specific biological responses. 
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Figure 5- 1. Characterization of 1.2 nm 3-MPA-AuNPs. 
(a) Transmission electron microscopy (TEM) image of 1.2 nm 3-MPA-AuNPs 
with  a  scale  bar  of  20  nm.  Analysis  of  399  individual  particles  yields  an 
average  particle  core  size  of  1.2  +/-  0.3nm.  (b)  Structure  of  AuNP  with  3-
mercaptopropionic acid ligands. (c) 
1HNMR analysis demonstrating that the 3-
MPA is attached to the surface of the nanoparticle. Impurities, if present would 
lead to sharp signals at less than 4 ppm chemical shift. The sharp signals at 
higher than 4 ppm are due to the NMR measurement solvent. (d) UV-visible 
spectrum of 1.2 nm 3-MPA-AuNPs dissolved in nanopure water. 
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Figure 5- 2. 1.2 nm 3-MPA-AuNPs in embryo media. 
Stability of solutions of 1.2 nm 3-MPA-AuNP at 50 µg/mL in (a) 100% embryo 
media (EM) and (b) 0% EM at 0, 18 and 114 hrs using UV-Vis. The decrease 
in  absorbance  across  the  spectra  to  zero  in  (a) indicates  complete  loss  of 
nanoparticles  from  solution,  as  opposed  (b)  where  essentially  no  loss  of 
particles is observed. (c) Table of nanoparticles that remain in solution at both 
10  and  50  µg/mL  over  time  when  suspended  in  varying  concentration  of 
embryo media.  
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Figure 5- 3.Embryonic zebrafish exposed to various percentage of EM. 
Embryos were dechorionated and exposed to various percentage of embryo 
media (0, 0.16, 0.8, 4, 20, and 100%) exhibited low mortality and malformation 
(a).  Exposed  120  hours  post  fertilizations  (hpf)  embryos  did  not  exhibit  a 
statistically significant change in behavior (b). Images were taken of embryos 
exposed to 0 and 100% EM at 120 hours post fertilization (hpf) (c). 
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Figure 5- 4.Toxicity of 1.2 nm 3-MPA-AuNP in various percentage of EM. 
Dechorionated  embryos  were  exposed  to  five  concentrations  of  1.2  nm  3-
MPA-AuNPs and six different solutions with varying ionic concentrations. As 
the ionic concentration decreased, mortality and malformations increased (a). 
Surviving embryos at 120 hpf were assessed for behavioral effects. Similarly, 
the  lower  concentrations  (0-0.8%)  caused  behavioral  changes  at  higher 
concentration,  while  the  higher  ionic  concentrations  (4-100%)  did  not  (b). 
Significance was determined using One Way ANOVA and a Dunnetts Post 
Hoc Test (p<0.05).  
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Figure 5S- 1. 1.5 nm MES-AuNP toxicity in EM and RO. 
Dechorionated embryos were exposed to five concentrations of 1.5 nm MES-
AuNPs suspended in 100% embryo medium and reverse osmosis water. The 
biological responses were indistinguishable between the two media. Data with 
* was statically significant when using a One Way ANOVA and a Dunnetts 
Post Hoc Test (p<0.05). 
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Abstract 
 
Embryonic  zebrafish  exposed  to  1.2  nm  gold  nanoparticles  (AuNPs) 
with  3-mercaptopropionic  acid  (3-MPA)  surface  group  fail  to  respond  to  a 
touch  on  the  caudal  fin  at  120  hours  post  fertilization  (hpf),  while  those 
exposed  to  1.3  nm  2-(2-(2-mercaptoethoxy)ethoxy)ethanol  (MEEE)  respond 
normally. Addition of a known neuromuscular stimulus, nicotine, revealed the 
3-MPA-AuNPs exposed embryos were not paralyzed. Immunohistochemistry 
labeling axons on Tg(NBT:MAPTGFP)zc3 embryos expressing GFP in primary 
motor neurons revealed that exposure to 3-MPA-AuNPs did not impact the 
number of motor neurons, but significantly reduced axonal projections, which 
may explain the observed inability to sense touch in the caudal fin. To provide 
insight  into  the  molecular  pathways  that  may  mediate  the  lack  of  a  touch 
response  and  the  differential  gene  expression  between  3-MPA-AuNP  and 
MEEE-AuNPs,  RNA-seq  was  performed  at  48  hpf  following  10  µg/mL 
exposure. We found 64 and 88 genes were differentially expressed by 3-MPA-
AuNPs  and  MEEE-AuNPs,  respectively,  compared  to  the  control.  We 
identified  the  most  statistically  perturbed  pathways  by  3-MPA-AuNPs  were 
neurophysiological  process  and  signal  transduction,  with  the  most 
misregulated gene being early growth response 1 (egr1). Collectively, these 
data  suggest  that  exposure  to  3-MPA-AuNPs  misregulates  egr1,  which 
impacts  axongenesis  in  the  caudal  fin  and  interferes  with  glutaminergic 
synapses  preventing  the  connection  of  sensory  neurons  and  impede  touch 152 
 
perception.  MEEE-AuNPs  impacted  genes  involved  in  immune  and 
inflammatory  systems  processes.  These  findings  confirm  that  surface 
functionalities of these nanoparticles contribute to the biological response and 
a systems toxicological approach in a relational and cost-effective model is a 
highly  productive  strategy  for  gaining  insight  into  nanomaterial-biological 
interactions. 
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Introduction 
Gold  nanoparticles  (AuNPs)  are  utilized  in  drug  delivery,  cellular 
imaging and cancer therapeutics 
1. With the increase in its application, the 
toxicological  data  on  AuNPs  is  slowly  growing.  In  vitro  studies  have 
demonstrated that some AuNPs can induce oxidative stress 
2, inflammation 
3 
and DNA damage 
4. These responses were dependent on the composition, 
size, and surface chemistry of the AuNPs. In a previous study, we assessed 
the interactions between nanoparticles and biological systems using a library 
of gold nanoparticles and the embryonic zebrafish. We found that embryos 
exposed to 1.2 nm gold nanoparticles functionalized with 3-mercaptopropionic 
acid  [3-MPA]  (3-MPA-AuNPs)  did  not  exhibit  the  characteristic  normal 
swimming  response  after  being  touched  on  the  caudal  fin 
5.  However, 
exposure  to  a  1.3  nm  gold  nanoparticle  functionalized  with  2-(2-(2-
mercaptoethoxy)ethoxy)ethanol  [MEEE]  (MEEE-AuNPs)  had  a  robust  and 
normal  touch  response 
6.  Since  mechanosensory  neurons  mediate  the 
zebrafish touch response 
7, determining the molecular mechanism underlying 
its absence is a simple assessment of sensory neurons and neuromusculature 
function.  
While there is a growing body of knowledge on the physical effects of 
NPs on development 
6, 8, there is virtually no data available on the genomic 
responses that precede effects. A valuable approach to investigating the mode 
of action underlying observed toxic effects is through the global measurements 154 
 
of  gene  expression  changes.  There  are  multiple  methods  to  conduct 
transcriptomics  to  identify  gene  expression  changes  after  exposure  to  a 
chemical or toxicant 
6, 9. The current method of choice is deep sequencing of 
cDNA  fragments  (RNA-seq),  which  is  highly  sensitive  and  provides  single-
base resolution to understand gene expression changes 
10. RNA-seq can be 
used to quantify and study genome-wide gene expression changes by aligning 
RNA-seq reads to a reference sequence to identify which genes (features) are 
expressed in a biological sample at a given point in time. The number of reads 
per  feature  is  counted  and  statistics  are  applied  to  calculate  and  infer 
expression  levels 
11.  Application  of  transcriptomics  to  understand  the 
nanoparticle-biological  interaction  will  help  advance  the  field  of 
nanotechnology by providing data that can be used to understand structure-
activity relationships associated with NP toxicity. 
The  focus  of  this  study  was  to  gain  a  better  understanding  of  how 
exposure  to  3-MPA-AuNPs,  but  not  MEEE-AuNPs,  leads  to  a  larvae  with 
impaired touch response.  We conducted RNA-seq using embryos exposed to 
vehicle control versus 10 µg/mL 3-MPA-AuNPs or 10 µg/mL MEEE-AuNPs 
from 6 to 48 hpf to understand how exposure to 3-MPA-AuNPs result in an 
abnormal touch response, impaired locomotor activity, and reduced peripheral 
axonal  projections.  We  found  that  developmental  3-MPA-AuNP  exposure 
impacts  genes  involved  in  neurophysiological  process,  apoptosis,  signal 
transduction,  and  neurogenesis;  therefore,  we  propose  that  perturbed 155 
 
neurogenesis  pathways,  specifically  EGR1,  mediates  the  touch  response 
deficiency.   
 
Results 
Gold nanoparticle characterization and biological response 
Two types of gold nanoparticles were precisely engineered with nearly 
identical attributes, except one was functionalized with 3-mercaptopronic acid 
(3-MPA) 
5]  and  the  other  2-(2-(2-mercaptoethoxy)ethoxy)ethanol  (MEEE) 
6. 
The  average  size  and  size  distribution  of  the  AuNPs  determined  by 
transmission electron microscopy (TEM) revealed the average particle size for 
AuNPs functionalized with 3-MPA was 1.2 ± 0.3 nm (N=399) and 1.3 ± 0.5 nm 
(N=667) for MEEE (Supplemental Figure 1 a and d). Characterization using 
nuclear magnetic resonance (
1H-NMR) spectrometry showed a broad peak at 
2.4 - 4.5 ppm (Supplemental Figure 1 b and e) which confirmed that the 
ligand was covalently attached and no impurities were detected. We used UV-
Vis absorption spectroscopy (Supplemental Figure 1 c and f) to confirm the 
degree  of  agglomeration.  The  thorough  characterization  techniques 
demonstrate the gold nanoparticles are pure and precisely engineered with 3-
MPA and MEEE ligands.  
In this study, we assessed the AuNPs‟s impact on embryonic zebrafish 
(Figure 1a). Exposure to either 3-MPA- or MEEE-AuNPs induced less than 20 
percent  morphological  malformations  for  all  concentrations  (0.016  –  50 156 
 
µg/mL).  However,  embryos  exposed  to  3-MPA-AuNPs  failed  to  respond  to 
touch  in  a  dose-dependent  manner  suggesting  that  the  surface  functional 
group drives the biological response. Embryos exposed to the ligands (MEEE, 
and 3-MPA) did not exhibit morphological malformations and had normal touch 
response (data not shown). 
 
3-MPA-AuNPs exposures impairs locomotor activity  
To determine whether embryos exposed to 3-MPA-AuNPs exhibited an 
abnormal touch response in the caudal fin because of a neuromuscular deficit, 
we exploited a known nicotinic acetylcholine (Ach) receptor agonist, nicotine, 
12  to  stimulate muscular  movement  at  120  hpf. We found  that  immediately 
following exposure to 20 µM nicotine (Figure 1b), larvae from both the control 
and 3-MPA-AuNP treatments exhibited a burst of swimming activity. For the 
first 10 seconds, there was a statistical difference in the total activity between 
the control and the 3-MPA-AuNP treated larvae. In the first 5 seconds, the 
control  larvae  swam  more  than  the  3-MPA-AuNP  treated.  In  the  next  4 
seconds, the 3-MPA-AuNP exposed larvae swam steadily at ~0.4 pixels, while 
the  control  larvae  decreased  to  0.2  pixels  at  7  seconds  with  no  further 
movement afterwards. Despite this difference, the total movement for larvae 
exposed  to  control  or  3-MPA-AuNPs  was  not  statistically  different  after the 
addition of nicotine. Thus, while these data demonstrate that exposure to 3-
MPA-AuNPs  impacts  locomotion,  it  does  not  cause  paralysis.  To  more 
thoroughly investigate the impact of 3-MPA-AuNP on locomotor activity, we 157 
 
tracked the average speed of the swimming larvae exposed to the control or 3-
MPA-AuNPs in a 5 minute light and dark cycle. As Figure 1c illustrates, the 
treated larvae average swim speed was significantly higher in the light, and 
lower in the dark, compared to the control. In the light, the control larvae speed 
was less than 1 mm/s, while the treated was ~1.25 mm/s. An inverse trend 
was observed in the dark, where the average control larvae speed was ~2.0 
mm/s,  and  average  speed  of  the  3-MPA-AuNPs  exposed  larvae  was  1.75 
mm/s (Figure 1d). The 3-MPA-AuNP exposed larvae swam a total distance of 
105 mm in the dark, while the controls travelled a total of 120 mm in the dark 
cycle, similar to the total swim distance (115 mm) of MEEE-AuNPs exposed 
larvae 
13.  The  swim  speed/distance  difference  between  the  3-MPA-AuNPs-
exposed  larvae  and  control  group  further  demonstrates  that  the  exposure 
significantly impacted locomotor activity. In contrast, MEEE-AuNPs exposure 
did  not  impact  locomotor  activity 
13,  suggesting  that  the  surface 
functionalization plays a role in the behavioral defects. 
 
Axonal projection is diminished in the caudal fin following exposure to 3-
MPA-AuNPs 
Based  on  the  abnormal  touch  response  and  swim  behavior  data 
demonstrating impaired locomotor activity, we hypothesized that exposure to 
3-MPA-AuNPs impaired neuronal development. To test this, we employed 72 158 
 
hpf  transgenic  embryos  that  express  GFP  in  primary  motor  neurons 
(Tg(NBT:MAPTGFP)zc3)  to  investigate  the  potential  impact  on  the 
development of  the  peripheral  nervous  system,  including  innervation  of  the 
caudal fin by whole animal immunohistochemistry targeting acetylated alpha 
tubulin  (AAT).  This  labels  most  axons  and  major  peripheral  processes  in 
developing embryos. Epi-fluorescent images of control (Figure 2a, c) and 3-
MPA-AuNPs exposed embryos (Figure 2b, d) revealed a reduction of axonal 
projections in the caudal fin fold in the treated embryos. 
 
Transcriptional profile of control, 3-MPA-AuNPs and MEEE-AuNPs 
For  each  of  3  replicates  per  treatment,  there  was  approximately  12 
million reads per replicate with a sequence length of 78 base pairs. These 
reads were mapped using Tophat 
14 to ensembl zebrafish assembly 9, which 
consisted of 17,919 annotated vega genes. Transcripts for each sample were 
identified  using  Cufflink 
15  and  assembled  together  to  create  a  merged 
annotation file with 32,480 genes. Each sample was analyzed with FastQC to 
determine the number of sequences and quality. As Table 1a illustrates, the 
average  total sequence  length for control, 3-MPA-  and  MEEE-AuNPs  were 
11,352,318, 13,536,905, and 13493,012 reads, respectively. Less than 127 
genes for each replicate failed to map (0.4%). These values passed quality 
control and provided confidence for future analysis.  159 
 
We determined differential gene expression between the two different 
functionalized gold nanoparticles and the control using the Cuffdiff program 
15. 
For each set of comparisons (control vs. 3-MPA-AuNPs, or control vs. MEEE-
AuNPs), the number of unmapped reads was identified (Table 1b). Cuffdiff  
provided the unmapped reads. Unmapped reads fell in the categories of fail, 
low data, no test or ok. Genes with a status of “no test” were placed in this 
category due to insufficient alignments for that gene to test, and those with 
“low  data”  were  categorized  accordingly  due  to  shallow  sequencing  or 
excessive complexity of the gene. Only reads with an “OK” status proceeded 
in the analysis. Approximately 60% of the reads tested belonged to the “OK” 
category  for  both  comparisons  (control  vs  3-MPA-AuNPs,  and  control  vs 
MEEE-AuNPs). We found 64 genes were differentially expressed by 3-MPA-
AuNPs and 88 genes by MEEE-AuNPs compared to the control (Table 1b, 
Supplemental  Table  2).  Within  the  64  statistically  significant  genes 
differentially expressed by 3-MPA-AuNP exposure, 57 were elevated, while 7 
were  repressed.  In  this  comparison,  there  were  ~1%  of  failed  reads,  and 
60.4%  that  mapped  successfully.  MEEE-AuNP  exposure  resulted  in 
differential  expression  of  88  genes  of  which  8  were  elevated  and  79  were 
repressed. 0.8% of reads failed to map while 59.4% were successful. Only 5 
genes were common between the two treatments (Supplemental Table 1). 
To  confidently  ascertain  that  exposure  to  3-MPA-  or  MEEE-AuNPs 
caused  gene  misregulation,  we  used  qRT-PCR  to  confirm  the  changes 160 
 
identified by RNA-seq. We confirmed four misregulated transcripts, two from 
each comparison that were elevated or repressed. As Table 2 illustrates, the 
direction  and  the  magnitude  of  the  gene  expression  changes  observed 
correspond between qRT-PCR and RNA-seq. 
 
3-MPA-AuNPs  induced  transcriptional  activity  and  impacts  on 
neurophysiological processes  
We  analyzed  the  differential  gene  expression  changes  between  the 
control  and  3-MPA-AuNPs  by  generating  a  heatmap  using  the  reads  per 
kilobase  of  exon  per  million  mapped  reads  (RPKM)  values,  which  is  a 
measure of transcriptional activity 
16.  Genes with RPKM values above 25 are 
considered to exhibit high levels of transcriptional activity 
14b. As Figure 3a 
illustrates,  the  control  expression  pattern  comprised  ~25%  of  genes  with 
associated RPKM values >25, while the expression pattern following 3-MPA-
AuNPs  exposure  comprised  40%  of  genes  with  RPKM  values  >  25.  To 
visualize  differential  expression  between  3-MPA-AuNPs  and  the  control,  a 
volcano plot was used to display the 64 statistically significant genes (Figure 
3b, red), Within the 64 differentially expressed genes, there were 28 and 48 
genes  with  a  RPKM  greater  than  25  in  the  control  and  3-MPA-AuNPs 
samples, respectively. The gene with the greatest transcriptional activity was 
BX296557.1 with a baseline RPKM value of 7,916 in the control and 74,377 in 
3-MPA-AuNPs.  161 
 
To understand the pathways that may have been affected by 3-MPA-
AuNPs, we utilized commercially available software, Metacore (GeneGo, St. 
Joseph, MI) to identify the most significant biological processes affected by 
this nanoparticle. We found that the top 10 statistically significant biological 
pathways  (p<0.05)  were  related  to  neurophysiological  process,  apoptosis, 
signal  transduction,  inflammation  signaling,  development,  reproduction  and 
immune response (Figure 5c). Neurophysiological processes were the most 
prevalent with three genes (EGR1, Junbl, PER2).  
 
MEEE-AuNPs impacts immune and inflammatory response  
We  identified  that  exposure  to  MEEE-AuNPs  leads  to  differential 
expression of 88 genes compared to the control. Approximately 26% of the 
control expression pattern consisted of moderately transcribed genes (RPKM 
values  less  than  10),  while  53%  of  the  MEEE-AuNPs  expression  profile 
consisted of moderately transcribed genes (Figure 4a). For both the control 
and MEEE-AuNPs samples, over 60% of the genes were highly transcribed 
with  RPKM  values  greater  than  25.  A  total  of  88  genes  were  significantly 
misexpressed  (Figure  4b).  Of  these  88  differentially  expressed  genes,  the 
control had 31 genes with a RPKM value higher than 25, while MEEE-AuNPs 
had 19. The most transcribed gene was zgc:158463 with a RPKM of 258 in 
the control and 666 in MEEE-AuNPs.  162 
 
A  pathway  analysis  approach  was  used  for  these  88  annotated 
differentially expressed genes (Figure 4c). We found the top 10 statistically 
significant  biological  processes  perturbed  by  MEEE-AuNPs  were  related  to 
immune  response  –  Th17-derived  cytokines,  proliferation  (positive  and 
negative  regulation  of  cell  proliferation),  signal  transduction, 
neurophysiological  process,  and apoptosis. The most  statistically  significant 
and  prevalent  pathway  was  immune  response  and  inflammation,  which 
comprised four genes: C/EBP, c-Fos, PTGS2, C/EBPbeta. 
 
Common gold nanoparticle response  
To find common gold nanoparticle gene expression pattern, we took the 
individual gene lists of control vs 3-MPA-AuNPs and control vs. MEEE-AuNPs 
gene list and compared those lists to one another (Figure 5a). By doing this, 
the new list consisted of genes common between the two AuNPs. We found 
that for 3-MPA-AuNPs, 59 of 64 differentially expressed genes were unique to 
that  gold  nanoparticle.  For  MEEE-AuNPs,  83  of  88  differentially  expressed 
genes were uniquely expressed. There were 5 genes that were common in 
both  comparisons  (control  vs  each  gold  nanoparticles).  These  genes  were 
hsp47,  fos,  BX548011.3,  fkbp5,  and  mmp9.  Of  these  5  genes,  hsp47, 
BX548011.3 and fkbp5 were differentially expressed in the same direction by 
both  3-MPA-  and  MEEE-AuNPs,  while  the  rest  were  elevated  following  3-
MPA-AuNPs exposure and repressed following MEEE-AuNPs exposure. 163 
 
Gold  nanoparticle  impacts  reproduction,  signal  transduction  and 
inflammation  
We chose to investigate how surface functionalization of nanoparticles 
affects  biological  processes.  To  accomplish  this,  the  3-MPA-  and  MEEE-
AuNPs  gene  lists  were  compared  to  the  control,  and  then  we  directly 
compared each functional group to identify the top ten statistically significant 
biological  processes  (Figure  5b).  Figure  5b  illustrates  that  the  biological 
processes that were significantly perturbed by both surface functional groups 
(p<0.05) were reproduction – gonadotropin regulation, signal transduction – 
leptin signaling, inflammation – IL-6 signaling, and anti-apoptosis. The genes 
involved  in  the  reproduction  –  gonadotropin  regulation  pathway  following 
exposure  to  MEEE-AuNPs  were  c-FOS,  NUR77,  COX-2,  and  for  3-MPA-
AuNPs, the genes misregulated were EGR1 and JunB. EGR1 played a large 
role in a number of the neuro-related pathways identified by Metacore. 
 
Discussion 
We  found  that  exposure  to  3-MPA-AuNPs  caused  morphological 
malformations and an abnormal touch response (i.e., failure to respond to a 
light touch on the caudal fin) 
5, while MEEE-AuNPs failed to produce adverse 
responses 
6,  13.  To  determine  if  this  response  failure  was  due  to  a 
neuromuscular defect, we used nicotine to assess locomotor activity in larvae 
lacking  a  touch  response.  The  ability  to  sense  and  to  move  is  achieved 164 
 
through different mechanisms. In this example, 3-MPA-AuNP exposed larvae 
lack a touch response in the caudal fin region, which can be interpreted two 
ways. Either the larvae can perceive touch but cannot physically move or they 
are  not  able  to  perceive  touch.  Therefore,  the  results  of  the  behavioral 
experiments  involving  addition  of  nicotine  to  3-MPA-AuNP  exposed  larvae 
demonstrate  that  because  mobility  was  preserved,  the  3-MPA-AuNPs 
perturbed the sensory portion of the circuit. To our knowledge, this is the first 
study to use nicotine as a challenge to determine if larvae had motor neuron 
defects after exposure to a nanoparticle. The larvae exposed to 3-MPA-AuNPs 
maintain  swimming  ability,  even  though  locomotor  activity  was  impacted. 
However, because the 3-MPA-AuNPs exposed larvae responded to nicotine, 
this test is not appropriate to evaluate whether the larvae can sense the touch. 
The  ability  to  swim  normally  indicates  that  neither  the  muscle  function  nor 
circuits underlying patterned motor output were impacted; suggesting that the 
sensory side of the touch response circuit is impaired.   
Nanoparticle  physicochemical  properties,  specifically  surface 
functionality,  greatly  influence  developmental  toxicity 
6,  8a.  The  nanoparticle 
core material (lead 
8a, 17, silver 
18, gold 
2, 19, etc) contributes to the toxicity when 
the  core  is  not  sufficiently  stabilized.  This  study  confirms  that  the  surface 
functionalization, in this case, 3-MPA, can impact bioactivity and causes both 
morphological and behavioral defects. Since every combination of core and 
surface  functional  group  cannot  be  tested,  a  systematic  approach  to  test 165 
 
precisely designed materials will allow us to determine which components of 
NPs  contribute  to  in  vivo  toxicity  and  establish  design  principles  for  safer 
nanoparticle products. 
Embryos exposed to 3-MPA-AuNPs had a lack of a touch response at 
120  hpf.  Glutamate  drives  touch  response  in  zebrafish  embryos  through  a 
rostral loop in the spinal cord 
20. The touch response is dependent on AMPA-
type glutamate receptor activation and confined to the most rostral part of the 
spinal  cord.  Using  whole  mount  immunohistochemistry  and  acetylated  α-
tubulin antibody, we found decreased axongenesis in the caudal fin following 
3-MPA-AuNP exposure 
21. Axons grow from head to tail into the tract of the 
post  optic  commissure  (TPOC)  beginning  at  18  hpf 
22.  In  this  study,  the 
nanoparticles are present at 6 hpf, which is prior to axongenesis, suggesting 
the  NPs  disrupt  the  axonal  growth  that  initiates  at  the  brain.  The 
immunohistochemistry  at  72  hpf  shows  that  the  axons  extending  from  the 
dorsorostral cluster (drc) are not affected, however, the drc axons extend into 
two directions and pioneer separate tracts; these peripheral extensions were 
less innervated, shorter and less branched compared to controls. Trowe et al 
(1996)  found  that  mutation  of  three  genes,  oxer,  dackel  and  pinscher, 
disrupted the mapping of axons along the optic nerve and tract 
23. There are a 
number of touch-insensitive mutants identified by the 1996 Tubingen large-
scale  chemical  mutagenesis  zebrafish  screen 
24.  For  example,  the  macho 
mutant had the most severe reduction in touch sensitivity compared to the 166 
 
three  other  touch-insensitive  mutants  with  reduced  voltage-gated  sodium 
current amplitudes in the rohan beard (RB). The severe reduction in touch 
sensitivity  is  similar  to  what  is observed  in  fish  exposed  to  3-MPA-AuNPs. 
Upon  further  characterization  of  these  mutants,  the  researchers  found  that 
most  had  reduced  voltage-gated  sodium  current  amplitudes  in  the  primary 
mechanosensory  RB  that  are  specialized  neurons  with  mechanoreceptors. 
This  suggests  that  the  functional  group  –  3-MPA  –  is  perturbing  the 
electrophysiology  of  the  RBs  and  thereby  reducing  the  number  of  axonal 
projections.    
Using  pathway  analysis  software,  we  found  the  neurophysiological 
processes were perturbed by 3-MPA-AuNPs. A key gene in these pathways is 
early growth response 1 (EGR-1). This gene was elevated in the RNA-seq. 
EGR-1 is a highly conserved zinc finger protein that is expressed early and 
plays  an  important  role  in  vertebrate  development 
25.  Its  diverse  biological 
functions include cell growth, differentiation and apoptosis. In zebrafish, it is 
only expressed in specific brain areas at 21 hpf, and expression increases in 
distinct domains of the central nervous system 
26. To cause an abnormal touch 
response, 3-MPA-AuNPs must be present from 6 to 48 hpf, which is the same 
time period EGR-1 is expressed in the forebrain and hindbrain. Pignatelli et al. 
found that the EGR-1 transcription factor promotes apoptosis of neuronal cells, 
and this apoptotic activity is mediated by a member of p53 family of proteins 
25. Furthermore, using morpholino oligonucleotides, Hu demonstrated that by 167 
 
knocking down EGR-1, axonogenesis was reduced in zebrafish 
21. Based on 
mutant zebrafish exhibiting touch insensitivity, Hortopan et al investigated the 
role of electrical activity and found that the mind bomb mutant zebrafish‟s brain 
exhibited spontaneous electrical activity 
27. They conducted a transcriptome 
analysis using microarray and found that several genes necessary for GABA-
mediated  signaling  were  suppressed.  These  150  differentially  misregulated 
genes were responsible for the abnormal electrical discharge in the zebrafish. 
These genes including glutamate decarboxylase, GAD1, a general marker for 
GABA-mediated synaptic function.  It is an enzyme responsible for catalyzing 
the  production  of  GABA  from  L-glutamic  acid.  Mind  bomb  mutants  have  a 
drastically reduced level of GAD1. This reduction of GAD1 impacts the level of 
glutamic  acid  in  the  mind  bomb  mutant.  The  electrophysiological  analysis 
demonstrated  that  touch  response  in  early  embryonic zebrafish  arises  only 
after glutamatergic synapses connect sensory neurons. The functional group, 
mercaptoproponic acid was used to induce seizures and also inhibits GAD 
28, 
which inhibits GABA synthesis. EGR-1 is also inducibility by seizure activity, 
stimulants, and salient physiological stimuli 
29. We hypothesize that embryos 
exposed to 3-MPA-AuNPs have reduced glutamate levels potentially affecting 
levels  of  GABA  and  L-glutamic  acid  and  that  EGR-1  plays  a  role  in  the 
reduced  axonal  projections.  Based  on  other  research  and  this  study,  we 
suspect that exposure to 3-MPA-AuNPs prior to the onset of axonogenesis 
causes misregulation of egr-1, which interferes with glutaminergic synpases 168 
 
and neuroplasticity, thereby preventing the connection of sensory neurons and 
touch perception.   
 
Conclusion and Prospects 
In  this  study,  we  learned  that  functional  groups  can  interfere  with 
embryogenesis  and  this  interference  causes  morphological  defects, 
neurological  perturbation  and  differential  gene  expression.  Specifically,  we 
demonstrated that surface functional groups on two gold nanoparticles caused 
differential  biological  responses  at  the  phenotypic  and  transcriptome  level. 
One functional group – 3-MPA, caused an abnormal touch response, while the 
other functional group – MEEE – did not. We found that exposure to 3-MPA-
AuNPs from 6 to 120 hpf resulted in embryos that were not paralyzed and had 
unaffected  motor  neurons.  However,  at  72  hpf,  these  embryos  had  a 
significant reduction in axonal projection at the caudal fin, which could explain 
the lack of sensation at that location. Transcriptome analysis of 3-MPA-AuNPs 
at  48  hpf,  identified  neurophysicological  processes  and  signal  transduction 
pathways  to  be  significantly  misregulated  and  MEEE-AuNPs  perturbed 
immune  and  inflammatory  systems.  Surface  functional  groups  greatly 
influence  the  adverse  responses  and  transcriptome  profile.  These  data 
support  the  usage  of  the  zebrafish  model  with  a  systems  transcriptome 
approach to help develop safer design principles. 169 
 
Materials and Methods 
Nanoparticle  Materials:  Hydrogen  tetrachloroaurate  (HAuCl4•  H2O),  was 
purchased from Sterm. Dichloromethane, tetrahydrofuran (THF), and all other 
compounds were purchased from Mallinckrodt Chemicals and Sigma-Aldrich 
Chemical Co, respectively. All chemicals were used as received. Barnstead 
Nanopure filtration system was used to prepare nanopure water (18.2 MΩ•cm 
resistivity). Dune Science amine functionalized SMART Grids were used for 
TEM  imaging.  Polyethersulfone  diafiltration  membranes  Omega 
TI10K  were 
purchased from Pall Life Sciences. 
Nanoparticle Synthesis of 3-MPA- and MEEE-AuNPs: This procedure has 
been reported previously by Truong et al (2011) 
6. Briefly, 1.3 nm phosphine-
stabilized  nanoparticles  (Au101(PPh)21Cl5)    were  dissolved  in 
dichloromethane/THF  mixture  with  3-mercaptopropionic  acid  or  MEEE- 
according to published literature procedure 
30. A solution of 45 mg of 1.3 nm 
Au101(PPh)21Cl5  in 20 mL of dichloromethane/THF (1:1 mixture) was added to 
a  solution  of  23  mg  of  3-mercaptopropionic  acid  in  30  mL  of  phosphate 
KH2PO4/K2HPO4 buffer  (10mM, pH=8).The mixture was stirred rapidly for 4 
hours at room temperature. Dark colored nanoparticles were transferred from 
the  organic  to  aqueous  phase,  creating  distinct  layers  that  were  later 
separated and the organic impurities were removed by washing the aqueous 
layer  with  dichloromethane.  The  crude  material  was  purified  from  excess 170 
 
ligand by diafiltration using 10kDA membrane with 50 volumes of nanopure 
water.   
AuNPs Characterization: Transmission electron microscopy (TEM) and UV-
Visible (UV-Vis) and proton NMR spectra were used to characterize the 3-
MPA- and MEEE-AuNPs. A Varian Unity Inova 300 MHZ instrument was used 
to collect proton NMR spectra at 25°C in deuterium (D2O). UV-spectra were 
obtained on a Hewlett-Packard 8453 diode array instrument using 1-cm quartz 
cuvettes. TEM images were collected using a FEI Titian microscope with Cs 
aberration  corrector.  Amine  functionalized  SMART  grids  were  soaked  in  a 
diluted nanoparticle solution (0.2 mg/mL) and then in nanopure water for 2 
minutes each. The grids were then air dried prior to imaging. 
Zebrafish  Exposure:  Adult  Tropical  5D strain  zebrafish  (Danio  rerio)  were 
reared  and  housed  in  standard  laboratory  conditions 
31  at  Oregon  State 
University  Sinnhuber  Aquatic  Research  Laboratory  (SARL)  in  Corvallis, 
Oregon.  Embryos  were  produced  by  group  spawns  of  adult  zebrafish  and 
staged according to Kimmel et al 
32. The chorion, an acellular envelope, was 
enzymatically removed at 4 hours post fertilization (hpf) according to published 
protocols  to  increase  bioavailability 
33.  Dechorionated  embryos  were 
transferred to individual wells of a 96 well plate with 100 µL of control (reverse 
osmosis water) or exposure solution. 171 
 
Zebrafish  Behavior  Assays:  Dechorionated  5D embryos  were  exposed  in 
individual wells of a 96 well plate filled with either reverse osmosis water (RO) 
water or exposure solution of 10 µg/mL of 3-MPA-AuNPs suspended in RO 
water from 6 to 120 hpf. These exposures were static and kept in the dark. At 
120  hpf,  we  evaluated  behavioral  responses  using  Viewpoint  LifeScience 
Zebrabox (Montreal, Canada). 
A) Locomotor behavior (light/dark): To assess the embryos ability to 
respond to a light stimulus, embryos were acclimated to the light for 5 
minutes (light period), followed by a 5 minute dark period, followed by a 
second  5  minute  light  period.  Forty-eight  embryos  were  used  per 
treatment, and three replicates were completed for the average speed 
in the light/ dark stimulus. 
B)  Sensory  response:  To  evaluate  whether  the  embryos  exhibited 
normal  motor  response,  we  used  the  quantization  algorithm  in  the 
Zebrabox. Under video recording, 20 µL of 100 mM nicotine (Sigma 
product number: N3876) was added using two multichannel pipettes to 
both the control and the 3-MPA-AuNPs treated. The activity level was 
recorded for 17 seconds in the light. Eight embryos per treatment and 
three biological replicates were used in the nicotine spike experiment. 
Behavior  Data  Processing  &  Statistics:  The  Zebrabox  output  files  were 
processed using a custom perl (http://www.perl.org/) script to summarize the 172 
 
total  movement  (pixel  changes  per  second)  of  the  larvae  in  the  dark  and 
immediately after the addition of nicotine. To evaluate for statistical difference 
in  the  light/dark  behavior  assay,  the  average  distance  sum  was  compared 
between control vs 3-MPA-AuNPs using an unpaired T-Test. The total pixel 
changes  over  the  17  seconds  were  summed  per  treatment  to  determine 
whether  the  locomotor  activity  was  affected.  An  ANOVA  with  repeated 
measures  was  used  for  every  second  to  evaluate  for  differences  in  the 
response to the nicotine stimulus. 
Immunohistochemistry: Adult Tg(NBT:MAPT-GFP)zc3 were spawned, and 
the embryos were dechorionated at 4 hpf. Embryos were exposed to either a 
vehicle control (RO water) or 10 µg/mL of 3-MPA-AuNPs from 6 to 72 hpf. At 
72  hpf,  embryos  were  collected  and  fixed  overnight  in  4ºC  using  4% 
paraformaldehyde  in  phosphate  buffered  saline  (PBS).  Details  on  the 
immunohistochemistry protocol used were previously published 
34. Monoclonal 
antibody,  acetylated  alpha  tubulin  was  used  at  a  dilution  of  1:2000.  A 
fluorescent secondary antibody Alexa 555 (Molecular Probes, Eugene, OR) 
was  used  at  1:1000  dilution  to  reveal  the  primary  antibody  labeling. 
Representative  images  of  the  caudal fin  were  taken  within  one week  on  a 
Zeiss Axiovert 200M motorized inverted microscope (Zeiss, Thornwood, NY). 
The Z stack feature on Axiovision software was set to create 16 micron-thick 
slices,  a  total  of  11  slices  of  the  caudal  fin.  Images  were  taken  at  a  10x 
magnification. 173 
 
llumina Direct RNA Sequencing - Sample Preparation: 5D embryos were 
dechorionated and exposed to RO water, 1.3 nm MEEE-AuNPs and 1.2 nm 3-
MPA-AuNPs  from  6  to  48  hpf.  Exposed  embryos  were  pooled  into  three 
replicates of 25 embryos, euthanized using MS-222 and washed with Milli-Q 
water. Excess water was removed from each replicate and 1 scoop of 0.5 mm 
zirconium  oxide  beads  (Next  Advance,  Product  #ZrOB05)  and  500  µL  of 
RNAzol (Molecular Research Center, Product #190) was added, and placed 
into a Bullet blender (Next Advance, Averill Park, NY) for 3 minutes at a speed 
of 8. Afterwards, samples were left in room temperature for 5 minutes prior to 
storage  in  -80ºC.  RNA  was  isolated  using  standard  protocol  published 
previously 
6. The supernatant was removed, and the RNA pellet was washed 
four  times  with  500  µL  of  75%  ethanol.  Between  each  ethanol  wash,  the 
samples were centrifuged for 3 minutes at 8,000 rcf. To suspend the RNA 
pellet, all ethanol was removed, and almost immediately (to avoid over drying 
the pellet), 12 µL of RNase- and DNase- free water was added to each sample 
and vortexed for 2-5 minutes at room temperature. The remaining samples 
were stored in the -80ºC until all quality assessments were conducted. The 
quantity  and  quality  of  the  total  RNA  isolated  was  measured  using  a 
Nanodrop-1000  Spectrophotometer  and  an  Agilent  Bioanalyzer  (Center  for 
Gene Research and Biocomputing, CGRB, Oregon State University, OR). All 
RNA  samples  passed  concentration,  and  quality  requirements 
(A260/A280≥1.8, and A260/A230≥1.8). 174 
 
Illumina Processing: Three µg of total RNA for 12 samples (three replicates 
of  each  treatment)  were  diluted  to  a  final  concentration  of  200  ng/µL  and 
submitted for library preparation at the Genomics Core of Lerner Research 
Institute (Cleveland, Ohio). The core generated standard bar-coded mRNA-
seq  libraries.  Three  lanes  of  a flow  cell  were  used  in  an Illumina  Genome 
Analyzer IIx. Each lane contained one replicate of each treatment (RO water, 
1.3 nm MEEE- and 1.2 nm 3-MPA-AuNPs) and was sequenced using single-
ended reads at a length of 78 base pairs. Bar-coded results for each lane were 
separated  and  then  sequence.txt  output  files  were  generated.  FastQC 
(Babraham Bioinformatics) was used to assess the quality of the sequencing 
experiments. 
RNA-seq Data Analysis: To check the quality of the sequencing experiments, 
FastQC  (Babraham  Bioinformatics, 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)  was  run  for  each 
sample. Each sequence.txt output file was mapped to the zebrafish Ensembl 
reference genome 9 using Tophat v1.3.3 with Bowtie 2 
14  to align short RNA-
seq  reads.  A  custom  zebrafish  bowtie  index  was  created  for  aligning  the 
sequencing  reads.  Tophat  default  settings  were  used  with  the  additional 
setting changes: a minimum intron length of 50, max intron set as 10000, and 
inner distance  between  mate  set  as  165. The  resulting  aligned  reads from 
Tophat  were  further  processed  using  Cufflinks  v1.1.0 
15  with  a  max  intron 
length of 10,000, p<0.05, an FDR of 0.05, and upper quantile normalization 175 
 
was used. Cufflinks was used to assemble the aligned reads into transcripts 
with a reference genome and to express these transcripts in Fragments per 
Kilobase  of  exon  per  Million  fragments  mapped  (FPKM).  The  FPKM  is  an 
expression of relative abundance of the transcript. To determine differential 
expression  of  genes  and  isoforms  between  control,  3-MPA-  and  MEEE-
AuNPs,  Cuffdiff  analysis  was  performed.  The  resulting  cufflink  assemblies 
were merged to create a final, merged annotation file. This merged annotation 
file was used in Cuffdiff to identify differential expression between treatments. 
The biological replicates were pooled for these analyses comparing the control 
to each of the nanoparticle treatments using the merged annotation file and 
Danio  rerio  Zv9  version  61  genome.  CummeRbund  v1.1.3 
16  was  used  to 
visualize results from Cufflinks.   176 
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Figure 6- 1. The development and behavior of embryos exposed to gold 
nanoparticles.  
(a) Heatmap demonstrating that exposure to MEEE functionalized gold nanoparticle 
does not induce adverse responses, but MPA caused a dose dependent abnormal 
touch  response.  Mortality  was  assessed  at  both  24  and  120  hpf,  while  only  the 
surviving  embryos  at  120  hpf  were  evaluated  for  16  morphological  malformations 
(n=16,  two  replicates).  When  100%  mortality  was  observed,  the  endpoints  were 
grayed  out  to  illustrate  there  were  no  survivors  at  that  concentration.  Surface 
functionalities  influenced  the  toxicity  of  the  cellulose  nanocrystals.    Endpoint 
evaluated  are  defined  as  follows:  MO24  =  mortality  observed  at  24  hpf;  DP24  = 
developmental  progression  at  24  hpf;  SM24  =  spontaneous  movement  at  24  hpf; 
NC24  =  notochord malformation  at  24  hpf.  Endpoints  evaluated  at  120  hpf  were: 
MORT = cumulative mortality; YSE = yolk sac edema; AXIS = axis defects; EYE = 
eye defects; SNOU = snout defect; JAW = jaw defect, OTIC = otic (ear) defect; PE = 
pericardial edema; BRAI = brain defect; SOMI = somite defect; PFIN and CFIN = 
pectoral and cadual fin defect; PIG = pigmentation abnormalities; CIRC = circulation 
defects; TRUN = trunk defect; SWIM = swim bladder abnormalities; NC = notochord 
defect  at  120  hpf  and  TR  =  touch  response  abnormality.  (b)  3-MPA  and  control 
exposed 5 day old larvae were stimulated with a neuromuscular stimulus, nicotine, 
and  swimming  activity  was  measured  for  17  seconds  afterwards.  Statistical 
significance  determined  by  a  one  way  ANOVA  with  repeated  measures.  (c) 
Swimming behavior of control and 3-MPA larvae that were in 5 minute of the light, 
and 5 minute in the dark. (d) The average speed of the control and 3-MPA larvae for 
the 5 minute light periods. Statistical significance determined by T-test, p<0.05. 
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Figure 6- 2. Whole mount immunohistochemistry on control and exposed 
embryos.  
Brightfield imaging (a) control and (b) 3-MPA-AuNP exposed embryos (c,d) 
Axonal projection labeled with acetylated alpha tubulin antibody. 
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Figure 6- 3. 3-MPA-AuNPs RNA-seq (a) gene expression profile (b) 
volcano plot of statistically significant genes and (c) top 10 significant 
biological process networks identified by metacore. 
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Figure 6- 4. MEEE-AuNPs RNA-seq (a) gene expression profile (b) 
volcano plot of statistically significant genes and (c) top 10 significant 
biological process networks identified by metacore. 
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Figure 6- 5.Functional group comparison.   
(a) Venn diagram comparing statistically significant genes between 3-MPA 
and MEEE. (b) Significant pathway comparison between the two surface 
functional groups. The black line indicates signifies (p<0.05).   
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Table 6- 1. Data analysis of RNA-seq results.  
(a) Total sequence reads for each replicate in the control, 3-MPA-AuNPs, and 
MEEE-AuNPs. (b) Detailed table illustrating the number of significant reads, 
and the quality of the reads out of 30,509. 
 
   
(a)      
Samples  Total Sequences  # of failed genes 
Control  11,362,318   
Rep 1   12,099,368  125 (0.38%) 
Rep 2   12,766,649  124 (0.38%) 
Rep 3   9,220,937  121 (0.37%) 
3-MPA-AuNPs  13,536,905   
Rep 1   15,985,052  122 (0.37%) 
Rep 2   9,371,914  124 (0.38%) 
Rep 3   15,253,749  127 (0.39%) 
MEEE-AuNPs  13,493,012   
Rep 1   12,318,958  121 (0.37%) 
Rep 2   15,687,783  127 (0.39%) 
Rep 3   12,471,297  124 (0.38%) 
 
 
(b) 
  Total # of 
Statistically 
Significant Genes 
# genes 
elevated 
# genes 
repressed 
Distribution of Reads 
# of Failed  # of no test  # of Ok 
Control vs 3-
MPA-AuNP 
64  57  7 
311/30,509 
(1%) 
11,759 
(38.5%) 
18,439 
(60.4%) 
Control vs 
MEEE-AuNP 
88  9  79  245 (0.8%) 
12,124 
(39.7%) 
18,137 
(59.4%) 
5% FDR, Upper Quantile Normalized 
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Table 6- 2. Confirmation of statistically significant genes determined by 
RNA-seq using qRT-PCR. 
 
Genes were selected from the statistically significant gene lists from control vs 
3-MPA-AuNPs, and control vs MEEE-AuNPs to determine if the misregulation 
identified by RNA-seq was correct. qRT-PCR confirmed that the direction of 
the  misregulation  was  consistent,  but  the  magnitude  was  not  necessarily 
identical.  
 
 
 
 
   

Gene Symbol 3-MPA-AuNPs MEEE-AuNPs Gene Accession ID Gene Name
EGR1
JUNBB
FOSL1
FOSB
1.92
4.39
1.56
1.89
2.03
2.14
Fold Change at 48 hpf
RNA-seq qPCR
NM_131248
NM_212750
NM_0011552
NM_001007312
early growth response 1
jun B proto-oncogene b
FOS-like antigen a
FBJ murine osteosarcoma
viral oncogene homolog B
 

2.57 2.67
RNA-seq qPCR
 
 188 
 
 
 
Figure 6S- 1. Characterization data of 3-MPA and MEEE-AuNPs using 
(a,d) TEM, (b,e) NMR, and (c,f) UV-Vis absorbance. 
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Table 6S- 1. Common 5 genes 
 
Ensembl Gene ID  ZF 
Gene 
Symbol 
ZF Description  ZF 
Gene 
ID 
Locus  CON_ 
RPKM 
MPA_ 
RPKM 
log2 
(fold_ 
change) 
MEEE_ 
RPKM 
log2 
(fold_ 
change) 
ENSDARG00000019949  hsp47  heat shock protein 
47  
30449  15:2873229
7-28736597 
22.37  36.091  0.69  31.44  0.50 
ENSDARG00000031683  fos  v-fos FBJ murine 
osteosarcoma viral 
oncogene 
homolog  
394198  20:4680330
7-46805437 
27.49  78.34  1.51  14.53  -0.91 
  BX5480
11.3 
    4:49787860
-49789795 
46.53  388.23  3.06  112.76  1.29 
ENSDARG00000028396  fkbp5  FK506 binding 
protein 5  
368924  6:41026921
-41046917 
39.22  17.45  -1.17  14.90  -1.39 
ENSDARG00000042816  mmp9  matrix 
metalloproteinase 
9  
406397  8:25134454
-25148890 
6.20  13.62  1.14  2.22  -1.47 
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Table 6S- 2. List of Statistically significant genes in (a) CON v 3-MPA-AuNPs and (b) CON v MEEE-AuNPs. 
 
(a) CON vs 3- MPA-AuNPs 
Ensembl Gene ID 
ZF Gene 
Symbol 
ZF Description 
ZF Gene 
ID 
Locus 
CON_ 
RPKM 
MPA_ 
RPKM 
log2 
(FC) 
ENSDARG00000008969  fgb  fibrinogen, B beta 
polypeptide  
337315  1:9127846-
9135580 
113.21  146.46  0.37 
ENSDARG00000074378  junb  jun B proto-oncogene   407086  1:52226931-
52228476 
7.28  16.81  1.21 
ENSDARG00000036840  krt15  keratin 15   406844  11:11635466-
11764765 
59.96  74.78  0.32 
ENSDARG00000056322  ldb3a  LIM-domain binding factor 
3a  
794339  13:22616976-
22690023 
125.57  154.30  0.30 
ENSDARG00000075121  hbegfa  heparin-binding EGF-like 
growth factor a  
797938  14:7015234-
7018245 
9.11  17.33  0.93 
ENSDARG00000037421  egr1  early growth response 1   30498  14:22333788-
22337652 
14.24  53.84  1.92 
ENSDARG00000055752  npas4  neuronal PAS domain 
protein 4  
724016  14:31506583-
31512448 
1.18  2.59  1.13 
ENSDARG00000019949  hsp47  heat shock protein 47   30449  15:28732297-
28736597 
22.37  36.09  0.69 
ENSDARG00000090352  si:dkey-97i18.5  si:dkey-97i18.5     16:33930174-
33932357 
7.68  17.61  1.20 
ENSDARG00000040432  klf2b  Kruppel-like factor 2b   117509  19:17847487-
17853240 
7.05  12.96  0.88 
ENSDARG00000004539  ptgs2a  prostaglandin-endoperoxide 
synthase 2a  
246227  2:20712496-
20719864 
16.71  32.62  0.97 
ENSDARG00000034503  per2  period homolog 2 
(Drosophila)  
140633  2:48423771-
48489514 
3.90  1.17  -1.74 
ENSDARG00000031683  fos  v-fos FBJ murine  394198  20:46803307- 27.49  78.34  1.51 191 
 
osteosarcoma viral 
oncogene homolog  
46805437 
ENSDARG00000091131  cry2b  cryptochrome 2b   83780  22:745664-
789091 
7.28  4.01  -0.86 
ENSDARG00000088371  junbl  jun B proto-oncogene, like   336038  3:8434975-
8436624 
21.69  64.19  1.57 
ENSDARG00000076221  zgc:198419  zgc:198419   100006523  3:32235717-
32257330 
16.60  38.99  1.23 
ENSDARG00000078342  zgc:194125  zgc:194125   100170833  3:32262322-
32263438 
12.20  29.38  1.27 
ENSDARG00000079938  zgc:173594  zgc:173594   100126128  3:32276513-
32278057 
19.80  44.07  1.15 
ENSDARG00000025428  socs3a  suppressor of cytokine 
signaling 3a  
335409  3:58237024-
58239849 
6.86  13.86  1.01 
ENSDARG00000045768  cry1a  cryptochrome 1a   100003956  4:11077566-
11091060 
10.38  4.16  -1.32 
ENSDARG00000028396  fkbp5  FK506 binding protein 5   368924  6:41026921-
41046917 
39.22  17.45  -1.17 
ENSDARG00000042816  mmp9  matrix metalloproteinase 9   406397  8:25134454-
25148890 
6.19  13.62  1.14 
ENSDARG00000036572  dusp2  dual specificity phosphatase 
2  
445057  8:42272845-
42276824 
3.77  9.03  1.26 
ENSDARG00000041339  zgc:92380  zgc:92380   445086  9:48849050-
48881933 
40.15  50.74  0.34 
  SRP_euk_arch      11:11559268-
11559563 
0.00  31.37  1.7976
9e+308 
  IER2      11:31914385-
31914898 
15.56  38.34  1.30 
  tef      12:20241114-
20249459 
24.55  18.20  -0.43 192 
 
  7SK      13:697629-
697951 
3.47  119.07  5.10 
  DKEY-111B14.2      16:16405421-
16405989 
5.16  60.15  3.54 
  JDP2 (2 of 2)      20:46823546-
46897470 
9.97  20.79  1.06 
  5_8S_rRNA      20:55787532-
55787686 
64.54  2156.84  5.06 
  BX296557.1      20:55789783-
55789875 
7915.68  74376.90  3.23 
  DUPD1  
(2 of 12) 
    20:7245361-
7255198 
9.99  25.78  1.37 
  CT027638.1      20:55449381-
55449469 
2833.08  19977.70  2.82 
  CT956064.6      20:55775928-
55776020 
7915.68  74351.50  3.23 
  5_8S_rRNA      20:55778117-
55778271 
64.54  2156.84  5.06 
  SRP_euk_arch      3:30399857-
30400153 
7.61  361.17  5.57 
  CT583728.5      4:43985365-
43985784 
10.29  113.35  3.46 
  5_8S_rRNA      4:43986292-
43986446 
64.54  2156.84  5.06 
  CU278559.3      4:44016453-
44016872 
10.29  113.35  3.46 
  5_8S_rRNA      4:44017380-
44017534 
64.54  2156.84  5.06 
  BX548011.3      4:49787860-
49789795 
46.53  388.23  3.06 193 
 
  5_8S_rRNA      4:43907850-
43908004 
64.54  2156.84  5.06 
  CT583728.20      4:43908512-
43908931 
10.29  113.35  3.46 
  5_8S_rRNA      4:43923410-
43923564 
64.54  2156.84  5.06 
  CT583728.8      4:43924072-
43924491 
10.29  113.35  3.46 
  5_8S_rRNA      4:43939606-
43939760 
64.54  2156.84  5.06 
  CT583728.12      4:43940269-
43940688 
10.29  113.35  3.46 
  5_8S_rRNA      4:49791968-
49792122 
64.75  2087.46  5.01 
  BX548011.5      4:49792629-
49793048 
10.29  113.35  3.46 
  AL935186.4      4:61296842-
61296934 
5144.75  56698.20  3.46 
  5_8S_rRNA      4:61299023-
61299179 
124.66  4769.95  5.26 
  PLA2G4C (4 of 5)      5:2043308-
2072826 
3.73  1.88  -0.99 
  BX537263.5      5:1187766-
1187854 
2833.08  19977.70  2.82 
  BX537263.8      5:1189499-
1189591 
7915.68  74351.50  3.23 
  5_8S_rRNA      5:1191688-
1191842 
64.54  2156.84  5.06 
  BX537263.6      5:1199413-
1199501 
2833.08  19977.70  2.82 194 
 
  BX537263.7      5:1201146-
1201238 
7915.68  74351.50  3.23 
  5_8S_rRNA      5:1203335-
1203489 
64.54  2156.84  5.06 
  5_8S_rRNA      5:4381835-
4381989 
64.54  2156.84  5.06 
  CU651569.4      5:4382497-
4382916 
10.29  113.35  3.46 
  C5H8orf4  
(1 of 2) 
    5:29511197-
29512206 
20.69  38.89  0.91 
  LONRF1      8:14160749-
14304260 
11.42  4.86  -1.23 
  CABZ01045618.2      Zv9_NA889:14
423-14511 
2833.08  19977.70  2.82 
 
 
(b)CON vs MEEE-AuNPs 
Ensembl Gene ID  ZF Gene 
Symbol 
ZF Description  ZF Gene 
ID 
Locus  CON_ 
RPKM 
MEEE_ 
RPKM 
log2 
(FC) 
ENSDARG00000093494  si:ch211-
217k17.9 
si:ch211-217k17.9   798921  1:52892867-
52895323 
36.13  19.40  -0.90 
ENSDARG00000015495  klf3  Kruppel-like factor 3 (basic)   117603  1:17336040-
17356958 
24.46  13.65  -0.84 
ENSDARG00000018308  ets2  v-ets erythroblastosis virus 
E26 oncogene homolog 2 
(avian)  
326672  10:143057-
261920 
22.81  8.06  -1.50 
ENSDARG00000005785  elovl7b  ELOVL family member 7, 
elongation of long chain 
fatty acids (yeast) b  
327274  10:46572429-
46574201 
43.55  14.07  -1.63 
ENSDARG00000019274  rasd1  RAS, dexamethasone- 393504  12:1576091- 22.52  13.20  -0.77 195 
 
induced 1   1577692 
ENSDARG00000021372  tob1b  transducer of ERBB2, 1b   406245  12:1044227-
1047498 
68.85  39.63  -0.80 
ENSDARG00000038639  elovl6l  ELOVL family member 6, 
elongation of long chain 
fatty acids like  
1E+08  13:21806732-
21812343 
14.67  8.74  -0.75 
ENSDARG00000012789  plek2  pleckstrin 2   567753  13:33347085-
33358213 
1.66  0.29  -2.54 
ENSDARG00000077726  ccrn4la  CCR4 carbon catabolite 
repression 4-like a (S. 
cerevisiae)  
572044  14:48963051-
48975762 
16.61  5.97  -1.48 
ENSDARG00000062788  irg1l  immunoresponsive gene 1, 
like  
562007  14:11625680-
11629239 
14.21  6.78  -1.07 
ENSDARG00000015355  fosl1  FOS-like antigen 1   564241  14:31611182-
31617315 
8.61  0.41  -4.39 
ENSDARG00000031929  stard10  START domain containing 10   100001416 
 
14:34245372-
34253070 
11.62  5.50  -1.08 
ENSDARG00000019949  hsp47  heat shock protein 47   30449  15:28732297-
28736597 
22.22  31.44  0.50 
ENSDARG00000055854  nr4a3  nuclear receptor subfamily 
4, group A, member 3  
548604  16:29573621-
29597577 
13.15  4.29  -1.62 
ENSDARG00000039943  fam46ba  family with sequence 
similarity 46, member Ba  
777768  16:36464081-
36473792 
22.86  13.55  -0.75 
ENSDARG00000006598  sgk2b  serum/glucocorticoid 
regulated kinase 2b  
559050  16:28781209-
28787898 
15.68  8.35  -0.91 
ENSDARG00000028804  ankrd9  ankyrin repeat domain 9   492328  17:29335654-
29336840 
35.78  13.80  -1.37 
ENSDARG00000040623  fosl2  fos-like antigen 2   558921  17:41427845-
41443739 
10.74  4.07  -1.40 
ENSDARG00000007377  odc1  ornithine decarboxylase 1   114426  17:52270217- 90.79  56.42  -0.69 196 
 
52283861 
ENSDARG00000055751  fosb  FBJ murine osteosarcoma 
viral oncogene homolog B  
492346  18:35109605-
35119433 
5.19  0.88  -2.57 
ENSDARG00000061635  myo5aa  myosin VAa   562188  18:37337380-
37479503 
13.75  9.93  -0.47 
ENSDARG00000035909  mfsd2ab  major facilitator superfamily 
domain containing 2ab  
445176  19:32113242-
32129452 
39.03  22.26  -0.81 
ENSDARG00000067848  itgb1bp3  integrin beta 1 binding 
protein 3  
447879  2:56106355-
56216886 
59.94  37.74  -0.67 
ENSDARG00000002412  elovl1a  elongation of very long 
chain fatty acids (FEN1/Elo2, 
SUR4/Elo3, yeast)-like 1a  
449816  2:19237375-
19299800 
19.26  10.78  -0.84 
ENSDARG00000031426  csrnp1a  cysteine-serine-rich nuclear 
protein 1a  
560270  2:24060403-
24073222 
11.09  5.10  -1.12 
ENSDARG00000078327  si:ch73-212j7.1  si:ch73-212j7.1   1E+08  20:3145229-
3163516 
3.84  1.92  -1.00 
ENSDARG00000014947  igfbp1a  insulin-like growth factor 
binding protein 1a  
317638  20:7029527-
7033442 
19.11  5.36  -1.83 
ENSDARG00000007823  atf3  activating transcription 
factor 3  
393939  20:37819240-
37825345 
7.83  2.75  -1.51 
ENSDARG00000010276  ptgs2b  prostaglandin-endoperoxide 
synthase 2b  
559020  20:34147105-
34152005 
7.12  2.22  -1.68 
ENSDARG00000031683  fos  v-fos FBJ murine 
osteosarcoma viral 
oncogene homolog  
394198  20:46803307-
46805437 
27.31  14.53  -0.91 
ENSDARG00000091669  si:dkey-17e16.17  si:dkey-17e16.17     21:25068445-
25075182 
23.50  7.83  -1.58 
ENSDARG00000009544  cldnb  claudin b   81581  21:25145794-
25146897 
109.95  69.55  -0.66 
ENSDARG00000077540  f2rl1.2  coagulation factor II  1E+08  21:7193751- 4.85  1.97  -1.30 197 
 
(thrombin) receptor-like 1.2   7201593 
ENSDARG00000017843  srsf1b  serine/arginine-rich splicing 
factor 1b  
393565  21:38403757-
38412580 
37.05  46.72  0.33 
ENSDARG00000020298  btg2  B-cell translocation gene 2   30079  22:745664-
789091 
99.50  57.81  -0.78 
ENSDARG00000070907  lcor  ligand dependent nuclear 
receptor corepressor  
558560  22:37648548-
37682613 
8.34  2.72  -1.62 
ENSDARG00000025522  sgk1  serum/glucocorticoid 
regulated kinase 1  
324140  23:31878817-
31931888 
60.67  33.44  -0.86 
ENSDARG00000000796  nr4a1  nuclear receptor subfamily 
4, group A, member 1  
431720  23:32389911-
32396444 
41.18  20.82  -0.98 
ENSDARG00000087303  cebpd  CCAAT/enhancer binding 
protein (C/EBP), delta  
140817  24:37059294-
37061674 
36.89  16.94  -1.12 
ENSDARG00000038429  csrnp1b  cysteine-serine-rich nuclear 
protein 1b  
322795  24:20257035-
20268667 
42.85  27.83  -0.62 
ENSDARG00000017665  snrk1  SNF related kinase 1   393806  25:13930212-
13960215 
7.05  4.20  -0.75 
ENSDARG00000035719  arl5c  ADP-ribosylation factor-like 
5C  
393819  3:15754356-
15762038 
10.60  5.19  -1.03 
ENSDARG00000007344  tcap  titin-cap (telethonin)   556258  3:21453654-
21455521 
7.49  1.44  -2.37 
ENSDARG00000019420  etnk1  ethanolamine kinase 1   565971  4:15954037-
15975107 
35.54  23.94  -0.57 
ENSDARG00000042909  lifra  leukemia inhibitory factor 
receptor alpha  
541493  5:7820161-
7886515 
5.38  3.46  -0.64 
ENSDARG00000068194  klf9  Kruppel-like factor 9   565869  5:27719778-
27722714 
14.03  5.26  -1.42 
ENSDARG00000019360  sec23b  Sec23 homolog B (S. 
cerevisiae)  
327268  6:6695928-
6712811 
73.11  34.45  -1.09 
ENSDARG00000028396  fkbp5  FK506 binding protein 5   368924  6:41026921- 38.96  14.90  -1.39 198 
 
41046917 
ENSDARG00000060316  cish  cytokine inducible SH2-
containing protein  
767678  6:41434717-
41437613 
20.79  14.21  -0.55 
ENSDARG00000009505  slmo2  slowmo homolog 2 
(Drosophila)  
378855  6:59776158-
59786039 
78.14  37.66  -1.05 
ENSDARG00000078619  pnp5a  purine nucleoside 
phosphorylase 5a  
791647  7:7457930-
7473128 
75.50  41.11  -0.88 
ENSDARG00000088589  si:dkey-165a24.2  si:dkey-165a24.2   1E+08  7:23842565-
23844302 
36.80  18.55  -0.99 
ENSDARG00000087440  si:dkey-165a24.4  si:dkey-165a24.4   557748  7:23847650-
23851383 
17.16  6.31  -1.44 
ENSDARG00000042816  mmp9  matrix metalloproteinase 9   406397  8:25134454-
25148890 
6.15  2.22  -1.47 
ENSDARG00000010572  slc25a25a  solute carrier family 25 
(mitochondrial carrier; 
phosphate carrier), member 
25a  
406541  8:2781135-
2791394 
27.26  14.70  -0.89 
ENSDARG00000042725  cebpb  CCAAT/enhancer binding 
protein (C/EBP), beta  
140814  8:29301376-
29302892 
39.82  17.78  -1.16 
ENSDARG00000010437  fam46c  family with sequence 
similarity 46, member C  
327154  9:21814157-
21819950 
24.87  16.54  -0.59 
ENSDARG00000034961  bzw1b  basic leucine zipper and W2 
domains 1b  
406812  9:50227-
57751 
92.60  54.11  -0.78 
ENSDARG00000041566  adamts1  ADAM metallopeptidase 
with thrombospondin type 1 
motif, 1  
565145  Zv9_NA908:84
739-93567 
17.92  5.38  -1.74 
  wu:fc34e06      1:41067044-
41078571 
13.56  6.16  -1.14 
  MUC3A      1:41080394-
41120369 
2.50  0.93  -1.42 199 
 
  si:ch73-
60g14.3,si:ch73-
60g14.4 
    10:24825218-
24847532 
7.81  1.42  -2.46 
  DHRS13 (2 of 5)      10:38118057-
38126716 
92.14  28.11  -1.71 
  FILIP1L (2 of 2)      11:46291043-
46293686 
13.59  7.65  -0.83 
  CABZ01048956.1      12:46994361-
47010486 
11.39  5.73  -0.99 
  MCU      13:4376328-
4525409 
10.51  6.60  -0.67 
  wu:fj08f03      14:11649672-
11655264 
8.08  4.35  -0.89 
  TUFT1 (1 of 2)      16:24543993-
24565999 
7.51  3.32  -1.18 
  BX005256.1      16:27061038-
27068162 
7.56  1.67  -2.18 
  THBS1 (2 of 2)      17:507055-
521798 
22.65  12.00  -0.92 
  CABZ01064941.1      17:288686-
297735 
18.49  8.58  -1.11 
  CU638738.1      17:50755159-
50764033 
5.07  2.11  -1.26 
  CREM (1 of 2)      2:43256632-
43297713 
13.03  4.75  -1.45 
  CT956064.3      20:55774137-
55775909 
175.66  422.88  1.27 
  zgc:158463      20:55786254-
55787467 
258.70  665.68  1.36 
  BX296557.6      20:55789894- 170.55  376.58  1.14 200 
 
55791666 
  ZNF462      21:537752-
568922 
12.31  6.62  -0.89 
  KLF4      21:611997-
627555 
12.07  3.17  -1.93 
  WWC1      21:35787421-
35920071 
4.34  2.00  -1.12 
  CHST6      25:35925934-
35939027 
8.76  3.98  -1.14 
  BX548011.3      4:49787860-
49789795 
46.22  112.76  1.29 
  AL935186.6      4:61294795-
61296820 
106.81  223.45  1.06 
  OSGIN1      6:50645617-
50655992 
10.02  20.06  1.00 
  VGF      7:27352318-
27354247 
7.23  3.30  -1.13 
  CU019646.2      7:21397518-
21398924 
7.41  1.90  -1.97 
  BSN (2 of 3)      8:55800920-
55824614 
4.60  3.25  -0.50 
  SIK1      9:9169114-
9178227 
50.97  17.37  -1.55 
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CHAPTER 7 - CONCLUSIONS 
Utilizing the rapid development and molecular and genetic tractability of 
the embryonic zebrafish model, we investigated the effects of different surface 
functionalization  of  lead  sulfide  nanoparticles  (PbS-NPs)  on  developmental 
toxicity. The ligand groups were insufficiently coating the core material, which 
impacted  the  rate  of  decomposition.  The  decomposing  PbS-NPs  were 
releasing lead ions causing the differential biological responses. 
To  further  investigate  the  impact  of  nanoparticle  functionalization  on 
developmental  toxicity,  we  used  nanoparticles  with  a  benign  gold  core  to 
assess the role of different ligand functional groups on biological responses. 
Using  gold  nanoparticles  (AuNPs)  functionalized  with  three  ligands,  we 
determined  that  each  induced  a  differential  biological  response.  Using 
inductively  coupled-mass  spectroscopy,  we  confirmed  that  the  individual 
phenotypic responses were not caused by differing  mass concentrations of 
gold  in  the  zebrafish tissues.  By  conducting  a  global genome analysis,  we 
identified  that  each  gold  nanoparticle  perturbed  different  pathways.  These 
results demonstrated that surface functional groups drive both biological and 
molecular response. Exposing the embryos to the same three AuNPs during 
early  development  and  raising  them  in  nanoparticle  free  medium  until 
adulthood  revealed  that  the  functional  groups  impacted  survivorship  and 
behavior  in  both  larvae  and adults.  Nanoparticle  surface functionalities  can 202 
 
influence the decomposition rate, which leads to changes in gene expression 
profiles, behavior and survivorship in adult fish.  
While  investigating  the  physiochemical  properties  causing  adverse 
responses,  we  found  that  the  standard  zebrafish  medium  caused 
agglomeration  of  nanoparticles,  which  could  result  in  changed  responses, 
therefore  confounding  the  interpretation  of  the  biological  responses.  The 
appropriate assay medium must allow the NPs to remain monodispersed. We 
varied the ionic strength of the assay medium, and found that low ions in the 
media  favored  dispersion.  Next,  we  studied  the  impact  of  external  ions  on 
embryonic  zebrafish  development  and  discovered  that  the  zebrafish  can 
tolerate  low  to  no  ions  in  the  media.  This  bodes  well  for  the  field  of 
nanotechnology, since it is possible (and necessary) to adjust the exposure 
media conditions to optimize NP dispersion prior to assessment  
Once the monodispersion problem was solved, we pursued the route by 
which AuNPs influence biological responses. We discovered that exposure to 
AuNPs  functionalization  with  3-mercaptoproponic  acid  caused  an  abnormal 
touch response. When tested alone, the functional group did not induce any 
adverse  effects.  Combining  the  use  of  a  neuromuscular  stimulus  and 
immunohistochemistry we discovered that the exposed larvae could not sense 
the touch in the caudal fin due to underdeveloped axonal innervation. Further 
investigation using deep RNA sequencing (RNA-seq) and pathway analysis in 
silico  suggested  that  perturbation  of  neurophysiological  processes  was  a 203 
 
major target of the 3-mercaptoproponic acid-functionalized AuNP. Our current 
hypothesis is that the highly elevated transcript, EGR1 (early growth response 
1), leads to reduced levels of glutamate, thereby affecting the level of GABA, 
which leads to nerve underdevelopment and the lack of a touch response.  
In summary, this thesis has established the embryonic zebrafish model 
as  a  powerful  platform  to  conduct  nanotoxicity  assessments  to  identify 
nanostructure-response  relationships  and  determine  how  nanomaterial 
characteristics influence bioactivity. The application of RNA-seq in conjunction 
with  molecular  techniques,  allowed  the  development  of  a  hypothesis  that 
misexpression  of  a  transcript,  early  growth  response 1,  plays  a  role  in  the 
reduced axonoal projections and abnormal touch response. By leveraging the 
molecular  advantages  of  the  zebrafish  model  and  conducting  numerous 
assays  in  a  rapid  manner,  we  quickly  move  toward  developing  safer 
nanoparticles. The data collected from these studies helps identify structure-
activity relationships, and begin to establish nano-design principles. 204 
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Appendix A. Evaluation of embryotoxicity using the zebrafish 
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Abstract 
The  embryonic  zebrafish  model  offers  the  power  of  whole-animal 
investigations  (e.g.  intact  organism,  functional  homeostatic  feedback 
mechanisms and intercellular signaling) with the convenience of cell culture 
(e.g.  cost-  and  time-efficient,  minimal  infrastructure,  small  quantities  of 
nanomaterial solutions required). The model system overcomes many of the 
current limitations in rapid to high-throughput screening of drugs/compounds 
and  casts  a  broad  net  to  rapidly  evaluate  integrate  system  effects.  
Additionally, it is an ideal platform to follow up with targeted studies aimed at 
the mechanisms of toxic action.  Exposures are carried out in 96-well plates so 
minimal  solution  volumes  are  required  for  the  assessments.    Numerous 
morphological,  developmental  and  behavioral  endpoints  can  be  evaluated 
non-invasively due to the transparent nature of the embryos.   207 
 
Introduction 
Numerous biological models can be employed for toxicity evaluations. 
In vitro techniques, such as cell culture systems, are often preferred because 
of they are both cost- and time-efficient. While these studies are useful, direct 
translation to whole organisms and human health is often difficult to infer. In 
vivo studies can provide improved prediction of biological response in intact 
systems but often require extensive facilities and infrastructure (Harper et al. 
2008).  Zebrafish  (Danio  rerio) offer a  number of  practical  advantages  as a 
model  organism  that  overcome  these  limitations,  making  these  vertebrates 
highly  amenable  for  toxicologically  relevant  research.  Zebrafish  can  be 
employed as a powerful in vivo model system to assess biological interactions 
and  are  an  outstanding  platform  to  detail  the  mechanisms  by  which 
substances  elicit  specific  biological  responses.  A  remarkable  similarity  in 
cellular structure, signaling processes, anatomy and physiology exist among 
zebrafish and other high-order vertebrates, particularly early in development 
(Blechinger et al. 2002, Rasooly et al. 2003, Rubinstein 2003, Spitsbergen and 
Kent 2003, Levin et al. 2004). Current estimates indicate that over 90% of the 
human open reading frames are homologous to genes in fish (Aparicio et al. 
2002).    Thus,  investigations  using  this  model  system  can  reveal  subtle 
interactions that are likely to be conserved across species.    
Features of the zebrafish‟s biology are favorable for adapting this model 
system  to  high-throughput  assays.  Female  zebrafish  are  able  to  produce 
hundreds of eggs weekly, so large sample sizes are easily achieved, allowing 208 
 
for  statistically  powerful  dose-response  studies.  This  abundant  supply  of 
embryos also makes it possible to simultaneously assess the toxicity of a large 
number of substances in a short period. The vertebrate‟s rapid developmental 
progression compared to other mammals makes it an ideal model for high-
throughput  screening  (Kimmel  et  al.  1995).  For  example,  neuronal  plate 
formation occurs at 10 hours post fertilization (hpf), followed by organogenesis 
at  24  hpf,  which  compared  to  a  rat  occurs  at  9.5  days  and  5-6  days 
respectively. The first heartbeat occurs at 30 hpf for the zebrafish and 10.2 
days for rats (Westerfield 1995). 
Zebrafish embryos can be individually exposed in wells of a multi-well 
plate so the required volume needed for the model is small; thus, only limited 
amounts  of  materials  are  needed  to  assess  an  entire  suite  of  biological 
interactions and responses. Early developmental life stages are often uniquely 
sensitive  to  environmental  insult,  due  in  part  to  the  enormous  changes  in 
cellular differentiation, proliferation and migration required to form multiple cell 
types, tissues and organs (Henken et al. 2003, Rubinstein 2003, Spitsbergen 
and Kent 2003, Levin, et al. 2004)). Since development is highly coordinated 
requiring  specific  cell-to-cell  communications,  if  exposure  to  a  substance 
during that critical period perturbed these interactions, development would be 
expected  to  be  disrupted.  Embryos  are  waterborne–exposed  to  a  chemical 
using  a  continuous  method  in  which  24  embryos  are  exposed  per 
concentration  in  individual  wells  of  a  multi-well  plate  from  8  to  120  hpf.  209 
 
Exposure until 120 hpf is the ideal duration for a developmental toxicity testing; 
primarily due to the vertebrate model‟s ability to obtain its nutrients from its 
yolk  sac  until  five  days,  which  will  not  introduce  new  confounding  factors. 
Perturbed  development  can  manifest  as  morphological  malformations, 
behavioral abnormalities or death of the embryos.  Zebrafish embryos develop 
externally and are optically transparent so it is possible to resolve individual 
cells in vivo throughout the duration of an exposure using simple microscopic 
techniques  and numerous  effects  can  be  assessed  non-invasively  over the 
course of development. 
 
Materials 
Zebrafish Husbandry 
1.  Fish water: 0.3 g/L Instant Ocean salts (Aquatic Ecosystems, 
Apopka, FL) in reverse osmosis (RO) water. 
2.  Incubator set at 28 ± 0.1 °C. 
Dechorination 
1.  Compound stereo microscope for viewing embryos.  
2.  90 mm glass petri dish. 
3.  50  mg/mL  pronase  (Sigma-Aldrich,  cat  #  81750)  in  RO  water.  
Measure 50 mg of pronase into a 1.5 mL microcentrifuge tube and 
fill  it  with  1  mL  of  RO  water.      Aliquot  50  l  into  1.5  mL 
microcentrifuge  tube  and  place  them  into  a  freezer  box,  then 210 
 
immediately place into the box into the freezer.  This will make 20 
1.5mL microcentrifuge tubes that can be stored for up to 4 months.  
Aliquots can be thawed just prior to use. 
4.  Timer. 
Exposure 
1.  Multi-well plates. 
2.  8 or 12 multichannel pipette. 
3.  50 mL reagent reservoir. 
4.  Wide-bore Pasteur pipette. 
Assessment 
1.  Anesthesia:    4mg/mL  of  3-aminobenzoate  ethyl  ester 
methanesulfonate salt (tricaine, Sigma-Aldrich, cat # A-5040) in RO 
water, pH adjusted to 7.0 with Tris-HCl, pH 9.0. 
2.  Methyl cellulose: 10 mg/mL of methyl cellulose (Sigma-Aldrich, cat # 
274429, see Note 1). 
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Methods 
Zebrafish Husbandry 
1.  Rear adult zebrafish Danio rerio in standard laboratory conditions of 
(Akimenko et al. 1995). 
2.  House  zebrafish  in  2.0-liter  polycarbonate  tanks  with  recirculating 
water  system.    Keep  adult  zebrafish  in  groups  to  allow  for  large 
quantities of embryos to be collected.  Group spawning also helps to 
increase genetic diversity. 
3.  Feed  the  fish  twice  daily  with  either  crushed  TetraMin®  Tropical 
Flake or live Artemia from INVE (Salt Lake City, UT). 
4.  Spawning: place male and female zebrafish into spawning baskets 
in  polycarbonate  tanks  the  afternoon  before  the  embryos  are 
needed.    Zebrafish  will  typically  spawn  when  the  lights  come  on 
after the 10 h dark period. 
5.  The  following  morning,  newly  fertilized  eggs  are  collected,  rinsed 
several times in system water and placed into fresh fish water in a 
150 mm plastic petri dish.  
6.  Remove embryos that are unfertilized or necrotic prior to placing the 
petri dish into the incubator to keep warm until the embryos reach 
six hours post fertilization (hpf) (Figure A-1) (Kimmel, et al. 1995).  212 
 
7.  Remove embryos that are not the same stage as the majority prior 
to experimental use (see Note 2). 
 
Dechorination 
1.  To avoid barrier effects potentially posed by the chorion, all embryos 
should be dechorionated at six hours post fertilization (hpf) using a 
modified  version  of  Westerfields  (2000)  (Akimenko,  et  al.  1995) 
protocol for pronase enzyme degradation. 
2.  Place six hpf embryos into a 60 mm glass petri dish with 25 mL fish 
water (see Note 3).  Up to 1200 embryos can be processed in a 
single dish using this method.   
3.  Add  50  µl  of  50  mg/mL  pronase  to  the  center  of  the  dish  and 
continuously swirl gently to mix the solution.  
4.  Set a timer for seven minutes, and continuously swirl the embryos 
while occasionally observing the petri dish under the microscope to 
check for embryos without chorions, chorion pieces in the solution 
and „deflated‟ chorions. 
5.  When  seven  minutes  have  passed,  or  when  the  above  are 
observed, remove the pronase solution by diluting the solution with 
fresh fish water, slowly decanting over the edge of the petri dish 
continuously for one minute, then repeat this procedure for a total of 
10 minutes (see Note 4).   213 
 
6.  After the rinse, allow the embryos to recover in the petri dish in an 
incubator (or a room at 28°C) until eight hpf (see Note 5). 
 
Exposure 
Waterborne exposure 
1.  Chemicals should be dissolved in fish water if possible (see Note 6).  
In  the  case  that  this  is  not  possible,  the  solvent  of  choice  for 
exposure  utilizing  the  embryonic  zebrafish  is  dimethyl  sulfoxide 
(DMSO) (see Note 7).   
2.  Pour each test solution into a 50 mL reagent reservoir, which will fit 
a multichannel pipette.  
3.  For each exposure concentration tested, use a multichannel pipette 
to fill 24 individual wells in a multi-well plate with 100 µl of chemical 
solution.  Seven concentrations and one control group can be tested 
using two 96-well plates.   
4.  At eight hpf, transfer viable, appropriately developing embryos into 
individual wells of a multi-well plate using a wide-bore glass pipette 
(see Note 8). 
5.   
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Microinjection exposure 
1.  If direct delivery of a chemical is necessary to ensure accurate dose 
delivery, embryos should be microinjected at eight hpf (see Note 9). 
2.  Align eight hpf embryos in troughs embedded in a 1% agarose plate 
filled with fish water as described by The Zebrafish Book (Akimenko, 
et al. 1995, Westerfield 1995). 
3.  Inject  each  embryo  with  2.3  nL  of  the  desired  chemical 
concentration or the appropriate vehicle control directly into the yolk. 
4.  Place each embryo into individual wells of a 96-well plate, each filled 
with 100 µl of fish water.  When directly delivering a chemical into 
the  yolk  sac,  any  concentration  above  0.1%  DMSO  caused 
developmental defects not attributed to the chemical.  If a chemical 
requires a solvent, two sets of serial dilutions should be made. The 
first  serial  dilution  should  be  100  times  higher  than  the  final 
concentration desired made with 100% DMSO. (see Note 10)  For 
the  second  set  of  serial  dilutions,  from  the  100%  DMSO  serial 
dilution, make a 1:10 dilution from the first serial dilution.  Make sure 
to have an appropriate control for each chemical, which includes the 
correct percentage of solvent used in each solution.  
5.  Incubate at 28ºC until first assessments at 24 hpf. 
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Assessment 
1.  At  24  hpf,  embryos  are  assessed  for  viability,  developmental 
progression  and  spontaneous  movements  (earliest  behavior  in 
zebrafish).   Developmental progression  is considered  perturbed if 
zebrafish  are  more  than  12  hours  delayed  compared  to  control 
animals.  Spontaneous movements are assessed over a 2 minute 
period and is considered perturbed if there is a lack of embryonic 
contractions and/or movement.    
2.  At  120  hpf,  larval  morphology  (body  axis,  eye,  snout,  jaw,  otic 
vesicle,  notochord,  heart,  brain,  somite,  fin,  yolk  sac,  trunk, 
circulation,  pigment,  swim  bladder;  Figure  A-2)  is  evaluated  and 
recorded  and  behavioral  endpoints  (motility,  tactile  response)  are 
thoroughly evaluated  in vivo.   Test for behavioral endpoints and 
then anesthetize animals for thorough morphological analysis. At the 
end of the assessments, zebrafish are euthanized with tricaine.  
3.  Evaluations  are  completed  in  a  binary  notation  (present  or  not 
present) (see Note 11). Control and chemical-exposed groups are 
statistically  compared  using  Fisher‟s  Exact  test  at  p<0.05  (Sigma 
Stat, SPSS Inc., Chicago, IL) for each endpoint evaluated (see Note 
12).           
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Notes 
1.  Methyl cellulose is unique in that it „melts‟ when cold and solidifies 
when  hot.    It  dissolves  best  in  cold  water;  however,  it  is  best  to 
disperse the powder form in warm water and then continue to mix 
while  chilling.    An  alternate  to  the  methyl  cellulose  is  Protoslo® 
(Carolina Biological Supply Company, Burlington, NC). 
2.  Eggs  can  sometimes  be  laid  and  fertilized  at  different  times  in  a 
group  spawns,  therefore  always  remove  embryos  that  are 
developing more rapidly or significantly slower prior to using them 
for an experiment. As an alternate, male and female pairs can be 
set up in several divided tanks, and the dividers can be removed at 
the same time.  The resulting stage matched embryos can then be 
pooled, prior to random embryo selection. 
3.  Do  not  bleach  embryos  is  their  chorions  are  to  be  removed  by 
pronase  digestion.    Bleaching  modifies  the  chorion  and  pronase 
treatment is completely ineffective.  In addition, when dechorinating 
embryos  it  is  essential  to  use  glass  petri  dishes.    Dechorinated 
embryos will stick to the bottom of plastic dishes and will be severely 
damaged during the procedure.  
4.  The newly dechorionated embryos are very delicate.  Water should 
be  administered  with  a  gentle  flow  and  not  directly  onto  the 
embryos.  Some of the embryos will not be out of their chorion even 217 
 
once the ten minute rinsing period is done.  More will emerge during 
the recovery period. 
5.  Once an embryo is dechorinated, do not bleach the embryos. 
6.  Chemicals or drugs that are thought to be inactive until metabolized 
to  an  active  form,  may  be  pre-exposed  to  induce  and  active 
conformation prior to waterborne exposures. 
7.  The  Sinnhuber  Aquatic  Research  Laboratory  at  Oregon  State 
University  has  demonstrated  that  an  embryo  elicited  no 
developmental deformities at 1% DMSO when waterborne-exposed 
(Usenko et al. 2007, Harper, et al. 2008, Usenko et al. 2008).  
8.  Be sure to allow the embryo to fall to the bottom of the wide-bore 
Pasteur  pipette  prior  to  touching  the  solution  in  the  wells.  If  an 
embryo  disintegrates  when  it  reaches  the  solution,  make  sure  to 
replace the solution and place a new embryo in the well. 
9.  All methods discussed are continuous waterborne exposure, but if 
no analytical method is available to determine biological uptake, an 
alternative is to directly deliver the chemical into the animal through 
microinjection.  Because embryos are transparent, tissue dose and 
distribution  can  also  be  determined  using  fluorescently  labeled 
materials and laser scanning confocal microscopy. 
10.  Make sure to vortex each microcentrifuge tube prior the next dilution 
to ensure it is a homogenous solution. 218 
 
11.  If more than 2 animals in the control group die, then the experiment 
is not valid and will need to be repeated.  Test chemicals may have 
specific targets in humans, but this target may not be completely 
conserved-structurally  in  other  vertebrate  models.    The  structural 
differences  between  vertebrates  and  humans  can  result  in  either 
false negatives or false positives.  For example, if a drug is designed 
to  target  a  human  specific structure  that  is  not  well-conserved  in 
zebrafish, upon exposure, the drug would not influence the zebrafish 
target. The effects observed when this occurs are considered false 
negatives. Vice versa, a false positive can also occur when effects 
observed due to a drug impacting a specific target expressed only in 
zebrafish,  but  this target  is not  structurally  conserved  in  humans. 
Another consideration is that chemical toxicity may be dependent on 
metabolic  activity.  False  negatives  and  false  positives  may  also 
occur if the metabolic activity in the zebrafish embryo is distinct from 
human  metabolic  activity.  It  is  possible  to  use  exogenous 
mammalian metabolic activation system to reduce false positive and 
false negatives (Busquet et al. 2008).  
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Figure A- 1. Six hours post fertilization embryos. 
a) Six hpf embryo with its chorion. b) Six hpf embryo after using pronase to 
enzymatically remove its chorion. 
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Figure A- 2. Visual assessment of zebrafish morphology. 
Images are given as examples of typical chemical-induced malformations 
observed in the zebrafish.
 
1. 120 hr mortality – dies between 24 and 120 hours post fertilization (hpf)
2. 24 hr mortality – dies before 24 hpf
3. 24 hr sp. Mov – no spontaneous movement at 24 hpf
4. 24 hr dev prog - delayed development
5. 24 hr notochord – notochord malformation (wavy notochord)
6. axis – curved or bent axis in either direction
7. brain  - brain malformations or necrosis
8. caudal fin –malformed or missing
9. circulation – no circulation or blood flow
10. eye – eyes malformed, missing or smaller/larger than normal
11. heart – heart malformation, pericardial edema (fluid around the heart)
12. jaw – malformed 
13. otic – malformed or missing
14. pectoral fin – malformed or missing
15. pigmentation – lack of pigmentation, overpigmentation
16. snout – shortened or malformed
17. somite – malformed or disorganized, missing somites
18. swim bladder inflate – failure of swim bladder to inflate
19. touch response – not responsive to touch at 120 hpf
20. trunk – short trunk, malformed or missing
21. YSE – yolk sac edema, swelling around the yolk sac
4
5
6, 18
6
7, 10
8
11, 12, 15, 16, 17, 18, 20, 21
12, 13
14
Control zebrafish 120 hpf
1. 120 hr mortality – dies between 24 and 120 hours post fertilization (hpf)
2. 24 hr mortality – dies before 24 hpf
3. 24 hr sp. Mov – no spontaneous movement at 24 hpf
4. 24 hr dev prog - delayed development
5. 24 hr notochord – notochord malformation (wavy notochord)
6. axis – curved or bent axis in either direction
7. brain  - brain malformations or necrosis
8. caudal fin –malformed or missing
9. circulation – no circulation or blood flow
10. eye – eyes malformed, missing or smaller/larger than normal
11. heart – heart malformation, pericardial edema (fluid around the heart)
12. jaw – malformed 
13. otic – malformed or missing
14. pectoral fin – malformed or missing
15. pigmentation – lack of pigmentation, overpigmentation
16. snout – shortened or malformed
17. somite – malformed or disorganized, missing somites
18. swim bladder inflate – failure of swim bladder to inflate
19. touch response – not responsive to touch at 120 hpf
20. trunk – short trunk, malformed or missing
21. YSE – yolk sac edema, swelling around the yolk sac
4
5
6, 18
6
7, 10
8
11, 12, 15, 16, 17, 18, 20, 21
12, 13
14
Control zebrafish 120 hpf225 
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Abstract 
The potential of the developing zebrafish model for toxicology and drug 
discovery is limited by inefficient approaches to manipulating and chemically 
exposing zebrafish embryos; namely manual placement of embryos into 96 or 
384 well plates, and exposure of embryos while still in the chorion, a barrier of 
poorly characterized permeability enclosing the developing embryo. We report 
the  automated  dechorionation  of  1600  embryos  at  once  at  4  hours  post 
fertilization (hpf), and placement of the dechorionated embryos into 96 well 
plates for exposure by 6hpf. The process removed ≥95% of the embryos from 
their chorions with 2% embryo mortality by 24 hpf and 2% of the embryos 
malformed at 120 hpf. The robotic embryo placement allocated 6-hpf embryos 
to  94.7  ±  4.2%  of  the  wells  in  multiple  96-well  trials.  The  rate  of  embryo 
mortality was 2.8% (43 of 1536) from robotic handling, the rate of missed wells 
was 1.2% (18 of 1536) and the frequency of multipicks was <0.1%. Embryo 
malformations  observed  at  24-hpf  occurred  nearly  twice  as  frequently  from 
robotic handling (16 of 864; 1.9%) as from manual pipetting (9 of 864; 1%). 
There  was  no  statistical  difference  between  the  success  of  performing  the 
embryo placement robotically or manually.  
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Introduction 
Toxicology  is  undergoing  a  paradigm  shift  recognized  by  the  U.S. 
Environmental  Protection  Agency  (EPA),  the  National  Toxicology  Program 
(NTP) and the National Research Council (NRC) (Schmidt EHP 2009). This is 
nowhere  more  evident  than  the  Tox21  agenda 
1,2  and  its  European 
counterpart,  the  REACH  initiative 
3,  which  will  fundamentally  rely  on  high 
throughput  screening  methods  made  possible  by  enormous  advances  in 
robotics,  digital  imaging,  computational  and  informational  tools  to  assess  a 
staggering backlog of over 60,000 chemicals now in production, for most of 
which little if any toxicology data exists. While the Tox21 vision emphasizes 
complete  transition  to  in  vitro  screening  for  toxicity  prediction,  for  the 
foreseeable  future  rapid  in  vitro  methods  will  not  eliminate  animal  toxicity 
testing,  but  serve  to  prioritize  chemicals  for  further  screening  in  animals. 
However, a bottleneck of time and money stands in the way of evaluating even 
a small fraction of the in vitro prioritized chemicals with conventional rodent 
models of human risk. A solution to the bottleneck is much faster, predictive 
animal  models  that  are  amenable  to  automation  platforms.  Zebrafish  has 
emerged as the choice for such a model. No other vertebrate is better suited 
to high throughput chemical screening 
4. 
Zebrafish  development  is  the  most  sensitive  life  stage  to  chemical 
exposure.  The  bulk  of  the  model‟s  utility,  and  hence  the  bulk  of  zebrafish 
toxicology  work,  is  centered  on  development.  Because  zebrafish  embryos 228 
 
remain  transparent  throughout  much  of  organogenesis,  adverse  effects  of 
chemical exposure on development of the brain, notochord, heart, jaw, body 
segmentation,  and  body  size  can  be  continuously  assessed  in  the  living 
animal under low magnification. An important developmental feature is that 
zebrafish embryos that are malformed, missing organs, or displaying organ 
dysfunction,  usually  survive  well  beyond  the  point  at  which  those  organs 
normally start to function. This feature is in stark contrast to rodents where 
heart  and  other  organ  malformations,  missing  or  dysfunctional  organs, 
typically cause a generalized in utero lethality. In a large scale (>1000 animal) 
rodent  screen,  such  endpoints  would  be  missed  with  anything  less  than 
Herculean efforts at detection 
4.  
As the only vertebrate model meeting the rapid, predictive toxicology 
needs  of  the  21st  century,  zebrafish  are  increasingly  used  by  public  and 
private  sector  interests  to  conduct  discovery  screens  of  chemical  libraries 
containing ≥1000 compounds (reviewed in 
5 and 
6; see also 
7-11). These same 
studies  also  highlight  near  exclusive  reliance  on  inefficient  approaches  to 
manipulating  and  chemically  exposing  zebrafish  embryos;  namely  manual 
placement of embryos into 96 or 384 well plates, and exposure of embryos 
while  still  in  the  chorion,  an  acellular  barrier  of  poorly  characterized 
permeability enclosing the developing embryo.  
Manual placement of embryos to microtiter wells is not a cost-effective 
use of laboratory personnel and, while barely feasible for screens of a few 229 
 
thousand  compounds,  is  completely  impractical  for  the  scale  needed  to 
address  the  rapidly  growing  backlog  of  conventional  and  nanomaterial 
chemistries  already  in  use.  When  working  with  dechorionated  embryos, 
manual  placement  by  humans  requires  considerably  more  refined  handling 
technique  than  embryos  in  the  chorion.  High  precision,  repetitive  motions 
necessitate many breaks for lab technicians, and the mundane nature of the 
task equates to frequent personnel turnover and inefficiencies associated with 
continual retraining.  
No chemically comprehensive assessment of chorion permeability has 
been  reported,  but  the  chorion  is  widely  suspected  to  influence  chemical 
uptake,  and  several  reports  confirm  that  it  is  an  uptake  barrier  for  metal 
nanomaterials 
12,13. Reported attempts at zebrafish chorion removal prior to 
24-hpf on a large (>100 embryo) scale have been plagued by generally low 
survival 
14, and exposure in the chorion continues to be a common practice in 
large screens. Such screens have yielded much information and potentially 
invaluable therapeutic discovery (reviewed in 
6), but it is tempting to speculate 
how much information has been missed because of permeability limitations of 
the chorion. A second, important limitation of not removing the chorion prior to 
exposure is that compounds that specifically inhibit the hatching process lead 
to secondary phenotypic responses. For example, the widely used insecticide 
cartap inhibits hatching resulting in secondary effects on the embryo such as 
wavy notochord, axis malformation, and somite defects
15. These effects are 230 
 
due to the lack of hatching, rather than a primary response to exposure to the 
chemical. The chorion can significantly confound the early life stage zebrafish 
toxicity  assay  by  leading  to false positives. When  we  consider the obvious 
potential for false negatives due to the aforementioned barrier effect, chorion 
removal is critical to improve the predictivity of the assay.  
Herein  we  report  rapid  and  cost-effective  automated  removal  of  the 
chorion from 2000 embryos at once at the 4-hpf stage, and placement of the 
dechorionated  embryos  into  96  well  plates  for  exposure  at  6hpf.  Two 
approaches were key to developing these platforms:  1) the use of pronase 
degradation of the chorion combined with automated agitation and washing of 
the  embryos,  and  2)  the  application  of  machine  vision-guided  robotics  to 
rapidly select and place the de-chorionated embryos into plate wells. A single 
station is used in our laboratory to plate >1000 dechorionated embryos per  
day, requiring approximately 4 hours and with a survival rate better than 95% 
by 120 hpf. 
 
Materials and Methods 
Zebrafish  
Embryonic  zebrafish  were  obtained  from  a  Tropical  5D  strain  of 
zebrafish (Danio rerio) reared in the Sinnhuber Aquatic Research Laboratory 
(SARL) at Oregon State University. Adults were kept at standard laboratory 
conditions of 28°C on a 14-h light/10-h dark photoperiod in fish water (FW) 
consisting  of  reverse  osmosis  water  supplemented  with  a  commercially 231 
 
available  salt  (Instant  Ocean®)  to  create  a  salinity  of  600  microsiemens. 
Sodium bicarbonate was added as needed to adjust the pH to 7.4. Zebrafish 
were group–spawned, and embryos were collected and staged as described 
by Kimmel
16. 
 
Automated Chorion Removal  
To  establish  an  inexpensive  and  highly  reproducible  method  of 
removing  chorions  from  about  1600  embryos  at  a  time  at  4  hours  post 
fertilization (hpf), a Belly Dancer shaker (ATR, Inc., Laurel, MD) was modified 
to accommodate a custom-machined, anodized aluminum shaker plate that 
holds 4 glass petri dish bottoms (100 mm x 15mm, VWR) and attached water 
delivery  tubing,  stainless  steel  nozzles  and  a  drain  port  (Figure  1).  The 
internal workings of the Belly Dancer were modified with a small pump and a 
parametric motion  controller  (Revolution  Robotics,  Inc.,  Corvallis,  OR).  The 
front panel was modified with an LED display and push button control. The on-
board pump supplied rinse water from an external heated (28
oC) carboy via 
the  tubing  and  nozzles  to  each  glass  dish  at  the  appropriate  time.  The 
movement of the shaker was controlled by the same system to deliver pulsed 
agitation  or  gentle  swirling,  precisely  when  needed,  to  dislodge  partially 
hydrolyzed chorions. The only manually performed steps were the addition of 
a pronase aliquot to commence digestion and pressing of the start button. No 
other steps were necessary to operate the device. The pronase digestion of 232 
 
the chorion was performed at 4-hpf. Approximately 2000 zebrafish Tropical 5D 
strain  embryos  were  received  from  the  Sinnhuber  Aquatic  Research 
Laboratory‟s  mass  spawning  facility  in  a  135  mm  plastic  dish  and  quickly 
cleaned by removing all dead, unfertilized or obviously abnormal embryos with 
an aspirator; a 5 – 10 minute process for a trained technician. Approximately 
400 - 500 embryos were placed in each of the 4 glass dishes in 25 ml of FW 
with  50  µl  of  50  mg/ml  pronase  (Fluka  #81748)  for  6.5  min  while  the 
dechorionator  platform  constantly  agitated.  The  pronase  was  then  flushed 
away by gently overflowing the dish with the pumped in FW for 10 minutes 
with 45 second agitation cycles separated by 15 seconds while still.  The total 
volume of fish water consumed was about 1L. After the pronase and rinse 
phases, the embryos were incubated for 20 minutes at 28
oC, agitated once 
more  to  dislodge  any  remaining  chorions  and  rinsed  again  to  remove  the 
dislodged  chorions.  The  dechorionation  was  evaluated  (Table  1)  by  gently 
removing approximately 100 embryos with a flame polished Pasteur pipette 
after  the  final  rinse  and  examination  under  a  dissecting  microscope  for 
pronase  or  mechanical  damage.  No  further  cleanup  of  the  dechorionated 
batches was performed prior to allocation to 96-well plates. 
   
Automated allocation of dechorionated embryos to 96-well plates. 
After the rest period, dechorionated embryos at approximately 5 - 6-hpf 
were  transferred  to  individual  wells  of  a  96-well  BD  Falcon,  tissue  culture 233 
 
polystyrene plate by a custom robotic pick and place system (Figure 2; video 
of  the  robotic  system  in  operation  can  be  viewed  at 
http://tanguaylab.com/Automation.html). We noted that the use of non-tissue 
culture  treated  polystyrene  plates  caused  rapid  disintegration  of  100%  of 
embryos once removed from the chorion. The system consisted of a 4-axis 
Selective Compliant Assembly Robot Arm (SCARA) (Denso Inc., Long Beach, 
CA) with a custom end-effector designed to replicate a handheld, wide bore, 
flame polished Pasteur pipette (Figure 2).  A 100 mm glass petri dish with 
approximately  400  embryos  was  loaded  into  a  well  lit  area  below  a  rigidly 
mounted  machine  vision  camera  (Allied  Vision  Inc.,  Stadtroda,  Germany). 
Custom  software  was  utilized  to  determine  the  precise  coordinates  of  a 
suitable embryo which were then passed to the robot control unit. Under the 
lighting  conditions  used,  normal  embryos  appeared  semitransparent  while 
dead embryos appeared bright white, a parameter easily distinguished by the 
machine vision. The robot was programmed to first draw 100 µl of embryo 
medium into the flame-polished pipette from a filling station at the beginning of 
each  cycle,  drive  the  pipette  to  coordinates  several  centimeters  above  the 
machine vision-selected embryo, and place the pipette tip 20 µm above the 
embryo coordinates. The embryo was gently aspirated along with an additional 
approximately 20 µl of embryo medium into the pipette via the onboard syringe 
pump, and the robot returned the pipette tip to the coordinates of the liquid 
surface of the next empty well of the plate. The wells had been prefilled with 234 
 
50 µl of embryo medium. A quick, gentle touch of the liquid surface was all 
that was required to cause the embryo to be released to the well by capillary 
action.  Positive  dispensing  pressure  was  not  needed  as  the  embryo  had 
settled to the bottom of the liquid column while the robot pivoted between the 
source plate and 96-well plate. We noted that an additional 2 - 3 µl of embryo 
medium was transferred to the well by capillary release of the embryo. The 
cycle  was  completed  with  an  aspirate  and  total  dispense  step  at  a  wash 
station and a subsequent 100 µl recharge at the filling station. The cycle was 
then repeated 95 times. Due to the affinity of dechorionated 6-hpf embryos for 
each other, the source petri dish had to be given a brief, 1 second swirl once 
during the loading of a plate to re-disperse the embryos, improving machine 
vision selection. 
 
Statistical analysis 
Performance of the robotic embryo placement was evaluated over 16 
trials in parallel with manual embryo loading of 96-well plates. The frequencies 
of successful well allocations between each method were compared by one 
way ANOVA where P < 0.05 was the threshold for no significant difference 
between the two methods.  
 
Results 
Automated chorion removal at 4 hours post fertilization 235 
 
The  performance  of  6  trials  of  enzymatic  chorion  removal  from 
approximately 1600 zebrafish embryos at once was assessed from random 
samples of about 100 embryos from each trial and summarized in Table 1. In 
each trial at least 95% of the 4-hpf embryos were successfully removed from 
the  chorion  where  success  was  defined  as  alive  at  24-hpf  with  no 
malformations evident by 120-hpf. The automated chorion removal resulted in 
only about 2% embryo mortality by 24-hpf and only 2% of the embryos were 
malformed at 120-hpf. Figure 3 depicts the type of mortal damage that 1 – 2% 
of the embryos were observed to have immediately following the automated 
dechorionation  process.    Early  damage  that  may  have  lead  to  2%  of  the 
embryos being malformed at 120-hpf was not visibly detected. 
 
Automated placement of dechorionated embryos into 96-well plates 
We  evaluated  the  success  of  robotic  96-well  loading  of  embryos 
dechorionated at 4-hpf that were 5 – 6-hpf at the time of plate loading. The 
standard  for  comparison  was  our  routine  method  of  manual  placement  of 
dechorionated  embryos  using  a  handheld  Pasteur  pipette.  Sixteen  96-well 
plate  comparisons  were  performed  in  parallel  and  the  results  were 
summarized in Table 2. The manual loading data were derived from several of 
the personnel in our laboratory who are equally adept at the technique. The 
robotic system successfully allocated embryos to 94.7 ± 4.2% of the wells and 
manual loading  successfully  allocated  embryos  to  94.9  ±  3.6%  of  the  well. 236 
 
There was no statistical difference between the success of the two methods 
(ANOVA F = 0.53; P < 0.01 that a significant difference existed). The criterion 
for success was that each well received only 1 embryo and that the embryo 
was alive and not visibly damaged or malformed at 24-hpf. We note that 2.8% 
(43 of 1536) of the unsuccessful wells were from mortality directly as a result 
of robotic handling. Mortality from manual loading accounted for 4% (62 of 
1536) of the unsuccessful wells. The robotic system missed 1.2% (18 of 1536) 
of the wells, but only one miss occurred from manual loading. The frequency 
of multipicks (2 embryos allocated to a single well) was similar for the robotic 
and  manual  loading  (3  and  2  embryos,  respectively  out  of  1536).  Embryo 
malformations observed 18 hours after plate loading (24-hpf) occurred nearly 
twice as frequently from robotic handling (16 of 864; 1.9%) as they did from 
manual pipetting (9 of 864; 1%). No bias toward dead or malformed embryos 
occurring in certain wells was ever observed. 
 
Discussion 
We have introduced automated platforms for high throughput chorion 
removal at 4-hpf and 96-well plate allocation at 6-hpf that consistently yielded 
95%  healthy  embryos.  Together,  these  automation  platforms  provide:  1)  a 
rapid and inexpensive circumventing  of the potential for false negative and 
false positive results imposed by the chorion on high throughput applications 
of the developmental zebrafish model and 2) a much less labor-intensive and 237 
 
more reliable means of carefully allocating dechorionated embryos to 96-well 
plates at a rate amenable to high throughput screening.  
This  is  the  first  report  of  an  en  masse  chorion  removal  method  for 
zebrafish embryos prior to 24 hpf, with a reproducibly high survival rate. While 
chorion removal at 24-hpf from 50-100 zebrafish embryos at once has been 
reported, initiating embryo exposure so late in development is likely to be of 
limited utility for large scale screens. Such screens lack a priori knowledge of 
compound  activity  and  must  therefore  maximize  opportunities  for  chemical 
„hits‟  by  chemically  exposing  during  the  widest  practical  window  of 
development.  A  recent  report  sought  to  quantify  the  success  of  pronase-
supported dechorionation at 6-hpf, as described by  
Westerfield 
17, for replicates of 50 embryos 
14. That study concluded that the 
use of pronase was generally damaging to 6-hpf embryos and demonstrated a 
normal development rate of only 75% and a mortality rate of nearly 40% 
14. 
Our demonstration of pronase-supported, automated chorion removal, at 4-
hpf,  from  1600  embryos  at  once,  consistently  yielded  ≥95%  survival  and 
normal development to 120-hpf indicating that a pronase-supported approach 
can  be  both  practical  and  scalable  to  meet  the  embryo  demands  of  high 
throughput screening. 
  To our knowledge this is also the first report of a reproducible method 
for robot- automated allocation of embryos to microtiter plates. A recent report 
described an image-based fluidic approach to rapid allocation of embryos to 238 
 
96-well plates 
18. Evidence of that system‟s performance was largely limited to 
the handling of embryos still in the chorion with only cursory performance data 
from dechorionated embryos. We have demonstrated the highly reproducible 
use of a small, industrial robotic arm approach to retrieve single dechorionated 
embryos at 6 – 7-hpf from an unsorted dish and allocate them to a 96-well 
plate with a better than 95% survival rate. It would also be straightforward and, 
in some instances, desirable to allocate more than one embryo per well, such 
as for monitoring subtle locomotor activity where a higher signal to noise ratio 
is achieved  with  multiple  embryos
7.  For  gross  malformation  endpoints,  one 
embryo per well minimizes the potential effects of dose titration from uptake by 
multiple animals in the same 100 µl volume. Another practical extension of the 
automation  would  be  for  sorting  transient  transgenic  reporter  animals 
fluorescing at the embryonic stage and fluorescent tagged morpholino injected 
embryos in high throughput gene knockdown assays. 
We did not include the time to complete plate loading for any of the 
robotic trials shown in Table 2, focusing instead on the ability of the modified 
SCARA  robot  to  handle  embryos  gently  with  high  survival  and  low 
malformation rates. Figure 4 summarizes the entire process with approximate 
times for completion. We note that while several variables affected the time 
required for the robotic system to complete a 96-well plate, by far the most 
important variable was density and dispersal of embryos in the source dish. 
Having  more  than  300  embryos  in  the  source  dish,  or  failing  to  keep  the 239 
 
embryos well dispersed with periodic swirling, noticeably slowed the rate at 
which  the  machine  vision  camera  and  software  could  select  a  sufficiently 
isolated embryo to map and direct the robot to retrieve. Once the source dish 
was  depleted  to  less  than  300  embryos  and  the  dispersal  was  kept  at  a 
maximum, the system consistently loaded one 96-well plate every 15 minutes. 
For comparison, laboratory personnel that perform the task on a daily basis 
consistently  loaded  one  96-well  plate  every  6  -10  minutes.  However,  three 
experienced loaders in our laboratory could only load a total of 18 - 20 plates 
before fatigue resulted in a successful loading rate of < 95% when the plates 
were observed at 24-hpf. The robotic system, facing no such limitation, offers 
an  obvious  advantage  when  throughput  demands  require  ≥200  plates  per 
week. Moreover, having developed the software for a single system, the cost 
of scaling the system to multiple SCARA robotic loading stations will be limited 
to hardware only.  
The automation platforms herein obviate persistent concerns about the 
chorion and its potential to limit the effects of chemical exposures, and they 
relieve a serious bottleneck to high throughput use of the developing zebrafish 
by  automating  embryo  allocations  to  assay  plates.  We  believe  that  these 
advances,  coupled  with  advances  in  automated  imaging  and  phenotype 
analysis, will  quickly  enable researchers to expand the scale and scope of 
toxicology and discovery research. 
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Figure  B-  1.  A  modified  shaker  platform-based  instrument  for  the 
automation of chorion removal from zebrafish embryos at 4 hours post 
fertilization. 
A) A frontal view of the modified Bellydancer shaker. The custom machined 
and anodized aluminum plate is at top and holds 4 x 100 mm glass dishes. 
The control panel consists solely of a start and a stop button, and a small LCD 
status display. B) A closer view of the shaker platform during a rinse phase of 
chorion removal.  Embryos are visible in the plates. The rinse water is pumped 
via the onboard pump from an off board heated source and delivered via the 
hose and nozzle assembly to gently overflow the plates and not suspend the 
embryos.  The  rinse  water  is  channeled  to  a  drain  port  at  the  rear  of  the 
platform.    Agitation  and  pump  control  are  via  the  custom  onboard 
microcomputer. 
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Figure  B-  2.  A  custom  robotic  station  for  the  automated  transfer  of 
dechorionated  zebrafish  embryos  from  the  dish  in  which  chorion 
removal occurred to a 96-well plate. 
A  and  B)  show  a  front  and  side  view  of  the  work  station.  An  extruded 
aluminum strut assembly rigidly supports the overhead camera. The station is 
supported from below by a steel tooling plate welded to a rigid steel table. The 
4-axis Denso SCARA robot is bolted to the tooling plate as it generates strong 
inertial forces during its movement. The syringe pump supplying the pipetting 
force is visible next to the base of the robot. Also visible are the lighted arena 
beneath the camera and the holder for the destination plate, and a second 
plate for pipette rinsing and preloading with water. C) The custom end effecter 
gently cradles a single, wide bore, flame polished Pasteur pipette connected to 
the syringe pump line. D) The lighted arena consists of an aluminum square 
with precisely located pins in the corners that serve as visible references for 
the  machine  vision  software.  The  circular  array  of  LED  units  provides  the 
optimal amount of contrast needed for the machine vision to clearly see the 
embryos. The units are commercially available, high intensity LED assemblies.  
When operating, the station is protected by a light curtain that, if interrupted, 
stops the robot‟s motion in less than 50 milliseconds.  245 
 
 
 
Figure B- 3. Mortal damage typically observed in 1 – 2% of 5-hpf 
zebrafish embryos immediately after the automated dechorionation 
process. 
The damaged embryos are indicated by arrows, all other embryos in the field 
are  normal.  Whether  the  low  frequency  damage  is  due  to  the  effects  of 
pronase digestion or motion is unknown. 
 
   246 
 
 
Figure B- 4. Process summary and timeline for automated chorion 
removal and embryo allocation to plate wells. 
Step 1, beginning at 4 hours post fertilization (hpf) consists of removal of dead 
or obviously abnormal embryos from the mass of 2000 embryos in a 135 mm 
Petri dish. It requires 5 – 10 minutes to complete the cleanup using a Pasteur 
pipette connected to a vacuum aspirator. Step 2, beginning immediately after 
1, requires the approximate division of the mass of embryos among 4; 100mm 
glass Petri dishes, the addition of a pronase aliquot to each and pressing the 
start button. The automated, gentle shaking, rinsing and rest period requires 
40 – 45 minutes. Step 3, beginning immediately after the post-dechorionation 
rest  period  and  rinse  to  remove  any  remaining  traces  of  chorion,  simply 
requires  the  movement  of  the  plate  of  400  embryos  to  the  SCARA  robot 
station and pressing the start button.  A single embryo is delivered to each of 
the 96 wells in 15 minutes.   247 
 
Table B- 1. Results of automated chorion removal at 4-hpf, observed at 
24- and 120-hpf. 
 
   
Results 
Trial date 
aEmbryos 
sampled from ≈ 
1600  Normal  
Dead at 
24-hpf 
Malformed 
at 24-hpf 
bDead at 
120-hpf 
cMalformed 
at 120-hpf 
7/18/2011  86  83  3  0  0  1 
7/25/2011  100  97  3  0  0  1 
7/26/2011  100  98  1  1  1  2 
7/27/2011  100  92  1  7  6  2 
7/28/2011  97  95  2  0  1  2 
7/29/2011  99  95  0  4  3  1 
Total  582  560  10  12  11  9 
Percent  100.0  96.2  1.7  2.1  1.9  1.5 
aThe dechorionator holds 4 x 100 mm dishes; approximately 400 embryos each from which 
roughly 100 were removed at once by Pasteur pipette after the process for evaluation.  
b Additional larval mortality at 120-hpf. Excludes mortality observed at 24-hpf 
c Additional larval malformation at 120-hpf. Excludes malformation observed at 24-hpf. 
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Table B- 2. Robotic pick & place performance on 6-hpf dechorionated zebrafish 
embryos compared to manual plate loading. 
   
Overall P&P performance  Specific P&P failures 
Trial date 
Wel
ls 
aWells allocated 
successfully 
bWells 
unsuccessful 
cP&P 
mortality 
dMissed 
wells 
eMulti-
picks 
fMal-
formed  
8/1/2011  96  86   (89.6%)  10   (10.4%)  2  5  0  3 
8/2/2011  96  90   (93.8%)  6   (6.3%)  4  0  0  2 
8/2/2011  96  93   (96.9%)  3   (3.1%)  2  0  0  1 
8/2/2011  96  95   (99.0%)  1   (1.0%)  0  0  0  1 
8/4/2011  96  85   (88.5%)  11   (11.5%)  9  0  0  2 
8/4/2011  96  91   (94.8%)  5   (5.2%)  2  1  0  2 
8/5/2011  96  88   (91.7%)  8   (8.3%)  6  0  0  2 
8/8/2011  96  87   (90.6%)  9   (9.4%)  6  0  1  2 
8/9/2011  96  89   (92.7%)   7   (7.3%)   4  2  0  1 
9/6/2011  96  95   (99.0%)  1   (1.0%)  0  1  0  _ 
9/6/2011  96  91   (94.8%)  5   (5.2%)  0  5  1  _ 
9/6/2011  96  96    (100%)  0  0  0  0  _ 
9/7/2011  96  84   (87.5%)  12   (12.5%)  8  1  3  _ 
9/7/2011  96  95   (99.0%)  1   (1.0%)  0  1  0  _ 
9/7/2011  96  95   (99.0%)  1   (1.0%)  0  1  0  _ 
9/7/2011  96  95   (99.0%)  1   (1.0%)  0  1  0  _ 
 
*  Ave = 94.7 ± 4.2% 
 
2.8%  1.2%  0.3%  1.9% 
      N = 16 trials                
   
Overall manual performance  Specific manual failures 
Trial date 
Wel
ls 
Wells allocated 
successfully 
Wells 
unsuccessful 
Manual 
load 
mortality 
Missed 
wells 
Multi-
picks 
Malfor
med  
8/1/2011
‡  96  87   (90.6%)  9   (9.4%)  6  1  1  1 
8/2/2011
‡  96  89   (92.7%)   7   (7.3%)   7  0  0  0 
8/2/2011
‡  96  87   (90.6%)  9   (9.4%)  8  0  0  1 
8/2/2011
‡  96  91   (94.8%)  5   (5.2%)  1  0  1  3 
8/4/2011
‡  96  86   (89.6%)  10   (10.4%)  10  0  0  0 
8/4/2011  96  91   (94.8%)  5   (5.2%)  5  0  0  0 
8/5/2011  96  91   (94.8%)  5   (5.2%)  3  0  0  2 
8/8/2011  96  88   (91.7%)  8   (8.3%)  6  0  0  2 
8/9/2011  96  96    (100%)  0  0  0  0  0 
9/6/2011  96  96    (100%)  0  0  0  0  _ 
9/6/2011  96  96    (100%)  0  0  0  0  _ 
9/6/2011  96  89   (92.7%)   7   (7.3%)   7  0  0  _ 
9/7/2011  96  89   (92.7%)   7   (7.3%)   7  0  0  _ 
9/7/2011  96  96    (100%)  0  0  0  0  _ 
9/7/2011  96  94   (97.9%)  2   (2.1%)  1  0  1  _ 
9/7/2011  96  95   (99.0%)  1   (1.0%)  1  0  0  _ 
   
Ave = 94.9 ± 3.6% 
 
4.0%  _  0.2%  1.0% 
      N = 16 trials                
*Robotic performance was not different from the overall success of manual loading   (F = 0.53; P < 0.01) 
aWell allocation is placement of one dechorionated 6-hpf embryo. 
bAn unsuccessful well allocation (errors 
c-e) was determined immediately after the trial and at 24-hpf for 
f. 
cEmbryo dead, usually partly or completely disintegrated, immediately after trial 
dEmbryo or disintegrated residue absent from well immediately after trial.                                                                
eMore than one embryo allocated to the same well 
fMalformations observed at 24-hpf; not recorded 9/6-9/7 
‡Lower apparent performance success of earlier trials reflects the performance of earlier software versions.  
 
 